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A myriad of previous research has suggested that circulating tumor cells (CTCs) can 
adhere to the blood vessel wall to eventually extravasate and form secondary tumors in 
a step-wise process similar to the leukocyte adhesion cascade. These steps require the 
cell, whether CTC or leukocyte, to bear specific surface proteins which can form 
transient interactions with E- and/or P-selectin expressed on the inflamed endothelium. 
These interactions facilitate initial cell tethering and rolling which lead to firm cell 
adhesion and extravasation. However unlike leukocytes, CTCs can originate from 
various primary sites, e.g. breast, colon, lung, prostate, etc. Moreover, cancer cells 
from each particular site (and possibly even varying from each person with cancer) 
can exhibit unique phenotypic expressions of selectin ligands. Briefly from the cell 
lines studied here, COLO 205 (colon cancer) cells abundantly expressed E-selectin 
ligands and established stable cell rolling on E-selectin surfaces, however, this cell 
line proliferates in two separate populations with a differential degree of E-selectin 
 binding capabilities. The MDA-MB-231 cell line (breast cancer) expressed E-selectin 
ligands, yet only interacted with E-selectin surfaces with cytokine treatments. The rare 
childhood eye cancer, retinoblastoma (RB), was found to metastasize without the 
expression of E-selectin ligands. The mechanism for the RB cell extravasation from 
the blood stream may proceed via the initial tethering of RB cells to circulating 
leukocytes where the RB:leukocyte aggregate adheres to the inflamed endothelium. 
Lastly, the ZR-75-1 cell line (breast cancer) also stably rolled on E-selectin surfaces 
largely due to the novel E-selectin ligand MUC1. The underglycosylated form of 
MUC1 was found to facilitate cell tethering when interacting with P-selectin, achieve 
stable cell rolling when interacting with E-selectin, and even produce firm cell 
adhesion events when interacting with intercellular adhesion molecule 1 (ICAM-1). 
Indeed, the challenge of CTC treatment is a major obstacle even when limited to the 
aspect of selectin ligand expression and cell adhesion to the endothelium. Fortunately, 
selectin:ligand based devices explored here and by other researchers may offer a 
viable method to capture CTCs from patient blood for further study and possible 
personalized treatments. 
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CHAPTER 1 INTRODUCTION 
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The adhesion and extravasation of circulating tumor cells (CTCs) facilitate the 
dissemination of tumor cells and eventually secondary tumors. The detection of 
circulating tumor cells is recognized to hold great potential in cancer prognosis and 
follow up, yet the basic biophysics of how these cells interact with the endothelium is 
not fully understood. Formation of metastases by invasive transformed cells accounts 
for 90% of all deaths in cancer patients.268 Interactions between CTCs and the 
endothelial lining of the vasculature are mediated by a variety of cell adhesion 
molecules that facilitate tethering and arrest of blood borne cancer cells to the blood 
vessel wall as the initial step in the growth of a metastatic tumor.  
 The mechanism of leukocyte recruitment from the bloodstream to diseased or 
inflamed tissue sites can be described as a multistep leukocyte adhesion cascade239, 177 
and has been extensively studied over the past two decades.34, 244 The cascade begins 
with capturing events (or tethering) of neutrophils from the bloodstream and 
subsequent neutrophil rolling along the endothelial layer34, 244 followed by firm 
adhesion or arrest and ultimately transendothelial migration into the tissue.247 
Recently, slow rolling, adhesion strengthening, intraluminal crawling, and paracellular 
and transcellular migration have been included in the cascade as additional steps.157 
Both tethering and rolling are mediated by selectins, a family of adhesion molecules 
presented by stimulated endothelial cells,149,150 and represent the first contact between 
leukocytes and the adhesive ligand (counter-receptor)-bearing endothelial cells.176, 273, 
243  
 Hydrodynamic shear force in the bloodstream has been found to control the 
leukocyte adhesion cascade. When exposed to physiologic shear stress in the 
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circulation, leukocytes can undergo passive deformation or cell flattening.63 Cell 
flattening is the greatest when cells contact the surface and has been correlated with an 
increase of contact surface area, which also increases the adhesion force of leukocytes 
to the surface.118, 124, 46 Moreover, substantial leukocyte microvilli stretching and 
tethering has been observed by neutrophils perfused over a P-selectin surface.231 The 
effect of shear forces on microvilli deformation was hypothesized to play a major role 
in facilitating cell adhesion dynamics234 and was supported by computational 
results.133 Furthermore, mechanical forces regulate the expression, distribution, and 
conformation of adhesion molecules present on leukocytes and the endothelial layer153, 
152, 163, 210 as well as the adhesion kinetics with their ligands.71, 95, 282 Therefore, shear 
forces are very important to the regulation of leukocyte recruitment. 
 Similar to leukocyte recruitment, tethering and rolling of CTCs to the blood 
vessel wall are also mediated by the selectin family.23, 100 Colon carcinoma cells have 
been demonstrated to slowly roll over vascular endothelium in vivo in a selectin-
dependent manner.126 For leukocytes, firm adhesion to inflamed endothelium is 
mediated by leukocyte beta-2 integrins (Mac-1, LFA-1) binding to endothelial 
intercellular adhesion molecule-1 (ICAM-1).55, 58 Similarly, for epithelial-type CTCs, 
the mucin MUC1 may play the role of beta-2 integrins, by binding to ICAM-1 to 
enable firm adhesion and eventually extravasation.216 Hydrodynamic shear force is 
also involved in regulating the interactions between cancer cells and the endothelium. 
Recently, the adhesion dynamics of CTCs under shear flow has been utilized to isolate 
and target CTCs using selectin-functionalized molecular surfaces.218 The leukocyte 
adhesion cascade and CTC tethering, rolling, and firm adhesion on the endothelium 
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indeed share many paradigms, as summarized in Figure 1.1.    
 
1.1 GLYCOPROTEIN GLYCOSYLATION AND CANCER PROGRESSION  
Complex carbohydrates, also referred to as glycans, are crucial components of the cell 
membrane and are present in the form of three major groups of glycoconjugates: 
glycoproteins, comprising a polypeptide covalently bonded to a carbohydrate moiety; 
glycosaminoglycans, glycans present as free polysaccharides or as part of 
proteoglycans; and glycosphingolipids, consisting of oligosaccharides glycosidically 
linked to ceramide, reviewed by Fuster and Esko.76 Cellular glycans are connected to 
proteins and lipids via a highly regulated post-translational modification called 
glycosylation that produces abundant and diverse glycoconjugates.201, 220 More than a 
decade ago, Apweiler et al. made the prediction that more than half of all eukaryotic 
protein species are glycoproteins based on the SWISS-PROT protein sequence data 
bank.9   
 A glycosphingolipid (GSL) is minimally defined as a monosaccharide bound 
to a ceramide backbone, though the structure of most GSLs is generally more 
complex. Glycosylation of a GSL begins with the addition of either a glucose or 
galactose residue to the ceramide creating glucosylceramide and galactosylceramide, 
respectively. Additional sugar units are then added in a stepwise fashion. 
Glucosylceramide is commonly combined with a galactose to form lactosylceramide. 
The addition of sugar units is very ordered and is facilitated by specialized enzyme 
families (i.e. fucosyltransferases, glucosyltransferase, galactosyltransferase, 
sialyltransferase).271 
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 The role of GSLs in signal transduction has been well studied (reviewed by 
Hakomori),94 but more recently, work has been done to distinguish the role in selectin-
mediated adhesion of cancer cells to vascular endothelium. GSLs were first shown to 
adhere to E-selectin through the use of flow chamber dynamic flow assays.274, 32 In 
past studies, GSLs are predicted to have a redundant role supporting the adhesion 
facilitated by glycoprotein selectin ligands.148,30 For instance, both inhibitors of GSL 
glycosylation and protease enzymes decreased the adhesion of colon carcinoma 
cells.33 However, work done by the Burdick lab has suggested that in head and neck 
squamous cell carcinoma GSLs, rather than glycoproteins, are the primary E-selectin 
ligands. (Wood et al, unpublished/in review). In addition, GSLs have been shown to 
play a critical role in the induction of the epithelial to mesenchymal transition (EMT) 
in mouse mammary cells.92 Because EMT is hypothesized to be a pivotal step in 
metastasis (reviewed by Micalizzi et al.),179 understanding the role GSLs play in the 
CTC adhesion cascade may be critical to understanding the overall metastatic process.  
 In order to identify and characterize the specific glycoproteins serving as 
ligands for the selectins, researchers use a variety of scientific approaches. These 
include, but are not limited to, gel electrophoresis, microarrays, and mass 
spectrometry. Two-dimensional electrophoresis (2-D electrophoresis) separates 
protein species based on two characteristics. Proteins are first separated based on 
isoelectric point (pI) and then on size. The gel can then be stained with silver and 
analyzed for density of each species. Alternatively, individual protein spots can be 
excised and extracted from the gel and subjected to further analysis. Mass 
spectrometry utilizes an electron beam that fractionates the proteins. The result is 
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charged fragments of proteins. Each fragment is assigned a mass to charge ratio (m/z). 
The combination of all the m/z values of a protein is the fingerprint. Proteins of 
interest can be analyzed using mass spectrometry and the resulting fingerprint can be 
compared to a library of known proteins in order for identification of the protein of 
interest.172 In order to study protein-protein interactions, many researchers utilize 
protein microarrays. Multiple species of proteins are printed onto a glass slide and the 
slide is then incubated with another protein or antibody and the resulting interactions 
are observed by colorimetric, fluorescent, or other detection methods. In addition, 
antibodies can be printed on a glass slide and the slide can then be incubated in a 
patient’s serum. The serum can then be probed for known cancer markers.245  
 Glycosylation occurs via two different pathways: O-glycosylation, where N-
acetylgalactosamine is attached to the O-terminus of serine or threonine residues of 
glycoproteins and N-glycosylation, glycosidic bonds that connect N-
acetylglucosamine and the N-terminus of asparagine residues of glycoproteins.52 It has 
been shown that glycosylation on the tumor cell surface changes during malignant 
transformations and that these altered glycans mediate key pathophysiological events 
during tumor progression.76, 270 Specifically, glycan alterations include the lack of 
expression and/or over-expression of certain structures, persistence of incomplete or 
truncated structures, accumulation of precursors, and the appearance of novel 
structures.270 Furthermore, tumor cells are found to express a unique repertoire of 
glycans. However, correlating the alterations of specific glycans to tumor cell 
proliferation is difficult in part due to the pleiotropic effects of prevalent N-
glycosylated glycoproteins. Examples of glycan families involved in tumor 
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progression include growth and proliferation, tumor invasion, metastasis, and 
angiogenesis and have been reviewed in-depth by Fuster and Esko.76 
 The roles of O-linked glycans and mucins in cell differentiation, regulation of 
cell growth through apoptosis, and proliferation have been extensively studied.77, 208 
O-glycosylation occurs frequently on secreted or membrane-bound mucins that are 
rich in serine and threonine.220 Moreover O-glycans, including Lewis antigens, are 
involved in the adhesion and invasion of cancer cells and are often altered and highly 
sialylated in cancer cells.25,182 Therefore, similar to leukocytes, glycosylation is 
necessary to facilitate cancer cell adhesion and rolling, which are initial steps in 
metastasis.  
 
1.2 METASTATIC CASCADE: ADHESIVE RECRUITMENT OF CANCER 
CELLS VIA SELECTINS 
Selectins are receptors for a variety of O-glycosylated ligands and mediate transient 
adhesion of cells to the endothelium. These receptor:ligand interactions represent the 
first contact of cancer cells to the endothelial wall, which facilitates tethering and 
rolling events.88, 125, 100, 23, 264 Furthermore, there is a wealth of evidence correlating 
metastatic potential to selectin mediated events of cancer cells. In particular, highly 
metastatic cancers, such as colon carcinoma and acute myeloid leukemia, abundantly 
exhibit E- and P-selectin ligands.73, 80 E- and P-selectin deficient mice have been 
shown to form fewer lung metastases from the highly metastatic colon cancer HT29,11 
and E-selectin specifically, has been proven crucial to the metastasis of colon cancer 
through the vascular wall.39 These cancer cells have also been shown to slowly roll 
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over vascular endothelium in vivo in a selectin-dependent manner.84 Therefore, similar 
to the leukocyte adhesion cascade, also initiated with cell tethering and rolling via 
selectin mediated interactions, cancer cells displaying selectin ligands are potentially 
involved in a ‘cascade’ of events that eventually lead to metastasis, i.e. the metastatic 
cascade.23 
 It is believed that tumor cells can not only interact with endothelial cells but 
also form multicellular complexes with platelets and leukocytes, which can then arrest 
in the microvasculature of distant organs, and eventually extravasate and establish 
secondary tumor sites.114, 116, 78 Borsig et al. used P- and L-selectin double deficient 
mice to demonstrate in vivo that the two selectins work synergistically to facilitate 
cancer metastasis and that L-selectin on leukocytes has a role in facilitating metastasis, 
following the interactions of platelets with tumor cells mediated by P-selectin.20 
Various types of cancer cells have been found to highly express ICAM-1, a cell 
surface adhesion protein that can mediate leukocyte firm adhesion through interaction 
with the CD11/CD18 adhesion complex.123, 101, 225, 170  
 Tumor cells have been reported to undergo extensive interactions with host 
cells including polymorphonuclear cells (PMNs).161 Such interactions between cancer 
cells and PMNs together with the normal interactions between PMNs and endothelial 
cells have been observed in breast cancer, advanced gastric cancer, colon cancer, and 
malignant melanoma,283, 159, 214 and could play important roles in cancer cell 
transendothelial migration under physiological flow conditions,160,238 although the 
mechanism remains unclear. To address this, Liang et al. examined the molecular 
interactions between endothelial cells, PMNs, and melanoma cells under defined 
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hydrodynamic shear conditions and found that PMN-facilitated melanoma adhesion to 
endothelial cells is shear dependent.160 The shear-rate dependency can be explained by 
the cell aggregation of PMN and melanoma cells through the binding of CD11/CD18 
adhesion complex and ICAM-1, which suggests a mechanism for receptor-ligand 
mediated leukocyte-tumor cell interactions. Recently, our group discovered that 
ABCG2+ stem-like retinoblastoma cells (RB143 and WERI-Rb27) preferentially 
express ICAM-1, which can support the heterotypic aggregation of retinoblastoma 
cells with PMNs in the bloodstream following the same mechanism mentioned above.  
A step-wise binding mechanism in which the leukocytes and retinoblastoma cells first 
interact and form small aggregates, roll on the E-selectin surface, and firmly adhere to 
the endothelial layer has been proposed.83 Interactions between selectin ligands and 
fibrin have also been shown to play an important role in cancer cell metastasis. Work 
done by the Konstantopoulos group has shown that CD44 expressed on colon cancer 
cells is the main receptor for fibrin, and that the CD44v-fibrin interaction dominates at 
low shear rates due to the increased interaction time between the two molecules.7,8,253 
In addition, fibrin has also been shown to be a bridging molecule between PMNs and 
CTCs, allowing for cancer cell-leukocyte aggregation.290   
 A group of important glycosylated ligands consist of oligosaccharides that bear 
sialic acid, fucose, and sulphate at the tips of O-linked glycans. These ligands are 
recognized by all three members of the selectin family: E-, P-, and L-selectin 
(reviewed in Ref 141). Sialic acids are terminal monosaccharides attached to cell 
surface glycoconjugates and play important roles in many physiological and 
pathological processes.89 Lewis type blood group antigens, a class of the ligands 
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described above, consist of the tetrasaccharide sialyl Lewis x (sLex; NeuAc α2,3 Gal 
β1,4 [Fuc α1,3] GlcNAc-R), built on galactose, N-acetylglucosamine and fucose, and 
its isomer sialyl Lewis a (sLea; NeuAc α2,3 Gal β1,3 [Fuc α1,4] GlcNAc-R), as 
illustrated in Figure 1.2.121, 269, 27 Over a decade ago, researchers found that tumor cells 
overexpress sLex or sLea on their surface glycoproteins or glycosphingolipids in lung, 
colon, gastric, and pancreatic carcinomas.20, 269, 127 The production and overexpression 
of sLex on tumor cells may be caused, in part, by transcripts of core 2 GlcNAc-T, an 
O-glycan that harbors sLex found to increase in human colon carcinomas.236  
 It is worth noting that the fucose modules of the sialy Lewisx/a motifs are 
crucial for their functions,164 requiring fucosylation that is catalyzed by 
fucosyltransferase enzymes, or FUTs. Each FUT has a distinct function and tissue 
expression pattern.49,167 Among the nine already discovered human FUT genes, six 
FUTs (FUT3-6, FUT7, and FUT9) were found to be involved in the synthesis of sialyl 
Lewis x (sLex).13 Our group demonstrated that colon and prostate cancer cells possess 
unique FUT s that are distinct from those required by hematopoietic cells and 
therefore can be targeted therapeutically without compromising immune function.106 
The adhesive interactions between endothelial selectins and their ligands on cancer 
cells were recreated by perfusing cancer cells through microtubes coated with human 
recombinant E-selectin. FUT3 siRNA was delivered with a novel flow-based method 
using P-selectin-conjugated nano-liposomes.109 At a physiological range of wall shear 
stress, the number of cancer cells recruited to the microtube surface (rolling/adherent) 
decreased dramatically after FUT3 knockdown, indicating the essential roles of FUTs 
in selectin mediated cell adhesion.106  
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 To date, a myriad of ligands for the three selectins both on leukocytes and on 
cancer cells have been discovered. Selectins have been found to interact with sLex and 
related sequences decorating P-selectin glycoprotein ligand 1 (PSGL-1), E-selectin-
ligand-1 (ESL-1), CD44, CD34, and mucosal addressin cell adhesion molecule 
(MadCAM) presented on leukocytes.121, 57, 213, 17, 250, 248 PSGL-1, first found on the tips 
of microvilli on leukocyte cell surface, is one of the main physiological ligands for 
leukocytes and one of the most characterized ligands, which binds to all three selectins 
with different affinities. PSGL-1 is a sialylated, mucin-like homodimer that displays 
mostly O-linked glycans. It was found to possess at least one sulfated tyrosine residue 
at the N- terminus of the molecule.185, 199, 278, 212 As described above, mucins bearing 
sLex/a structures on cancer cells may also function as significant selectin ligands. 
Interestingly, cancer cells also share multiple well established selectin ligands with 
leukocytes, including ESL-1 and PSGL-1, first identified on human metastatic prostate 
cancer cells.56 Aigner et al. have identified and characterized another mucin like 
glycoprotein as a ligand for P-selectin. Human CD24 on a breast (KS) and a small cell 
lung carcinoma (SW-2) cell line, both negative for PSGL-1, were found to bind to P-
selectin under static conditions.3 Using the parallel flow chamber assay, they 
confirmed the physiological role of CD24 as a ligand for P-selectin on KS cells in the 
presence of shear stress.84 Later, Myung et al. reported the role of CD24 on MCF7 
breast cancer cells as a ligand for E-selectin under flow191 by measuring the binding 
kinetics of CD24 with E-selectin with surface plasmon resonance (SPR). The 
identification of CD24 as a ligand for both P- and E-selectin may provide better 
understanding of the adhesion and invasion mechanisms of metastatic breast cancer.  
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 Recently, carcinoembryonic antigen (CEA) and CD44 variant isoforms have 
been shown to cooperate in mediating colon cancer cell adhesion to L- and E-, but not 
P-, selectin under physiological flow.158, 35 Thomas and coworkers also observed 
sialofucosylated glycoprotein(s) mediated selectin binding in CD44-knockdown cells 
and identified podocalyxin-like protein (PCLP) as an alternative selectin ligand using 
immunoaffinity chromatography and tandem mass spectrometry.271 Shirure et al. have 
also shown that gangliosides, groups of glycosphingolipids on BT-20 and MDA-MB-
468 breast cancer cell lines, function as E-selectin ligands that mediate adhesion to 
activated endothelium.284 In a 1997 review, Varki stated that selectins could also 
recognize nonsialylated or nonfucosylated molecules such as heparan sulfate 
glycosaminoglycans, sulfated glycolipids such as sulfatides, and sulfoglucuronosyl 
glycosphingolipids.269 Recently, it was also discovered that E-selectin binding to the 
breast cancer cell line 4T1 is restricted to sLex or closely related structures while P-
selectin binding can involve a varied group of compounds, including Ca2+ independent 
but sulfur dependent, heparinase/chondroitinase sensitive binding to non-Lewis 
structures, implying that P-selectin ligands on the surface of the 4T1 cells are mostly 
heparin sulfate/chondroitin sulfate proteoglycans.183 These non-sialylated P-selectin 
ligands could play a crucial role in tumor cell migration.  
 
1.3 EFFECTS OF FLUID MECHANICAL FORCES ON GLYCOPROTEIN 
MEDIATED CELL ROLLING AND ADHESION  
The intravascular environment can dramatically alter tumor cell functionality and 
viability. In particular, blood circulation creates hydrodynamic shear forces and can 
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cause cell deformation and activation of signaling cascades. In the case of the 
colorectal carcinoma cell lines, HT116, shear stress causes an increase in cell 
proliferation and expression of the transforming growth factor beta 1 and plasminogen 
activator inhibitor-1 genes.119 Interestingly, B16 melanoma cell viability significantly 
decreased when exposed to physiological shear stress over a time frame of minutes to 
hours.26 Likely, this type of cell death is caused by mechanical damage to the cell 
membrane.5 Under physiologic flow conditions, glycoproteins and glycolipids have 
been found to mediate adhesion to the vascular wall33 and, therefore, shear forces help 
facilitate cancer cell rolling and adhesion in a manner similar to the leukocyte 
adhesion cascade. The physical interactions of cancer cells with their 
microenvironment and their modulation by mechanical forces have been shown to 
play crucial roles in the metastatic process, reviewed by Verdier et al. and Wirtz et 
al.272,279   
 Much effort has been made to develop numerical models to describe the 
important cellular and molecular scale mechanisms of cell rolling. For example, Dong 
and coworkers described the importance of shear flow and cell deformability in cell 
rolling mechanics using both an in vitro experimental system and numerical 
simulation of cell rolling with the finite element method. In their study, the Hookean 
spring model with a deterministic kinetic equation was used to simulate receptor-
ligand interactions under hydrodynamic force. They found that cell 
deformation/flattening causes fewer disturbances to the flow and therefore reduces the 
overall shear stress on the cell surface.61, 62  
 Jadhav and coworkers developed a 3-D computational model that simulated 
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receptor-mediated rolling of a deformable cell on a ligand-coated surface in a linear 
shear field.115 In this model, parameters were chosen to describe PSGL-1-mediated 
leukocyte rolling on a P-selectin- decorated planar surface, where the motion of an 
elastic capsule near a plane in a linear shear field was simulated. The model 
successfully predicted the degree of cell deformation at a given shear rate and that the 
cell-substrate contact area decreases with increasing cell membrane stiffness.  
 One of the most popular and effective methods to simulate specific adhesive 
interactions between model cells and surfaces under shear flow is adhesive dynamics 
(AD), developed by Hammer and coworkers.96 Bond formation and breakage 
stochastically correspond to the association and dissociation rates, respectively, of the 
binding receptors and ligands. The basic idea is that adhesion molecules can be 
modeled as compliant springs, shown in Figure 1.3, and the kinetics of single-bond 
failure described by the Bell model.14  
 𝑘! =   𝑘!! exp 𝑟!𝐹 𝑘!𝑇  
 
This model has been successful in mapping out a state diagram for an idealized 
spherical, rigid cell with adhesion molecules randomly distributed about its surface, 
linking different adhesion dynamics to mechanochemical properties of the adhesion 
molecules. Furthermore, experimentally measured values of mechanochemical 
properties of selectins were found to self-consistently fall within the rolling regime of 
the state diagram.41 Recently, deformable microvilli parameters were added to this 
model by Caputo and coworkers.36 The deformation was predicted to significantly 
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influence the rolling behavior of leukocytes, an observation also seen in 
experiments.206 Using this updated AD model, our group investigated whether force-
dependent L-selectin shedding is necessary for L-selectin-mediated neutrophil rolling 
under flow conditions.151 It was verified with AD simulations that L-selectin is 
cleaved from the neutrophil surface during rolling under hydrodynamic shear flow, 
shown in Figure 1.3, in agreement with previous experimental work.229 A comparison 
of an updated state diagram and an adhesive dynamics model without microvilli41 
suggests that deformable microvilli decrease the impact of the reactive compliance on 
adhesion. Another variant combines Stokesian dynamics,22 utilizing a Langevin 
equation for hydrodynamic and thermal forces, and adhesive dynamics.142  
 As the importance of cell-cell collisions and hydrodynamic interactions is being 
recognized in the adhesive recruitment of cells to surfaces, researchers are now aware 
of several such mechanisms that contribute to the rate of cell recruitment in 
concentrated systems that lead to differences between in vitro and in vivo 
observations.6, 275 To address this, King and Hammer developed a novel computational 
approach to simulate cell adhesion to surfaces in a dense multicellular environment, 
called multiparticle adhesive dynamics (MAD).132, 131, 135, 130 Fusing a stochastic Monte 
Carlo simulation of single receptor-ligand bonds and calculations of concentrated 
suspension flow at low Reynolds number, MAD simulations predict the accelerated 
recruitment of leukocytes to inflamed endothelium caused by multicellular 
hydrodynamic interactions and were verified both in vitro132, 131 and in vivo.134, 136 
With this success, the MAD program has been expanded to include viscoelastically 
deformable cells, highly parallel implementations, and intracellular signaling leading 
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to cell activation.144 To characterize the dynamics of circulating tumor cells traveling 
along the endothelium, the interaction constants between tumor cells and the 
endothelium and their relationships with velocity or loading rates need to be 
investigated. 
 Our group has developed a selectin-mediated and flow-based platform 
technology to capture and enrich cell subpopulations. Mirorenathane (MRE) tubes 
with an inner diameter of 300 µm were coated with human recombinant endothelial 
selectin and connected to a pressure driven syringe pump and cell sources. A 
population of hematopoietic stem and progenitor cells (HSPC) from human bone 
marrow that express CD34 were isolated when perfused over P-selectin coated 
microchannels.281 These P-selectin functionalized microtubes were also used to purify 
CD45+ mature mononuclear blood cells without alteration of surface phenotypes, 
which have practical use in the fields of transplantation, regenerative medicine, and 
gene modification.195 To date, few methods exist to reduce blood borne metastatic 
load.  The existing methods, although effective, rely on filtration of patient blood 
through extracorporeal devices, which cause patient discomfort and require very 
frequent hospital visits.209, 66, 74, 222, 192 To address this, our group demonstrated a novel 
biomimetic method to capture CTCs in flow via adhesive interactions with endothelial 
selectins and induce apoptotic signals with tumor necrosis factor (TNF) related 
apoptosis-inducing ligands (TRAIL).59 Compared with cancer cells treated under static 
conditions, rolling cells on the selectin coated surface under flow conditions showed a 
much greater apoptotic population.59 This selectin-based technology has the advantage 
of capturing viable CTCs that can be further characterized by releasing the bound CTC 
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in the absence of calcium.138 Recently, E-selectin-mediated adhesive interactions were 
utilized inside an E-selectin coated polydimethylsiloxane (PDMS) microbubble 
system to capture COLO 205 cells under flow conditions.1 The COLO 205 cells 
trapped inside the microbubbles were allowed to proliferate and form tumor spheroids 
for drug toxicity studies.   
 
1.4 MUC1 AND CANCER METASTASIS  
Another class of glycoproteins is the mucin family of high molecular weight 
macromolecules. Mucins are normally associated with secreted mucus that provides 
lubrication between the lumen and cell surfaces and adhere to the epithelial layer for 
protective purposes.107, 99 Generally, mucins can be divided into gel-forming, 
transmembrane, and soluble categories which are summarized in depth elsewhere.99, 
215 Briefly, gel-forming mucins contain cysteine-knot and von Willebrand factor 
domains, as well as cysteine-rich tandem repeat regions which aid in the formation of 
oligomers. Transmembrane mucins contain transmembrane domains which connect 
the mucins to the cell surface. Soluble mucins lack any of the aforementioned domains 
and are generally smaller than the mucins in the previous categories. All mucins, 
however, are structurally similar due to their serine, threonine, and proline rich 
domains. These domains are normally in the variable tandem repeat regions.  
Therefore, a major hallmark of the mucin family is the ability to be heavily ‘sugar-
coated’ via multiple O-glycosylation sites.38, 97 
 In regards to cancer, transmembrane mucins are by far the most prevalent.215 
Of particular importance is the MUC1 glycoprotein due to its abnormal over-
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expression in nearly all types of cancer. MUC1 is normally expressed in mammary 
(MUC1 was first isolated from human milk79), respiratory, female reproductive, 
gastrointestinal, middle ear, and salivary glandular surfaces79, 24, 154, 223, 28 and in the 
pancreas.171, 258 It has been found to be over-expressed in breast, ovarian, lung, 
pancreatic, prostate, gastric, and colorectal cancers221, 31, 86, 4, 292 where the high 
expression generally correlated with greater mortality rates.259, 65, 139, 93, 168  
 MUC1 is expressed aberrantly on cancer cells in two ways: variant glycoforms 
and its location on the cell surface. The tandem repeat region of MUC1 consists of 25-
150 repeat units of 20 identical amino acid sequences rich in serines and threonines, 
which have a high propensity for O-glycosylation. With respect to the normal MUC1 
glycosylation, MUC1 on cancer cells exhibit fewer glycosylated sites as well as 
shortened oligosaccharides;162 both factors lead to the exposure of the core protein, as 
shown in Figure 1.4.29,60 Interestingly for pancreatic and colon tumors, glycoforms of 
MUC1 containing the sLea and sLex oligosaccharides,31 and the increased detection of 
MUC1 carrying sLex/a have been linked to poor prognosis in patients with lung 
adenocarcinoma.113 The second way MUC1 is abnormally expressed is in its uniform 
distribution across the cancer cell surface.128, 292 Normally, MUC1 is localized at the 
apical border of epithelial cells.   
 There are different hypotheses for the functional role of MUC1 and cancer 
progression. First, mucins are primarily thought to have lubricating and protective 
purposes.292, 128, 257, 285 A study of the MUC1 responses to oxidative stress suggests that 
MUC1 can protect the cancer cell from cell death via reactive oxygen species.285  
Using atomic force microscopy, another recent study indicated that mucin O-
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glycosylation could act as a mechanical barrier, limiting the cytotoxic effects on a 
multidrug resistant ovarian cell line.276 Secondly, since MUC1 glycoforms contain 
several selectin interacting O-glycans (e.g., sLex and sLea), it is reasonable to postulate 
that MUC1 can facilitate cell adhesion via carbohydrate:selectin interactions.  In fact, 
despite the anti-adhesive role of MUC1 on normal cells, E-selectin:MUC1 interactions 
have been reported.289, 288, 69 In particular, the MUC1:E-selectin interaction has been 
shown to be shear dependent and an order of magnitude more efficient than CD43.69 
Furthermore, for epithelial-type CTCs (e.g., from breast, prostate), MUC1 may play 
the role of beta-2 integrins, by binding to ICAM-1 to enable firm arrest and 
transendothelial migration.216 Recently, kinetic off-rates of monovalent and 
multivalent interactions between MUC1 epitope and antibody were measured using 
dynamic force spectroscopy, providing therapeutic opportunities to target the MUC1 
core epitope. In conclusion, the mucin family, specifically MUC1, may be important 
factors in cancer progression either as a protective role and/or as a cell adhesion 
facilitator, which enhances the cancer cell metastatic cascade.   
 This thesis will discuss four different types of E-selectin mediated interactions 
between cancer cells and the endothelial adhesion molecules in the context of 
metastasis. In Chapter 2, a dynamic COLO 205 population switch presenting unique 
molecular differences as well as E-selectin functionalized microbubbles as a 
microfluidic system for 3D tumor spheroid culturing will be discussed. Chapter 3 will 
cover the effect of human plasma and pro-inflammatory cytokines on increasing the 
adhesiveness of highly metastatic MDA-MB-231 breast cancer cells. Chapter 4 will 
describe an alternative metastatic cascade where E-selectin ligand lacking 
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retinoblastoma cells form aggregates with circulating leukocytes and subsequently 
establish rolling and adhesion on E-selectin coated surfaces. In Chapter 5, MUC1, a 
novel ligand for E-selectin and ICAM-1 will be characterized using ZR-75-1 and 
MCF7 breast cancer cells. The future work section includes plans for animal models to 
validate the in vitro cell based results as well as the development of non-invasive 
prenatal diagnostic tools to isolate selectin ligand and EpCAM expressing fetal 
trophoblasts in circulation.  
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Figure 1.1: Cell adhesion cascade and representative selectin ligands for both 
leukocyte and cancer cells. The leukocyte adhesion cascade and CTC tethering, 
rolling, and firm adhesion on the endothelium share many paradigms. Most of the 
selectin ligands on leukocytes except L-selectin are also present on cancer cells. 
Recently, novel ligands on cancer cells have been observed to facilitate selectin-
mediated rolling on the endothelium. 
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Figure 1.1: A schematic of the leukocyte and cancer cell adhesion cascade 
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Figure 1.2: Selectins only bind to glycosylated ligands. Selectin molecules require 
glycosylation in order to bind to a receptor. As shown in the above figure, CTCs will 
not interaction with the vascular endothelium unless their membrane proteins (or 
lipids) are glycosylated. The insert in the right panel shows the addition of sLex, a 
typical glycosylation found on CTCs, to a membrane protein. 
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Figure 1.2: A schematic of selectins binding to glycosylated ligands 
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Figure 1.3: The adhesive dynamics simulation of cell adhesion under flow. (A) 
Schematic of the model system: a rigid spherical cell is covered with a random 
distribution of adhesion molecules, with the appropriate counter-receptor molecules 
randomly placed on the wall. Individual molecular bonds are modeled as compliant 
springs. Bonds are randomly formed and broken subject to the appropriate kinetics 
that depend on the instantaneous force loading determined by the bond endpoints. The 
cell slowly rolls forward due to the hydrodynamic force and torque exerted by the 
surrounding fluid flow.137 (B)-(F) Instantaneous cell rolling velocity in AD simulations 
and experiments at a shear rate of 400 s-1, (B) the average instantaneous velocity of 
five rolling cells in simulations; (C) a rescaled graph of (B) matching to y-axis with 
(D)-(F); (D)-(F) the experimental instantaneous rolling velocity of individual 
neutrophils on a sLex coated flow chamber surface.151   
Reproduced with permission from Ref. 85 and 95.   
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Figure 1.3: A schematic of the adhesive dynamics simulation of cell adhesion 
under flow 
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Figure 1.4: Involvement of the mucin family in selectin-mediated tumor cell-
endothelium interactions. Only the tandem repeat regions are depicted for both MUC1 
and MUC4. Compared to the common E-selectin ligands such as PSGL-1 and ESL-1, 
both mucins are longer (~four times) and display more glycosylated sites, with MUC4 
being much longer than MUC1. Carcinoma associated mucins usually involves 
aberrant localization and underglycosylation (represented by the missing glycans on 
some of the side branches in this illustration).  
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CHAPTER 2 DIFFERENTIAL ADHESION AND CAPTURE OF 
COLORECTAL CANCER CELLS MEDIATED BY E-SELECTIN  
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2.1 DYNAMIC SWITCH BETWEEN TWO ADHESION PHENOTYPES IN 
COLORECTAL CANCER CELLS  
2.1.1 INTRODUCTION 
Colorectal cancer is one of the most frequent human tumors, which can metastasize to 
liver, lung, and peritoneum. Significant intratumoral genetic heterogeneity has been 
demonstrated in advanced colorectal carcinoma, indicating the importance to re-
evaluate the use of genetic markers for prognosis.10 Reduction or loss of E-cadherin 
that mediates homotypic cell-cell adhesion has been shown to promote the progression 
of several carcinomas including colorectal cancers.112, 117, 200, 203 This reduced cell-cell 
adhesiveness permits cells to deviate from normal cell growth patterns, resulting in the 
destruction of histological structures. As an important member of the cadherin family, 
the cytoplasmic domain of the Ca2+ dependent transmembrane glycoprotein E-
cadherin regulates the structural and signaling activities required for adhesion through 
interactions with β-catenin, α-catenin and plakoglobin (γ-catenin).255 Wnt signal 
mediated tyrosine phosphorylation of β-catenin has been established as an important 
regulatory mechanism behind cytoplasmic protein stabilization as the phosphorylated 
protein has less affinity to both the APC/GSK-3/Axin complex and E-cadherin.47  
Metastasis is a complex and highly organized process that involves a series of 
distinct steps.198 The formation of metastases by invasive transformed cells accounts 
for 90% of all deaths in cancer patients.277 To form secondary tumors, cancer cells 
must invade the surrounding tissue and enter either the bloodstream or the lymphatic 
system.  Similar to the leukocyte adhesion cascade which is initiated via cell 
tethering and rolling through selectin mediated interactions, cancer cells displaying 
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selectin ligands are potentially involved in a series of events that eventually lead to 
metastasis, i.e. the metastatic cascade.82, 111, 158, 202 
Following intravasation, selectins can interact with a variety of O-glycosylated 
ligands and, in turn, mediate the transient adhesion of cells to the endothelium.  
These receptor-ligand interactions represent the first contact between cancer cells and 
the endothelial wall, which facilitates tethering and rolling events.88 Sialic acids are 
terminal monosaccharides attached to cell surface glycoconjugates and play important 
roles in many physiological and pathological processes.89 Over a decade ago, 
researchers found that tumor cells overexpress sialyl Lewis x (sLex) or sialyl lewis a 
(sLea) on their surface glycoproteins and/or glycosphingolipids in lung, colon, gastric, 
and pancreatic carcinomas.20 sLex-bearing human colon adenocarcinoma cell lines 
including COLO 205 and LS174T have been shown to undergo extensive adhesive 
interactions with E- and P-selectin under flow conditions.1, 98 Recently, we utilized the 
interaction between E-selectin ligands and human recombinant E-selectin to localize 
COLO 205 cells into functionalized microbubbles under flow to initiate the growth of 
tumor spheroids.1   
The human colon carcinoma cell line COLO 205 was established from the 
ascetic fluid of a male patient with poorly differentiated colorectal carcinoma by 
Semple et al.233 Interestingly, this cell line has a unique morphological character in 
that it grows simultaneously in both adherent and suspended states in culture. We have 
observed that when separated, both suspended and adherent populations of COLO 205 
generate their counterpart populations and re-establish an equilibrium ratio over time.  
In this study, we examined the kinetics of this phenomenon and investigated the tumor 
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heterogeneity between the COLO 205 adherent and suspended populations and 
biochemical factors that modulate this equilibrium ratio.  
 
2.1.2 MATERIALS AND METHODS 
Cell Line and Cell Culture 
The COLO 205 cell line was obtained from ATCC (American Type Culture 
Collection, Manassas, VA). Gibco® RPMI media (Life Technologies, Grand Island, 
NY), supplemented with 10% Fetal Bovine Serum (Life Technologies), 100 IU/mL 
penicillin and 10 µg/mL streptomycin (Life Technologies) was used as growth media. 
Cells were cultured in BD FalconTM 75 cm2 cell culture flasks at 37ºC in an incubator 
supplied with 5% CO2. To collect the adherent COLO 205 cells, enzyme free 
dissociation buffer (Life Technologies) was added after removing the suspended 
population. 90% cell viability was confirmed with trypan blue dye exclusion using a 
hemocytometer.  
 
Cell Population Assay 
Adherent and suspended populations of COLO 205 cells were separated and deposited 
in 6-well plates. At time points 0, 0.5, 1, 2, 4, 6, and 8 hr, cells were collected and 
counted as described above. In separate experiments, adherent and suspended COLO 
205 cells were separated and labeled with Cell Tracker Green and Orange (Life 
Technologies, Grand Island, NY), respectively. The adherent green cells were then re-
plated at 0.2 million cells per well in a 12-well plate and allowed to reach an 
equilibrium adherent:suspended ratio for 8 hr. Likewise, the suspended orange cells 
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were re-plated at the same concentration and equilibrated for 8 hr. The suspended and 
adherent populations for both the green and orange cultures were separated again.  
Finally, the orange suspended cells were deposited into the wells containing only the 
green adherent layer. The numbers of orange and green cells in the suspended and 
adherent layers were counted from 500 µL cell solutions of each population using a 
flow cytometer every 2 hr for 10 hr, to assess the rate of phenotype “flip-flop”.  
 
Reverse Transcription 
Total RNA from COLO 205 suspended and adherent cells was prepared and purified 
separately using RNeasy Plus Mini kit (Qiagen). The 40 µL reverse transcription 
reaction system includes 10 µg of total RNA, 1 µL of M-MuLV Reverse Transcriptase 
(New England Biolabs), 0.5 µL of RNase Inhibitor (New England Biolabs), 1 µL of 
Random Primers (Invitrogen), 2.5 µL of dNTP Mix (New England Biolabs) and 4 µL 
of MuLV Reverse Transcriptase reaction buffer (New England Biolabs). The reaction 
mixture was incubated inside the RT-PCR (Bio-Rad) instrument at 42º C for 1 h, 
followed by an inactivation step at 95º C for 10 minutes. 
 
Real-Time Quantitative PCR (Qpcr) 
10 ng of cDNA produced by the reverse transcription of total RNA was used in each 
quantitative PCR reaction. Also included in the 20 µL qPCR reaction system were 10 
µL iQTM SYBR Supermix (Bio-Rad), 1 µL of 2 µM forward primer and 1 µL of 2 µM 
reverse primer and nuclease free water.  
Primer for β-catenin qPCR (product size: 166 bp) 
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5’-GAAACGGCTTTCAGTTGAGC-3’ (Forward) 
5’-CTGGCCATATCCACCAGAGT-3’ (Reverse) 
Primer for GAPDH qPCR (product size: 170 bp) 
5’-AGAGCACAAGAGGAAGAGAGAGAC-3’ (Forward) 
5’-AGCACAGGGTACTTTATTGATGGT-3’ (Reverse) 
qPCR reactions were carried out in 96 well real-time PCR plates (Bio-Rad) using a 
Bio-Rad MyIQ Real-time PCR detection system. The qPCR reaction included 5 min at 
95º C to activate the polymerase and 50 PCR cycles (uncoupling step at 95º C for 20 
seconds followed by annealing step at 59º C for 20 sec and elongation step at 72º C for 
30 seconds), followed by a melting temperature analysis to test for any nonspecific 
amplification. All the qPCR reactions were performed in triplicate. The expression 
level of β-catenin gene in each cell population was normalized to the expression level 
of the standard gene GAPDH.  
 
siRNA Transfection 
β-catenin siRNA was purchased from Applied Biosystems (Silencer® pre-designed & 
validated siRNA, ID: s436). LipofectamineTM RNAiMAX (Invitrogen) reagent was 
used to transfect the COLO 205 cells with β-catenin siRNA as described by the 
manufacturer.  
 
E-Cadherin Coated Bead Incubation  
Protein A coated polystyrene beads (500 µL, 1% w/v, Spherotech, Lake Forest, IL) 
were first incubated with 2 mL of 50µg/ml mouse anti-human E-cadherin monoclonal 
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antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) on ice for 45 minutes. 
Conjugated beads were washed once with 1 mL PBS and then resuspended with 500 
µL of fresh media. 250 µL of bead-containing media was added to COLO 205 cells 
cultured in 6-well plates and incubated for 2 hr at 37ºC before cell counting and 
mRNA analysis.  
 
Flow Cytometry 
Adherent and suspended populations of COLO 205 cells were separated, washed with 
1X DPBS, and resuspended in 1X DPBS with 1% BSA to a final concentration of 
200,000 – 300,000 cells in each sample.  Antibodies or appropriate isotype controls 
were added to cell suspensions and incubated over ice for 45 min.  Following the 
incubations, the cells were washed three times with 1 mL of 1X DPBS to remove any 
unbound antibody. Flow cytometry samples were analyzed using an Accuri C6 flow 
cytometer (Accuri Cytometers Inc., Ann Arbor, Michigan, USA) and plots were 
created using the FCS Express package.  
 
Proteome Profiler Assay 
Human Phospho-kinase Antibody array kit (R&D systems) was used to analyze the 
phosphorylation profiles of several key kinases and their protein substrates in both the 
adherent and suspended COLO 205 cells. Adherent and suspended cells were 
separated, washed in ice cold PBS buffer, and pelleted before adding the lysis buffer 
provided with the array kit. Total protein concentrations were determined by Bradford 
colorimetric assay (Bio-Rad). The nitrocellulose membranes provided with the kit 
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were processed and developed as per the manufacturer's instructions.  
 
Immunoblotting 
Whole cell lysate from both subpopulations was freshly made using RIPA lysis and 
extraction buffer. The lysate protein concentrations were measured using Bradford 
assay (BioRad). SDS-PAGE was performed using 7.5% polyacrylamide gels and 
proteins were transferred to a nitrocellulose membrane, incubated with primary 
antibodies against β-catenin (Biolegend) and β-actin (Santa Cruz Biotechnology) 
overnight at 4º C. Goat anti-rabbit IgG-HRP (Santa Cruz Biotechnology) and rabbit 
anti-mouse IgG-HRP (Abcam) were used as secondary antibodies.  
 
Cell Rolling Assay 
Microrenathane tubing with 640 µm internal diameter (Braintree Scientific) was cut to 
a length of 50 cm, functionalized with Protein G (10 µg/mL) and Fc chimera E-
selectin (20 µg/mL, R&D), and blocked with 5% BSA or milk (Sigma). 
Functionalized microtubes were then secured to the stage of an Olympus IX81 
motorized inverted microscope (Olympus America, Melville, NY).  A CCD camera 
(model no: KP-M1AN, Hitachi, Tokyo, Japan) and DVD recorder (model no: DVD-
1000MD, Sony Electronics) were used to record experiments for offline analysis. 
Adherent and suspended COLO 205 cells were separated and suspended in flow buffer 
at 1 x106 cells/mL and perfused through protein coated microtubes using a syringe 
pump (KDS 230, IITC Life Science, Woodland Hills, CA) at a wall shear stress of 1.0 
dyn/cm2.  
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qPCR Profiling of EMT-Associated Genes 
RNA was extracted from adherent and suspended cells by TRIZOL method. First 
strand cDNA was synthesized using the Invitrogen first strand cDNA synthesis kit. 
Qiagen EMT PCR array including qPCR primers for signature genes during EMT was 
performed in the Biorad iQ quantitative PCR machine to compare gene expression 
exhibited by the two populations using the 2-ΔCt method. Gene expression was 
normalized to the housekeeping genes GAPDH and β-actin.  
 
Plasma Isolation and Treatment 
Whole peripheral blood was drawn from informed consenting healthy donors by 
venipuncture into BD Vacutainer tubes. Collected whole blood was centrifuged for 25 
min at 500 rpm. The plasma layer on top was carefully removed without disturbing the 
interface and passed through a sterile 0.2 µm filter. 50% of the isolated plasma 
supplemented culture media was used to culture COLO 205 cells at 2 x 105 cells/well 
in 6-well plates prior to experiments.   
 
2.1.3 RESULTS 
Separation of Adherent and Suspended Subpopulations Resulted in the Re-
Establishment of the Equilibrium Ratio 
When cultured in monolayers, COLO 205 cells grow simultaneously in both adherent 
and suspended states. While the adherent COLO 205 cells grow in small aggregates 
(2-dimensional islands), the suspended population grows as individual cells. To 
separate the two populations, suspended cells were collected and plated in a new 
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culture flask while fresh media was added to the original flask containing the adherent 
population. Cell counting and viability assay were performed using trypan blue dye 
and a hemocytometer at various time points including 0, 0.5, 1, 2, 4, 6, and 8 hr.  
Interestingly, each flask initiated with either all adherent or all suspended cells was 
observed to re-establish an “equilibrium ratio” of 70% adherent cells to 30% 
suspended cells within 8 hr, as shown in Figure 2.1. A simple mathematical model was 
formulated to approximate the kinetics for the adherent (A) and suspended (S) cells to 
re-establish the equilibrium ratio:   
!"!" =   −𝑘!𝐴 + 𝑘!𝑆      (1) 
 𝐴 + 𝑆 = 𝑁   𝑇𝑜𝑡𝑎𝑙  𝑛𝑢𝑚𝑏𝑒𝑟  𝑜𝑓  𝑐𝑒𝑙𝑙𝑠             (2) 
 𝑎𝑡  𝑒𝑞𝑢𝑖𝑙𝑖𝑏𝑟𝑖𝑢𝑚,%  𝑎𝑑ℎ𝑒𝑟𝑒𝑛𝑡  𝑐𝑒𝑙𝑙𝑠 = 𝐴!" 
 𝑑𝐴𝑑𝑡 = 0 
 0 = − 𝑘! + 𝑘! 𝐴!" + 𝑘!𝑁      (3) 
 
The above differential equation gives the general solution,  
 𝐴 = 𝑐!𝑒! !!!!! ! + 𝑐! (4) 
with initial conditions  
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𝑡 = 0,𝐴 = 𝐴!, 
yielding the solution 𝐴 = 𝐴! − 𝐴!" 𝑒! !!!!! ! + 𝐴!" (5) 
 
The best-fit solution to this simple model was compared with the experimental data in 
Figure 2.1, and shows excellent agreement, implying that the phenotypic switch can be 
approximated with first-order kinetics. These simplified approximations suggest that 
the changes in gene and protein expressions which cause the dynamic population 
switches could occur within 30 min. 
 
Dynamic Switching Between the Suspended and Adherent Cells Occurred Rapidly and 
Reaches Equilibrium Over Time 
The adherent and suspended cells were separated and labeled with CellTracker green 
and CellTracker orange dyes, respectively. To determine whether the existence of two 
subpopulations was maintained by a dynamic switch between the two states, the 
labeled cells were plated separately at the same seeding density. After they reached the 
previously observed equilibrium ratio (time to reach equilibrium ratio was determined 
by previous experiments to be 8 hr), the suspended layer from the originally 
suspended population (in orange) was added to the adherent layer of the originally 
adherent type (in green). As shown in Figure 2.2, after 2 hr, a significant number 
(~30%) of orange suspended cells were identified in the adherent layer (since the 
percentage of orange cells in the suspended population was 70%) and ~15% of green 
adherent cells were identified in the suspended layer (since the percentage of green 
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cells in the adherent population was ~85%), indicating that the cells dynamically 
switched from one population to the other. At t=4 hr there was an increase in the 
percentage of orange and green cells in the suspended and adherent populations 
respectively, indicating that some cells that had switched from one state to the other at 
t=2 hr switched back again. After t=6 hr both populations stabilized with ~70% of 
orange cells in the suspended state (30% being in the adherent state) and ~85% of the 
green cells in the adherent state (~15% in the suspended state).  Taken together, our 
results indicate that there is a dynamic switch between population states to reach an 
approximate equilibrium ratio of 7:3 (adherent:suspended).  
 
Phosphorylated Kinases are Upregulated in the Suspended Population 
Relative phosphorylation levels of 12 key kinases and their protein substrates in both 
adherent and suspended COLO 205 cells were measured. As depicted in Figure 
2.3(A), 9 out of 12 key kinases were found to be expressed at relatively elevated levels 
in the suspended COLO 205 cells compared to their adherent counterparts, among 
which the phosphorylation of β-catenin showed the greatest increase. The overall 
increase in the kinase phosphorylation activity in suspended cells can be explained by 
their significantly higher β-catenin gene expression (Figure 2.3(B)) and excessive Wnt 
responsive gene activity such as C-myc. The increased phosphorylation of β-catenin 
protein observed in the suspended cells is also expected to reduce their binding affinity 
to both E-cadherin and APC, causing the suspended cells to detach and form 
individual cells in suspension. Increased kinase phosphorylation activity has also been 
recently reported to inhibit integrin mediated cell-ECM interactions.242 
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Suspended Cells Show Increased Expression of Β-Catenin and Decreased Expression 
of E-Cadherin 
Immunoblotting results, shown in Figure 2.3(C), indicated that the total (surface + 
intracellular) β-catenin protein expression was elevated in the suspended COLO 205 
cells. Furthermore, flow cytometry results indicated that suspended cells express less 
E-cadherin and more phosphorylated β-catenin compared to adherent cells (Figure 
2.3(D) & (E)).  
 
Manipulation of Β-Catenin and E-Cadherin Expression Result in Increased Number of 
Adherent Cells 
An average 75% decrease in β-catenin gene expression as measured by qPCR was 
achieved by treating COLO 205 cells with β-catenin siRNA. As a result of the 
significant decrease in β-catenin gene expression, the equilibrium ratio between 
adherent and suspended cells (7:3) shifted towards the adherent state, to a measured 
ratio of 9:1 (Figure 2.4). This increase in the COLO 205 adherent cell population 
suggests that β-catenin may play a role in its own gene regulation, in addition to being 
an important linker protein in E-cadherin mediated cell-cell interactions. It was 
observed that the β-catenin siRNA was not able to completely abolish β-catenin 
mRNA expression, leaving enough β-catenin and reduced Wnt signaling to assist the 
β-catenin:E-cadherin complex mediated homotypic cell aggregation.102, 197 Likewise, 
incubating COLO 205 cells with E-cadherin antibody coated microspheres, thereby 
externally forcing cell-cell adhesion, was also found to induce a significant increase in 
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the adherent cell fraction, shifting the ratio to 9:1 (Figure 2.4 and inset). Furthermore, 
β-catenin gene expression decreased by 45% in these artificially clustered cells 
compared to control.  
 
Suspended COLO 205 Cells Express More Sialyl Lewis Acids and Show Significantly 
Stronger Interaction with E-Selectin Coated Surfaces under Physiological Shear 
Stress  
To further explore the population transition in COLO 205 cells, a flow based adhesion 
assay was used to investigate the adhesion phenotypes of both adherent and suspended 
populations. As shown in Figure 2.5(C), suspended COLO 205 cells were found to 
have a rolling velocity of 1.52 ± 0.05 µm/s under 1 dyne/cm2 shear stress, significantly 
slower than the adherent cells rolling at 2.10 ± 0.04 µm/s, indicating a more adhesive 
phenotype on the E-selectin coated surfaces. Compared to adherent cells, suspended 
cells were found to have elevated sLex and sLea expression by 60% and 80%, 
respectively (Figure 2.5(A) and (B)).  
 
Human Plasma Induces a Pro-Suspension Population Shift and Increased Β-Catenin 
Expression  
To assess whether COLO 205 cells may behave differently once they have entered the 
bloodstream, human plasma was isolated from healthy donors and added to the culture 
media. Interestingly, as shown in Figure 2.6(A) and (B), the majority of COLO 205 
cells shifted to the suspended state, leaving significantly fewer adherent cells 
compared to control conditions with area of fluorescence quantified in Figure 2.6(C). 
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Plasma-treated COLO 205 cells were also found to have greater expression of CD44, 
an E-selectin ligand, and phosphorylated β-catenin (Figure 2.6 (D) and (E)). 
 
Suspended Cells Show Increased Expression of Several EMT-Associated Genes 
The adherent-to-suspended transition is reminiscent of the epithelial-to-mesenchymal 
transition (EMT), which is characterized by a loss of cell adhesion and increased cell 
invasion in many cancers. Several EMT-associated genes were found to be 
upregulated in the suspended cells by qPCR. Notably, mRNA of fibroblast growth 
factor binding protein 1 (FGFBP1), matrix metalloproteinase-2 (MMP-2) and secreted 
protein that is acidic and rich in cysteine (SPARC) were >3-fold higher in suspended 
COLO 205 cells, as shown in Figure 2.7.  
 
2.1.4 DISCUSSION 
Cancer metastasis is a complex process involving a series of steps. The motivation for 
this study was based on our discovery of distinct adherent and suspended COLO 205 
populations that consistently equilibrate to a 7:3 ratio (adherent-to-suspended) over 8 
hr. Furthermore, results from Cell Tracker dye labeling revealed that COLO 205 cells 
dynamically switch from one subpopulation to the other while maintaining the same 
7:3 ratio.  
The expression levels of phosphorylated kinases show that many kinases and 
their protein substrates are relatively more active in the suspended cell population 
compared to the adherent population. This is consistent with previous studies which 
suggest that the phosphorylation of proteins correlates with the mesenchymal 
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phenotype of tumor cells.227, 50 Two of the widely studied markers of epithelial and 
mesenchymal phenotypes are E-cadherin and β-catenin, respectively.21 Flow 
cytometry results reveal that adherent cells express more E-cadherin, while suspended 
cells express more phosphorylated β-catenin.  
Manipulation of the β-catenin gene and surface E-cadherin expression in 
COLO 205 cells resulted in a shift in the population ratio with an increased number of 
adherent cells. Transfecting siRNA against β-catenin in COLO 205 cells shifted the 
adherent:suspended equilibrium ratio from 7:3 to ~9:1. Similarly, by introducing E-
cadherin monoclonal antibody coated microbeads to the cell culture, the equilibrium 
ratio was also altered to ~9:1 and β-catenin gene expression was found to decrease by 
50%. Taken together, these results suggest an interesting concurrent ‘inside-out’ and 
‘outside-in’ regulatory system, where the decrease in β-catenin gene expression within 
these cells as well as the externally induced elevation of E-cadherin surface expression 
are both able to drive an increase in the adherent:suspended population ratio.   
Interestingly, suspended COLO 205 cells were also found to roll on E-selectin 
at a significantly slower velocity under physiologically relevant shear stresses when 
compared to the adherent cell population. This suggests that if given the chance to 
intravasate into the blood vessel, the suspended cell population may establish stronger 
interactions with the inflamed endothelium.  Recent studies from our group reported 
that blood plasma triggers an adhesive phenotypic switch of breast cancer cells on E-
selectin coated surfaces under flow by upregulating E-selectin ligand and glycan 
expression.39, 81 In this study, similarly, plasma treatment was found to elevate CD44 
expression for COLO 205 cells, in addition to inducing a preferential shift from the 
  45 
adherent to the suspended cells, suggesting a more invasive phenotype with stronger 
interaction with the inflamed endothelium. Furthermore, upregulation of 
phosphorylated β-catenin expression was also observed. The dynamic population 
switch observed in this study suggests a potential mechanism which increases the 
likelihood of extravasation of the circulating tumor cells from the bloodstream to 
develop secondary tumor sites.  
Several EMT-associated genes including FGFBP1, MMP-2 and SPARC are 
upregulated in suspended COLO 205 cells. FGFBP1 and MMP2 have been previously 
shown to be upregulated in metastatic colorectal cancers relative to normal colon 
epithelia.205, 256 As a mesenchymal cell marker, SPARC expression has been identified 
during breast cancer EMT which correlates with a basal-like phenotype.228 In contrast, 
transforming growth factor beta 1 (TGFB1) was downregulated in the suspended 
population of COLO 205 cells compared to the adherent population. As TGFB1 is 
considered to drive EMT through both paracrine and autocrine signaling,230 its 
transient upregulation in the adherent COLO 205 population may induce EMT and 
thus promote the transition to the suspended state. These results strongly suggest that 
the transition from the adherent to the suspended state creates cells that express both 
mesenchymal-like phenotype and genotype from a cell line of epithelial origin and 
may be considered EMT-like.   
 
2.1.5 CONCLUSION 
The colorectal cancer cell line, COLO 205, uniquely proliferates as adherent and 
suspended populations where cells can dynamically switch from one population to the 
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other while maintaining a constant 7:3 (adherent-to-suspended) equilibrium population 
ratio. The suspended population expressed significantly more phosphorylated β-
catenin and less E-cadherin compared to the adherent population. “Inside-out” 
manipulation, β-catenin siRNA knockdown assays, and “outside-in” manipulation, 
introduction of E-cadherin coated microspheres, both shifted the equilibrium 
population ratio to 9:1. Therefore, the expression of β-catenin and E-cadherin regulate 
the proliferation and switching of COLO 205 cells as two distinct populations. 
In the context of metastasis, the suspended COLO 205 population represents a 
more invasive phenotype. Suspended cells expressed 60% more sLex and 80% more 
sLea than adherent cells which resulted in significantly slower rolling velocities on E-
selectin coated microtubes. Moreover when cells were cultured in human plasma, the 
expression of phosphorylated β-catenin increased, shifting the majority of cells into 
the suspended population where sLex and E-selectin ligand CD44 expression both 
increased as well. Upregulation of the EMT markers FGFBP1, MMP-2 and SPARC 
within the suspended population suggests mesenchymal-like cells and therefore a 
much more aggressive population. Future studies could focus on the regulation of 
phosphorylated β-catenin or E-cadherin to control the aggressiveness of colorectal 
cancers to help prevent metastases.  
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Figure 2.1: COLO 205 adherent and suspended population reformation and 
stabilization. Adherent and suspended cells were separated and re-plated in fresh 
RPMI media (data referred to as ‘originally adherent’ and ‘originally suspended’) The 
originally adherent and suspended culture flasks were monitored over 8 h by 
performing cell count at 0.5, 1, and 2 h intervals and the fraction of adherent cells in 
all conditions was plotted against time. A simple ODE model was derived for the 
adherent fraction as a population balance on adherent and suspended cells.  Solutions 
to the ODE model were plotted for the best-fit model parameters of k = 0.5 h-1 
(enough time to allow changes in gene and protein levels) and Aeq = 0.7.  
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Figure 2.1: COLO 205 adherent and suspended population reformation and 
stabilization 
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Figure 2.2: Dynamic population switch. (A)-(C) Dynamic switch between the 
adherent and suspended COLO 205 population. (D) Percentage of orange cell tracker 
dye labeled cells in the suspended layer (SUS) and green cell tracker dye labeled cells 
in the adherent layer (ADH) over 10 hours.  
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Figure 2.3: Differential protein and gene expression between the adherent and 
suspended COLO 205 cells. (A) Phosphorylation levels of COLO 205 adherent and 
suspended cells. (B) Relative β-Catenin gene expression comparison between the 
adherent and suspended population. Suspended cells have an average of 2.5 fold 
higher β-Catenin expression. (C) Immunoblotting of β-Catenin protein expression in 
the two populations. (D) and (E) Flow cytometry plots of anti-E-cadherin and anti-
phophorylated β-Catenin antibody labeling. Isotypes, suspended population, and 
adherent population were colored in grey, blue, and red respectively.  
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Figure 2.3: Differential gene and protein expression between the adherent and 
suspended COLO 205 cells 
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Figure 2.4: Gene expression change of β-catenin and population switch after siRNA 
transfection and microsphere incubation. β-catenin gene expression was reduced after 
treating the overall COLO 205 population with siRNA. A 20% increase in the 
adherent cell fraction was observed. In a separate study, the overall COLO 205 cell 
population was incubated with E-cadherin antibody coated microspheres, which 
induced an increase in the adherent cell fraction and a 50% decrease in β-Catenin gene 
expression.   
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Figure 2.4: Gene expression change of beta-catenin and population switch after 
siRNA transfection and microsphere incubation 
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Figure 2.5: Differential ligand expression and adhesion profile of adherent and 
suspended COLO 205 cells. (A) and (B) Flow cytometry histogram plots of COLO 
205 adherent (red) and suspended (blue) cells labeled with anti-sLex and anti-sLea 
mAbs. Isotype controls are shown in grey. (C) Rolling velocity analysis of adherent 
(red) and suspended (blue) under 1 dyn/cm2 shear stress. *** p<0.0001 
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Figure 2.5: Differential ligand expression and adhesion profile of adherent and 
suspended COLO 205 cells 
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Figure 2.6: Phenotypic changes of COLO 205 cells induced by plasma treatment. (A) 
and (B) Immunofluorescence images of the adherent cells after culturing in control 
and 50% plasma supplemented media, respectively. Cells were pre-incubated with 
fluorescently conjugated cell tracker dye prior to plating. (C) Quantification of the 
relative area of fluorescence with Image J. Two-tailed Student t-test was performed for 
statistical analysis. P = 0.008 (D) and (E) Flow cytometry histogram plots of CD44 
expression on cell surfaces and intracellular phosphorylated β-catenin expression on 
the control (blue) and plasma treated (red), respectively. Isotype control was also 
performed and shown in grey.  
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Figure 2.6: Phenotypic changes of COLO 205 cells induced by plasma treatment 
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Figure 2.7: Real-time PCR of EMT-associated gene expression was performed in 
both suspended and adherent populations. mRNA expressions with >3-fold change 
include FGFBP1, MMP2, SPARC and TGFB1. The fold difference is shown in both 
graph and table below after normalizing to expression level in the adherent cells.  
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Figure 2.7: EMT-associated gene expression of the 
adherent and suspended COLO 205 cells 
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2.2 CONTINUOUSLY PERFUSED MICROBUBBLE ARRAY FOR 3D 
TUMOR SPHEROID MODEL 
* This section is adapted from the following publication: S. Agastin, U. T. Giang, Y. 
Geng, L. A. DeLouise and M. R. King. Biomicrofluidics. 5:024110, 2011 
 
2.2.1 INTRODUCTION 
Considering the rising costs of developing new anticancer therapies, it is of prime 
importance to develop efficient, inexpensive, and high throughput anti-cancer therapy 
testing systems, which more realistically mimic complex in-vivo solid tumor 
pathophysiological conditions. The conventional method to screen therapies and drug 
targets is to first culture the tumors cells in suspension and/or monolayers. However, 
recent work has shown that many new therapies and drug targets lose their efficacy 
when applied in 3D tissue environments, despite their promising results when tested 
on tumor cells cultured with conventional methods.11  
Multicellular tumor spheroids (MCTSs) represent a complexity level beyond 
monolayers of cells in which hypoxic and necrotic cells are surrounded by highly 
aggressive, metastatic cells.  This tumor spheroid structure more closely resembles in 
vivo tumors, which provides insights into the growth of tumors as well as the 
complexity of the tumor microenvironment. To date, tumor spheroids have been used 
in cancer research for several decades and have contributed to our current 
understanding of cancer biology.  They have been investigated in the contexts of 
experimental radiotherapy, photodynamic treatment, hyperthermia, and target specific 
chemotherapy and immunotherapy.53, 54, 64, 187, 232 Moreover, recent studies have shown 
that the gene expression profiles,19, 224 growth kinetics, and metabolic rates224 of 
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MCTSs are similar to clinical conditions and hence, are believed to mimic in vivo 
solid tumors in their response to new drug targets and immunological factors. 
Therefore, MCTSs could help eliminate less efficient cancer drugs and therapies in 
earlier stages of testing before they enter expensive animal testing, and promote 
innovative drug targets that would otherwise fail in the traditional drug screening 
assays.   
Commonly used culture techniques to create tumor spheroids include the 
hanging drop method,122, 263 the liquid-overlay technique,37 and the gyratory rotation 
technique.254 In the hanging drop method, spheroids are grown in hanging drops 
placed on an inverted microplate. In the liquid-overlay technique, cells are grown on 
culture plates covered with a thin film of agar, preventing cells from attaching to the 
surface so that individual cells can grow into aggregates or spheroids. In the gyratory 
rotation technique, trypsinized cells are cultured in a stirred flask, thus preventing 
them from adhering to the substrate and favoring cell-cell interactions. All these 
techniques have disadvantages such as the formation of unequal sized spheroids, long 
cultivation time, inaccessibility for testing in the growth platform, and difficulty to 
adapt to high throughput screening platforms. Current efforts to develop new systems 
are underway using modern microfabrication techniques to generate uniformly sized 
spheroids over shorter time frames.75, 193, 226 Our group recently reported the growth of 
homogenously sized 3D melanoma aggregates in microbubble compartment arrays266 
that were fabricated using polydimethylsiloxane (PDMS) gas expansion molding.85  
MCTSs are a frequently used in vitro model of avascular tumor growth and the 
physiological tumor microenvironment. Avascular tumors occur at early stages of 
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tumor growth in which nutrients from the blood are obtained by the tumor mass only 
through its outer surface as blood vessels are not yet formed within. Similar conditions 
occur again when the tumor progresses into a metastatic state and cells escape and 
migrate to a new location. The continuous perfusion culture enables one to recapitulate 
the tumor microenvironment with realistic concentration gradients and establish 
physiologically relevant drug profiles in the exposed spheroids.   
In this study, we exploit the microbubble technology and develop a simple 
microfluidic device to maintain uniformly sized tumor spheroids in an array format.  
Tumor spheroids are created and allowed to proliferate under flow condition in this 
device, mimicking in vivo avascular tumor conditions and are accessible for imaging 
and analysis.   
 
2.2.2 MATERIALS AND METHODS 
Cell Culture 
Colon cancer COLO 205 cell line (ATCC number CCL-222) and breast cancer cell 
line MDA-MB-231 (ATCC number HTB-26) were obtained from ATCC (Manassas, 
VA). COLO 205 and MDA-MB-231 cell lines were maintained in RPMI 1640 
(Sigma) and DMEM media respectively with 10% (v/v) fetal bovine serum and 100 
U/mL Penicillin-streptomycin at 37°C in a 5% CO2 incubator.  
 
COLO 205 Spheroids 
COLO 205 MCTS formation was initiated using a modified hanging drop method. 
COLO 205 cells cultured in culture flasks were trypsinized for 5 min and then 
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resuspended in fresh RPMI 1640 media at a concentration of 1.5×106 cells/ml. An 
array of 5 µl droplets of cell suspension was then placed on the lid of the 60 mm Petri 
dish.  The lid with droplets was then inverted over the Petri dish containing 5 ml of 
RPMI medium. Aggregate formation was examined using bright field microscopy 
after incubating for 12 h. The formed spheroids were transferred by pipette and gently 
resuspended in 1X DPBS with Mg2+ and Ca2+ (Invitrogen) at a concentration of 2×105 
cells/ml and used in cell capture experiments. Spheroid aggregates larger than 100 µm 
in diameter were subjected to gentle pipetting to generate smaller aggregates.  
   
COMSOL Simulation  
 Before culturing cells inside the microfluidic system, a COMSOL simulation model 
was developed to understand the flow characteristics within the microbubbles under 
physiological shear flow. The Navier-Stokes equation with no slip boundary 
conditions was used to solve the model.  A Newtonian fluid with density 1 x 103 kg/ 
m3 and viscosity 0.01 Pa.s was used to represent the flow buffer.  Shear stresses in 
the range of 2 - 10 dyn/cm2 were used for the COMSOL simulations and spheroid 
seeding into the microbubbles. Fluid was perfused through the microbubbles 
containing tumor spheroids at 0.6 dyn/cm2 to mimic the fluid mechanical environment 
of the microcirculation and postcapillary venules.174    
 
COLO 205 Cell Preparation For Cell Capture Experiments 
COLO 205 cells were trypsinized from the tissue culture flask using AccutaseTM 
(Sigma) and then incubated in fresh media at 37°C in a shaker for up to 3 h for surface 
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receptor recovery. The cells were then resuspended in 1X DPBS containing Mg2+ and 
Ca2+ to a concentration of 2×105 cells/ml. Cell viability of > 95% was confirmed by 
the trypan blue exclusion test prior to each cell capture experiment. 
 
PDMS Microbubble 
Microbubbles in the size range of 200-500 µm in diameter with 50-200 µm top 
openings (in square, circular and triangular shapes) were fabricated in PDMS using the 
gas expansion molding (GEM) technique described in detail elsewhere85. A vacuum-
assisted coating (VAC) technique85 was used to completely fill up the microbubble 
with liquid and remove any trapped air bubbles. 1X DPBS was pipetted on top of the 
microbubbles to completely cover the top openings before placing the microbubbles 
inside a vacuum chamber. Negative pressure was applied for 30 minutes to draw out 
the air trapped inside the microbubbles and cause the injection of PBS buffer into the 
microbubble cavities. The primed PDMS microbubbles were then used in the 
perfusion chamber assembly. The average size of the microbubbles used in this 
spheroid capturing experiment was 207 ± 9.7 µm in diameter with 99 ± 1.8 µm 
circular top openings. For each experiment, a microbubble array consisting of 25-30 
microbubbles was used. 
 
Perfusion Chamber 
The perfusion chamber was assembled by mounting a rectangular parallel plate flow 
chamber (Glycotech, Rockville, MD) on top of the PDMS microbubble array. A 125 
µm thick rubber gasket was used to seal the device with the PDMS surface and create 
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a rectangular path for the perfusion flow. To create a tight sealing and prevent any 
airbubbles from entering, the top plate with the gasket was connected to the vacuum 
pump by a Tygon tubing. The top of the parallel plate chamber is made of transparent 
polycarbonate that allows for easy imaging. Medical grade Tygon tubing                                      
was used to connect the chamber inlet to the cell suspension and the outlet to the 
syringe. Ethanol (70% v/v) was perfused through the chamber for 15 s to sterilize the 
tubing and flow chamber. Sterile 1X DPBS buffer was perfused to remove any 
residual ethanol prior to cell capture experiments.   
 
PDMS Surface Preparation 
The PDMS surface was incubated with 0.5 µg/mL of recombinant E-selectin/Fc 
Chimera (R&D systems) in PBS for 45 min. To prevent nonspecific binding of cells, 
the surface was then incubated with 3% filter sterilized bovine serum albumin (BSA) 
for 90 min.   
 
Cell Capture Inside PDMS Microbubbles 
PDMS surfaces were prepared as described above for both spheroid and single cell 
capture inside the microbubbles, mimicking the postcapillary venules where activated 
endothelial cells express selectins on their luminal surface. COLO 205 cells were 
suspended in PBS and perfused through the parallel flow chamber at 2 dyn/cm2 shear 
stress. Interactions between the E-selectin counter ligands expressed on the cell 
membrane surface and immobilized E-selectin facilitate tethering and rolling of the 
cells on the functionalized PDMS surface. The rolling cells were trapped in the 
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microbubble cavity as they approached the microbubble openings under flow 
conditions. The microfluidic system with cells trapped inside was then maintained at 
37°C in a 5% CO2 incubator with perfusion of fresh RPMI media at 0.6 dyn/ cm2 
shear stress.  
Before the cell capture experiments, the assembled apparatus was secured to 
the stage of an Olympus IX81 motorized inverted epifluorescence microscope 
(Olympus Americam Melville, NY). A CCD camera (Hitachi, Tokyo, Japan) and 
DVD recorder (Sony Electronics) were used to perform image capture for offline data 
analysis.  
 
Cell Staining and Doxorubicin Toxicity Assay 
Viable COLO 205 and MDA-MB-231 cells were stained by incubation with 10 µM 
CellTracker Green and CellTracker Blue (invitrogen) for 45 min at 37°C. Cells were 
washed twice with PBS buffer to remove excess dye. The CellTracker probes stay 
within living cells through several generations and are inherited by daughter cells after 
cell fusion. Dead cell staining was performed using propidium iodide (PI) which 
intercalates into free double stranded nucleic acids in unhealthy cells. Doxorubicin 
was added to the RPMI culture medium at a concentration of 10 µM to test its toxicity 
on both monolayer and spheroid cultures.  
 
Imaging and Data Analysis 
Tumor cells and spheroids cultured inside the microbubbles were imaged using a Zeiss 
710 laser scanning confocal microscope. A 25× lens was used to acquire confocal z-
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stacks of depth of 50-200 µm with a z-stack interval of approximately 2 µm. Images 
were uploaded to the Zen 2009 software (Carl Zeiss MicroImaging GmbH) for 
analysis. The number of cells within a spheroid mass was estimated from the volume 
of the 3D spheroid image reconstructed from z-stacks divided by the average volume 
of a tumor cell (1200 µm3). 
 
2.2.3 RESULTS AND DISCUSSION 
It is well understood that the tumor microenvironment plays a critical role in the tumor 
growth, progression, metastasis and drug resistance. Recent studies show that the 
mechanical microenvironment plays a major role in modulating tumor cell responses, 
tissue development and maintenance.42, 235 It is shown that flow induced shear stress in 
tumor cells up-regulate some key genes (cyclin B1 and p21CIP1) and down-regulate 
several other genes (such as cyclins A, D1, cyclin dependent protein kinases). In 
addition to creating physiological shear stress inside the microbubbles, perfusion flow 
also establishes a physiologically relevant drug concentration profile to the exposed 
spheroids. 
Figure 2.8 shows the streamline directions, shear stress profile, velocity 
profile, and complex flow paths created inside the microbubble by the perfusion flow. 
The fluid velocity decreases sharply in magnitude with distance from the bubble top 
opening. To characterize the streamlines inside the microbubble and to determine the 
flow rate range at which the cells can be kept inside the bubble, 5.27 µm diameter 
polymer beads (Bangs Labs) were introduced into the microbubbles under perfusion 
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flow. Here the consistent sizes of the beads made the characterization process simple 
and efficient. The beads were observed to travel slowly at the lower end of the circular 
motion and then gain momentum as they approach the bubble top opening, as shown 
in Figure 2.9a and 2.9b. Cells and microbeads trapped inside the microbubble cavity 
were found to travel in circular trajectories and rarely escape from the bubble when 
the fluid velocity was less then 2.21 cm/s (10 dyn/cm2 shear stress) at the bubble 
opening. The experimental system used for spheroid capture inside the microbubble 
cavity and perfusion culture is illustrated in Figure 2.9c and 2.9d.   
COLO 205 cells were captured inside the microbubble by rolling on the E-
selectin functionalized planar PDMS surface of the microbubble chip via 
ligand:receptor interactions and fall into the microbubbles, as shown in Figure 2.10a 
and 2.10b. Captured COLO 205 cells were cultured inside the microbubbles for 2 days 
to form loose aggregates (Figure 2.10). This technique was also used to capture 
spheroids initiated by the falling drop method inside the microbubbles followed by 
culture for up to 5 days with fresh RPMI media in perfusion. The sizes of the 
spheroids captured inside each bubble were controlled by the duration of the 
perfusion. This technique was also effective in controlling the spheroid size variability 
between microbubbles. In an experiment with 20 microbubbles, the average number of 
cells captured in each bubble was 95.8 ± 5.6 SD. The spheroids then formed inside 
each microbubble and proliferated. The fluid flow inside the bubble pushes the 
spheroids to the bottom and sides of the spheres resembling hemisphere-shaped 
spheroid clusters with raised edges.  
Confocal images of the cultured spheroids were taken and pseudo-colored to 
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indicate distance from cells to the microbubble bottom surface, as shown in Figure 
2.11a(1) and 2.11a(2). Figure 2.11b shows the viability of cell spheroids cultured 
inside the microbubble system. Dead cells inside the spheroids were counted using PI 
staining and 3D confocal imaging. A greater number of dead cells were detected at the 
bottom of the spheroids near the microbubble spheroid junction. Results from the 
toxicity assay of a common chemotherapy drug, doxorubicin (10µM), on COLO 205 
cells cultured in a monolayer (Figure 2.12a), COLO 205 spheroids in static culture 
(Figure 2.12b), and COLO 205 spheroids cultured inside the microbubble perfusion 
culture (Figure 2.12c) are demonstrated in Figure 2.12. COLO 205 spheroids showed 
greater resistance to doxorubicin compared to the monolayer COLO 205 cells, 
consistent with previous research on drug resistance of colon and breast spheroid 
cultures.178, 188 This increased doxorubicin resistance in the spheroid cells may be due 
to cell-cell contact responses, internal protective mechanisms, and/or mass transfer 
limitations. Higher drug resistance in spheroids cultured inside the microbubble in 
perfusion flow compared to spheroids cultured in static suspension culture was also 
observed. The difference in the drug toxicity is likely due to limited exposure of cells 
to doxorubicin within the microbubbles, which may resemble the conditions prevailing 
in avascular tumor growth in vivo. The increased resistance demonstrated by spheroids 
in perfusion culture is similar to standard MCTS models studied by others.59, 105, 253  
Cells located at the top of the spheroids exposed to the media reflect the 
situation of actively growing tumor cells adjacent to capillaries in vivo. The cells at the 
microbubble bottom, on the other hand, become quiescent and undergo necrosis or 
apoptosis to form a secondary necrotic core. This arrangement of heterogeneous cell 
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populations and the creation of pathophysiological gradients within the spheroids in 
microbubbles are similar to the micrometastases and avascular tumor microregions. 
The advantages of the microbubble array technique include the ability to 
maintain the size uniformity of the spheroids and easy non-invasive testing during 
their growth. Attempts were also made to improve specific cell capturing efficiency of 
the microfluidic system. For instance, COLO 205 cells were mixed with MDA-MB-
231 cells that do not roll on the E-selectin coated PDMS surface in different ratios. 
The different adhesion phenotypes were used to sort the cells in the capture 
experiment (Figure 2.13). Good enrichment of COLO 205 cells was observed over the 
range of concentrations studied. The specific cell capture capability and easy control 
over the size uniformity of the spheroids make this model well suited for the 
development of co-culture spheroids. This separation process could be further 
improved through the optimization of the microbubble arrangements and opening 
shapes. Later in Chapter III, the MDA-MB-231 cell line, a highly metastatic breast 
cancer cell line that lacks E-selectin interactions, was used as a model to study the 
adhesive phenotype changes when exposed to cytokines and other factors.  
 
2.2.4 CONCLUSION 
A cost-effective 3D spheroid culture system which reflects the in vivo behavior of the 
cells in tumor tissues holds great potential for future drug development. We developed 
a simple microfluidic approach to culture tumor spheroids in perfusion culture that 
creates a 3D microenvironment, which resembles disease conditions. COLO 205 
spheroids created using the hanging drop method were captured and kept viable inside 
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the microbubbles for 5 days with a continuous perfusion of fresh culture.  
Doxorubicin toxicity was compared between COLO 205 monolayer cells, spheroids 
cultured in suspension culture under static conditions, and spheroids cultured in the 
microbubbles by perfusion culture. Greater resistance was observed in spheroids 
cultured in the bubbles, likely due to a combination of cell-cell contact responses, 
mass transfer limitations, and limited exposure of the cells to the drug. The 
microenvironment inside the microbubbles and flow conditions produced by the 
microfluidic system may resemble conditions prevailing in avascular tumor growth.  
The described technique is advantageous due to its low cost, ability to be automated 
and its usefulness for high throughput drug screening. Moreover, this model could be 
used to study therapeutic problems related to metabolic and proliferative gradients and 
3D cell-cell and cell-matrix interactions. Further investigations on the enrichment of 
specific cell types and the capture of primary tumor cells within microbubbles to 
create spheroid co-cultures are currently under way. 
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Figure 2.8: A COMSOL model was used to demonstrate the flow characteristics 
inside the PDMS microbubbles that were assembled within a Glyotech parallel plate 
flow chamber. Streamline side view (a) and top view (b) show the three-dimensional 
circular flow paths produced inside one microbubble. The COMSOL model slice plot 
(c) shows the flow velocity magnitude inside one microbubble. The velocity decreases 
sharply with distance from the bubble top opening. The shear stress plot (d) shows the 
shear stress magnitude exerted by the perfusion flow at the inner surface of the 
microbubble. COMSOL simulation conditions: Perfusion flow rate: 0.403 ml/min; 
fluid velocity: 2.12 cm/sec; shear stress at the PDMS surface: 10 dyn/cm2; 600 µm 
diameter microbubble with circular 100 µm top opening. 
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Figure 2.8: COMSOL model demonstrating the flow characteristics inside the 
PDMS microbubbles 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  75 
Figure 2.9: Micrographs of microbead trapping, parallel flow chamber setup, and 
hanging drop assay. (a) Sequential images of the microbeads trapped and circling 
inside the microbubble. Black arrows indicate the direction of the perfusion flow. Red 
and green arrows follow two different beads in their circular trajectories. These values 
are in agreement with the COMSOL simulation results (Figure 2.2.1c). (b) The 
circular paths taken by the two beads were highlighted using ImageJ software, (c) 
Schematic of the parallel plate flow chamber set up. (d) Micrograph of the 
experimental set up used for the spheroid perfusion culture including syringe pump, 
parallel flow chamber, and cell solution, (d3) Microdroplets placed on the petri dish 
lid for COLO 205 spheroid formation. 
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Figure 2.9: Micrographs of microbeed trapping, parallel flow chamber setup, 
and hanging drop assay 
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Figure 2.10: Micrographs of E-selectin functionalized microbubbles. (a) Micrograph 
showing COLO 205 cells rolling on the PDMS surface functionalized with E-selectin 
recombinant protein at a shear stress of 2 dyne/cm2. The edges of the microbubble and 
its triangular top opening are outlined in green. (b) Higher magnification micrograph 
showing rolling cells entering the microbubble openings. (cl, c2, and c3) Micrographs 
showing COLO 205 cells captured inside the microbubbles and cultured for two days 
under flow condition at 37 °C and 5% CO2 at humidified conditions. (dl‚ d2‚ and d3) 
Micrographs showing COLO 205 tumor spheroids cultured inside the microbubbles in 
4X, 10X, and 20X, respectively. 
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Figure 2.10: Micrographs of cells cultured in E-selectin functionalized 
microbubbles 
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Figure 2.11: Top view (al) and side view (a2) of a spheroid cultured inside a 
microbubble. The spheroids are pseudo-colored to indicate the distance from the 
microbubble bottom surface, (b) 3D image of the COLO 205 spheroid cultured inside 
a microbubble by perfusion, stained with Propidium Iodide (PI) and imaged with 
confocal microscopy for the cell viability assay. Live cells were stained using 
Invitrogen Celltracker probe. (c) Viability of COLO 205 spheroids cultured inside the 
microbubbles by perfusion culture as a function of seeding duration. 
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Figure 2.11: Top and side view of a spheroid cultured inside the microbubble 
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Figure 2.12: Toxicity assay of COLO 205 cells cultured in monolayer and spheroids. 
(a) Toxicity of doxorubicin drug on COLO 205 cells cultured in monolayers. The 
percentage of cells viable after 48 h was 16.67%±1.49 SD. (b) Doxorubicin toxicity on 
COLO 205 spheroids cultured in agar-coated plates under static conditions. The 
percentage of cells viable after 48 h of treatment was 42.85%±3.97 SD. (c) 
Doxorubicin toxicity on COLO 205 spheroids captured and cultured inside 
microbubbles by perfusion flow. The plotted values are the average number of viable 
cells in each microbubble. Three microbubbles were used for the perfusion 
experiments and two microbubbles for the untreated group. The percentage of cells 
viable after 48 h of perfusion culture was 51.36%±1.93 SD. Doxorubicin at 10 µM 
concentration was used in all three conditions. 
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Figure 2.12: Toxicity assay of COLO 205 cells cultured in monolayer and 
spheroids 
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Figure 2.13: Results of specific cell capture and enrichment study. COLO 205 tumor 
cells stained with Invitrogen CellTracker Green were mixed with MDA-MB-231 
tumor cells stained with Invitrogen CellTracker Blue at different ratios and used for 
cell rolling and capture inside the bubbles. MDA-MB-231 cells did not roll on E-
selectin coated PDMS. The principal mechanism behind the enrichment is that the 
perfused cells rolling on the PDMS surface have an elevated probability of entering 
the bubbles compared to non-rolling cells. 
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Figure 2.13: Specific cell capture and enrichment using E-selectin coated 
microbubbles 
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CHAPTER 3 PHENOTYPIC SWITCH IN BLOOD: EFFECTS OF PRO-
INFLAMMATORY CYTOKINES ON BREAST CANCER CELL 
AGGREGATION AND ADHESION  
 
 
* This section is adapted from the following publication: Y. Geng, S. Chandrasekaran, 
J. W. Hsu, M. Gidwani, A. Hughes, and M. R. King. PLOS ONE. 8(1): e54959, 2013 
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3.1 INTRODUCTION  
Cancer mortality is predominantly caused by the dissemination of cancer cells from 
the primary tumor to distant organs where secondary sites are formed via a metastatic 
progression. Breast cancer, one of the most diagnosed forms of cancer, still causes 
high mortality rates due to the emergence of invasive, therapy-resistant cancer cells.251 
There are conflicting ideas on the nature of these invasive cells, from their population 
size within the primary tumor211, 217 to their methods of dissemination (lymphatic204 or 
hematogeous82) and the process of metastasis within blood vessels.262, 83, 286                                                                                                                   
 One mode of cancer metastasis is through the bloodstream, which involves the 
escape of cancer cells from the primary tumor site into the circulatory system via 
intravasation. Circulating tumor cells (CTCs) can then interact and adhere to the 
endothelial lining of the vasculature through a series of receptor-mediated events, 
commonly referred to as the metastatic adhesion cascade. This cascade mimics the 
leukocyte adhesion cascade (reviewed in 82) where the initial contact between cancer 
cells and the endothelium is facilitated by a family of endothelial adhesion molecules 
called selectins.88, 125 Firm adhesion of CTCs on the endothelium then allow 
extravasation and subsequent secondary tumor site formation.  
 There are several factors in the blood that are secreted by lymphocytes and 
macrophages known to facilitate the metastatic progression and potentially interact 
with CTCs within the bloodstream. In particular, interleukin-6 (IL-6) and tumor 
necrosis factor-alpha (TNF-α) have been reported to be elevated in the blood serum of 
patients diagnosed with advanced stage breast tumor and correlate with an increased 
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number and size of metastatic sites.16, 143 IL-6 and TNF-α have been shown to 
promote the growth and invasiveness of colon and prostate cancer epithelial cells in 
vitro and in vivo.12, 155 Studies have also shown that cancer cell chemokine receptors 
also play a role in determining the destination of metastases.189 
 MDA-MB-231 is a well characterized metastatic breast cancer cell line 
isolated from pleural effusion of a patient with adenocarcinoma suffering from 
widespread metastasis, and is known as a ‘basal’ or ‘triple-negative’ cell line with 
stem cell-like or post-Epithelial-Mesenchymal Transition (EMT) features and fails to 
express estrogen receptors, progesterone receptors or human epidermal growth factor 
receptor 2 (HER2). MDA-MB-231 cells have been previously reported to express E-
selectin ligands such as CD44V4 as well as selectin-binding moieties such as sialyl 
lewis x (sLex).196, 287 Despite their expression of functional E-selectin ligands, it was 
observed that MDA-MB-231 cells do not adhesively interact with E-selectin coated 
microtube surfaces under flow, as reported here. In the present study, the effect of 
plasma, cytokine treatments, and 3-D spheroid culture conditions on altering the 
adhesion phenotype of MDA-MB-231 cells on E-selectin functionalized microtubes 
was investigated. It was hypothesized that human plasma, tumor spheroid culture, and 
exposure to pro-inflammatory cytokines such as IL-6 and TNF-α could induce robust 
interactions between metastatic breast cancer cells in circulation and the inflamed 
endothelium.  The findings of this study suggest new therapeutic approaches targeting 
specific cytokine(s) and their receptor(s) to help prevent the metastatic progression of 
breast cancer cells in transit. 
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3.2 MATERIALS AND METHODS 
Reagent 
Recombinant E-selectin-IgG1 chimera was purchased from R&D systems 
(Minneapolis, MN). Blotting grade blocker non-fat dry milk was obtained from Bio-
Rad Laboratories (Hercules, CA) and Protein-G was purchased from EMD 
Biosciences (San Diego, CA). FITC Mouse IgG1 k isotype control, purified mouse 
anti-human CD15s (clone CSLEX), and APC rat anti-mouse IgM were all purchased 
from BD Biosciences (San Jose, CA). FITC mouse anti-human CD44V4 was obtained 
from AbD Serote (Germany). Ca2+ and Mg2+ free DPBS (Invitrogen, Camarillo, CA, 
USA), calcium carbonate (Sigma Chemical Co., St. Louis, MO, USA), low endotoxin 
(1 ng/mg), and essentially globulin-free Bovine Serum Albumin (Sigma Chemical 
Co., St. Louis, MO, USA) were used to prepare flow buffer for cell adhesion assays. 
Nuclear ID™ cell viability reagent was obtained from Enzo Life Sciences 
(Farmingdale, NY).  
 
Breast Cancer Cell Culture  
Breast cancer cell line MDA-MB-231 was purchased from ATCC and maintained in 
10% Fetal Bovine Serum (FBS; Cellgro), 1% penicillin-streptomycin (Invitrogen), and 
high glucose Dulbecco's Modified Eagle Medium at 37°C with 5% CO2 in a 
humidified incubator. 
 
Plasma Isolation and Treatment 
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Whole peripheral blood was collected from informed consenting healthy female 
donors using sodium–heparin tubes with a venoject vacuum system. Collected whole 
blood was centrifuged for 25 min at 500 rpm. The plasma layer on top was carefully 
removed without disturbing the interface and passed through a sterile 0.2 µm filter. 
50% of the isolated plasma was used for cell culture while the rest was stored in -80°C 
for other assays. MDA-MB-231 cells were plated at 2 x 105 cells/well in 6-well plates. 
Isolated plasma and culture medium at a 1:1 ratio were used to treat cells for 48 h.  
 
Tumor Spheroid Generation Using PDMS Coated Plate 
Dow Corning’s Sylgard® 184 silicone elastomer kit in a 10:1 base to curing agent 
ratio (w/w) was used to cure PDMS 40.  The pre-polymer components were manually 
mixed with a pipette tip in a 50 mL tube for 60 s. 300 µL of PDMS pre-polymer was 
pipetted into each well of a 24-well plate and allowed to settle at room temperature 
(RT) for 30 min.  The plates were then cured at 60 °C for 4 h.  MDA-MB-231 cells 
were plated at 5 x 104 cells/well and cultured for 48 h.  
 
Pro-Inflammatory Cytokine and Metformin Treatment 
Human recombinant IL-6 (R&D) and TNF-α (R&D) were added to the culture media at 
a range of concentrations from 1-25 ng/mL. Cell rolling assay and flow cytometry were 
performed after 48 hr treatments (single cytokine or combined). For 
blocking/neutralization experiments, 0.1 mM Metformin (1,1-dimethylbiguanide 
hydrochloride) or 1 µg/mL of mouse anti-human IL-6R monoclonal antibody was added 
with the IL-6 treatment.  
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Neuraminidase Treatment  
After IL-6 treatment and prior to rolling experiments, MDA-MB-231 cells were 
treated with 0.1 U/ml Vibrio Cholerae neuraminidase (Roche Biochemicals, 
Indianapolis, IN) for 45 min at 37°C to cleave terminal sialic acid residues. After 
enzyme treatment cells were washed and incubated with 0.1% BSA to block 
nonspecific interactions. 
 
MTT Assay 
MDA cells were seeded into each well of a 24-well culture plate. After 12 hr in 
culture, the medium was withdrawn and replaced with 0.5 mL fresh DMEM culture 
medium or cytokine spiked medium. After 2 days in culture, all media was withdrawn 
and replaced with 0.5 mL fresh DMEM medium. Next, 50 µl MTT stock solution (5 
mg MTT powder/1 ml PBS) was added into each well and incubated at 37°C for 1 hr. 
Media was then removed and replaced with 0.5 mL DMSO for 5 min incubation at 
RT. Absorbance was measured at a wavelength of 570 nm with background 
subtraction at 660 nm. 
 
Cell Viability Assay  
The Nuclear-ID™ Blue/Red cell viability reagent (GFP-Certified™), a mixture of a 
blue fluorescent cell-permeable nucleic acid dye and a red fluorescent cell-
impermeable nucleic acid dye that is suited for staining dead nuclei was used to 
determine cell viability. MDA-MB-231 cells with various treatments including 
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control, plasma, IL-6, IL-6 + Metformin, and TNF-α were grown in imaging ready 
glass coverslip mounted 24-well plates at 5 x 104 cells/well. Cells were incubated with 
the Nuclear-ID reagent at 1:1000 dilution for 30 min at 37°C and imaged with a Zeiss 
710 confocal microscope (10X objective) with a dual filter set for DAPI (Ex/Em: 
350/470nm) and Texas Red (Ex/Em: 540/605 nm).  
 
Flow Cytometry 
After 48 h in culture, untreated and treated (plasma, tumor spheroid, IL-6, and TNF-α) 
MDA-MB-231 cells were removed from culture plates using an enzyme-free cell 
dissociation buffer solution to preserve membrane proteins and prevent clumping.  
After washing with PBS, the cells were resuspended in 1% BSA in DPBS to a final 
concentration of 250,000 cells per sample. Antibodies against CD44V4 and sLex or 
appropriate isotype controls were added to the cell suspensions and incubated over ice 
for 45 min. Following incubation, cells were washed twice with 500 µL of 1% BSA to 
remove any unbound antibody. Flow cytometry samples were analyzed using an 
Accuri C6 flow cytometer (BD Bioscience, San Jose, CA).   
 
Cell Rolling Assay 
Micro-renathane tubing with 640 µm internal diameter (Braintree Scientific) was cut 
to a length of 50 cm, functionalized with Protein G (10 µg/mL) and Fc chimera E-
selectin (20 µg/mL, R&D), and blocked with 5% BSA or milk (Sigma). 
Functionalized microtubes were then secured to the stage of an Olympus IX81 
motorized inverted microscope (Olympus America, Melville, NY).  A CCD camera 
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(model no: KP-M1AN, Hitachi, Tokyo, Japan) and DVD recorder (model no: DVD-
1000MD, Sony Electronics) were used to record experiments for offline analysis. 
MDA-MB-231 cells were suspended in flow buffer at 1 x106 cells/mL and perfused 
through protein coated microtubes using a syringe pump (KDS 230, IITC Life 
Science, Woodland Hills, CA) at a wall shear stress of 1.0 dyn/cm2.  “Rolling” cells 
were defined as those observed to translate in the direction of flow with an average 
velocity less than 50% of the calculated hydrodynamic free-stream velocity 153.  
 
Quantification of cytokine concentration using enzyme-linked immunosorbent 
assay (ELISA) 
Healthy donor plasma was isolated as described above. Conditioned media was harvested 
from both 2-D culture and 3-D tumor spheroid culture. Anti-human IL-6 and TNF-α 
ELISA kits from eBioscience (San Diego, CA) were used to quantify the cytokine 
concentration. Standard curves were performed per instruction and the concentration of 
cytokines in each sample was calculated accordingly.  
 
Real-time quantitative PCR (qPCR) 
10 ng of cDNA produced by the reverse transcription of total RNA was used in each 
quantitative PCR reaction. Also included in the 20 µL qPCR reaction system were 10 
µL iQTM SYBR Supermix (Bio-Rad), 1 µL of 2 µM forward primer and 1 µL of 2 µM 
reverse primer and nuclease free water.  
Primer for CD44 qPCR  
5’-TATAAGCTTTTCGCTCCGGACACCAT-3’ (Forward) 
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5’-ATAAGATCTTTCTGGAATTTGGGGTG-3’ (Reverse) 
Primer for GAPDH qPCR  
5’-AGAGCACAAGAGGAAGAGAGAGAC-3’ (Forward) 
5’-AGCACAGGGTACTTTATTGATGGT-3’ (Reverse) 
 qPCR reactions were carried out in 96 well real-time PCR plates (Bio-Rad) 
using a Bio-Rad MyIQ Real-time PCR detection system. The qPCR reaction consisted 
of 5 min at 95º C to activate the polymerase and 50 PCR cycles (uncoupling step at 
95º C for 20 sec followed by annealing step at 59º C for 20 sec and elongation step at 
72º C for 30 sec), followed by a melting temperature analysis to test for any 
nonspecific amplification. The expression level of CD44 gene in MDA-MB-231 cells 
with different treatment was normalized to the expression level of the standard gene 
GAPDH.  
 
3.3 RESULTS 
Blood Plasma Triggers an Adhesive Phenotypic Switch of Breast Cancer (Bca) Cells 
on E-Selectin Coated Surfaces under Flow  
When grown in 2-D monolayers with culture media, highly metastatic MDA-MB-231 
breast cancer cells showed no adhesive interactions with E-selectin coated surfaces 
under flow conditions (Figure 3.1a) despite the expression of the E-selectin ligand 
CD44V4 and the binding moiety sLex (Figure 3.1b). This is contradictory to its 
reported high metastatic potential from in vivo studies where MDA-MB-231 cells 
were found to efficiently metastasize to distant organs through the bloodstream,180 
where selectin-mediated tethering and rolling events have been shown to play 
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important roles, as reviewed in.146, 280  
 A more physiological method of culturing cancer cells is presented where 
human blood plasma is used in combination with culture media. The plasma treatment 
was found to switch the MDA-MB-231 cells from non-interacting to adhesive (Figure 
3.1a) where conventionally cultured MDA-MB-231 cells (control) exhibited no rolling 
cells on an E-selectin coated surface and plasma cultured cells exhibited strong rolling 
behavior with rolling velocities of 5.72 ± 0.32 µm and a 10-fold increase of cell flux 
compared to control cells (Figure 3.1c). It was found that sLex expression was 
upregulated on cells cultured in plasma compared to control cells (Figure 3.1b), which 
may contribute to the resulting adhesive phenotype.  
 
Pro-Inflammatory Cytokines IL-6 and TNF-Α Induce Adhesive Recruitment of Bca 
Cells and is Blocked by the Anti-Inflammatory Drug Metformin  
Pro-inflammatory cytokines have been linked to poor prognosis in metastatic breast 
cancer patients with elevated IL-6 and TNF-α cytokine in their blood plasma.16, 143 
Similar to culture in plasma, MDA-MB-231 cells cultured in IL-6 and TNF-α 
supplemented media also induced the adhesive phenotypic switch resulting in cell 
rolling velocities of 11.90 ± 0.28 µm/s and 14.22 ± 0.85 µm/s for IL-6 and TNF-α 
conditions, respectively, twice that of plasma and the combination of IL-6 and TNF-α 
treated cell rolling velocities (Figure 3.2a). Treatment with IL-6 and TNF-α at 
physiologically relevant concentrations such as 25 pg/mL also induced rolling on E-
selectin coated microtubes at rolling velocities of 15.43 ± 1.31 µm/s and 17.03 ± 2.21 
µm/s, respectively. Furthermore, whereas TNF-α upregulated both CD44V4 and sLex 
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expression compared to control cells, IL-6 only upregulated sLex (Figure 3.2b) 
suggesting the importance of increased sLex moieties. Blocking the IL-6 receptor with 
anti-IL-6R monoclonal antibody effectively hindered the adhesive phenotype resulting 
in nearly abolished cell flux on the E-selectin surfaces (Figure 3.2a). Treating cells 
with an isotype control for the monoclonal antibody did not affect the IL-6 induced 
MDA-MB-231 cell rolling on E-selectin coated microtubes (data not shown). In some 
experiments, IL-6 treated MDA-MB-231 cells were incubated with neuraminidase for 
1 hr to cleave sLex from the cell surface. Interactions between MDA-MB-231 cells and 
the E-selectin coated surfaces were abolished after neuraminidase treatment, 
indicating that the rolling behavior of MDA-MB-231 cells is E-selectin:sLex 
dependent (Figure 3.2a). Interestingly, the anti-inflammatory drug Metformin (1,1-
dimethylbiguanide hydrochloride), a frequently used drug to treat type 2 diabetes, 
showed similar effects to the IL-6R antibody. Metformin has been shown to target 
Stat3 and induce apoptosis in triple-negative breast cancers as well as significantly 
decrease serum IL-6 level in breast cancer patients.51, 165  
 
Plasma, IL-6, and TNF-Α Promote Breast Cancer Cell Growth as Aggregates 
When plated in a 24 well plate with imaging ready glass coverslip built-in wells, 
control cells were found to grow as monolayers with very little occurrence of 
aggregation (Figure 3.3a). Monitoring the cell proliferation and viability under various 
cytokine treated culture media conditions demonstrated that not only do MDA-MB-
231 cells proliferate at an increased rate in the presence of IL-6 and TNF-α (Figure 
3.3g), an increased number of aggregates (Figures 3.3b, d, and e) was observed. A 
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similar and enhanced effect was observed in human plasma (Figure 3.3f) where the 
large degree of aggregation is reminiscent of tumor spheroids. Therefore, the cell 
growth and formation as aggregates may cause the adhesive phenotypic switch, 
especially considering that MDA-MB-231 cells grown in IL-6 and Metformin formed 
a negligible number of aggregates (similar to control cells, Figure 3.3c). MTT assay 
also indicated increased cell proliferation when MDA-MB-231 cells were treated with 
high concentrations of IL-6 and TNF-α (Figure 3.3g).   
 
3-D Tumor Spheroid Culture Increases the Interactions between BCa cells and E-
selectin Coated Surfaces by Upregulating CD44V4 and sLex Expression 
Similar to elevated cytokine concentrations, the increased occurrence of tumor 
spheroids and circulating tumor microemboli has been linked to poor prognosis and 
increased metastatic potential.70, 87 Culturing MDA-MB-231 cells as 3-D tumor 
spheroids in conventional culture media (Figure 3.4a) had an even greater effect on 
cell adhesiveness to an E-selectin coated surface. Comparable to plasma and cytokine 
treated conditions, cells grown as spheroids also showed significantly increased 
CD44V4 and sLex expression (Figure 3.4b) while inducing more stable rolling on E-
selectin coated surfaces under flow. Moreover, as shown in Figure 3.4c, MDA-MB-
231 cells grown in tumor spheroid conditioned media also demonstrated the adhesive 
phenotypic switch with an average rolling velocity of 7.72 ± 0.32 µm/s, although 
significantly faster than MDA-MB-231 cells grown in 3-D spheroids (4.02 ± 0.17 
µm/s). mRNA expression of CD44 was also measured for all conditions (IL-6, TNF-α, 
tumor spheroid, and plasma) via real time quantitative PCR (qPCR). As shown in 
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Figure 3.4d, all conditions resulted in upregulation of CD44 mRNA expression 
compared to control.  
 
IL-6 and TNF-α Concentrations in Blood May Regulate the Recruitment of BCa Cells 
to the Inflamed Endothelium  
Interestingly, the tumor spheroid (3-D) conditioned media contained significantly 
higher concentrations of both IL-6 and TNF-alpha (Figure 3.5a) than that of healthy 
donor plasma. Conditioned media from 2-D culture was also assayed and the 
concentrations of both IL-6 and TNF-alpha were significantly lower than 
physiological cytokine concentrations sufficient to have an effect on the phenotype of 
MDA-MB-231 cells. To explore the effects of cytokine concentration on the adhesive 
behavior of MDA-MB-231 cells, human recombinant IL-6 was added to cell culture 
medium at a range of concentrations consisting of 1, 5, 10, and 25 ng/mL.  MDA-
MB-231 cells treated with 25 ng/mL of IL-6 demonstrated the strongest interactions 
with the E-selectin coated surface with a rolling velocity of 5.46 ± 0.31 µm, 
comparable to the rolling velocity of plasma cultured cells (Figure 3.5b). Overall, 
MDA-MB-231 cells showed more robust interactions with E-selectin coated surfaces 
as the concentration of IL-6 was increased, resulting in greater numbers of cells 
recruited via the adhesion cascade.  
 
3.4 DISCUSSION 
There is compelling evidence supporting the strong interplay between various types of 
inflammation and cancer progression suggested by numerous clinical and 
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epidemiological studies.45, 90 The recruitment of tumor-associated immune cells during 
the inflammation that accompanies tumor progression, has been shown to promote 
tumor growth and contribute to angiogenesis, invasion, and metastasis.44 Infiltration of 
these tumor-promoting immune cells as well as various inflammatory cytokines, 
particularly TNF-α and IL-6, has been found in the breast tumor microenvironment.15 
 A clinical study reported elevated levels of pro-inflammatory cytokines in the 
serum of breast cancer patients when compared to healthy individuals.166 As one of the 
well characterized ‘triple-negative’ breast cancer cell lines, MDA-MB-231 has been 
reported to also be mesenchymal stem cell-like.156 Furthermore, ‘triple-negative’ 
breast cancers have been found to correlate with inflammatory states such as obesity 
and diabetes where pro-inflammatory cytokines, including IL-6, are highly expressed.  
 The lack of interaction between culture medium grown MDA-MB-231 cells 
with E-selectin coated surfaces, as observed in this study, was rather unexpected 
considering their reported high metastatic potential from both in vitro and in vivo 
studies. Human plasma, IL-6, and TNF-α supplemented culture conditions have been 
shown to induce an adhesive phenotypic switch, allowing MDA-MB-231 cells to 
establish stable rolling on E-selectin coated surfaces under physiological flow. Plasma 
factors such as fibrinogen as well as other cytokines such as IL-1β and IFN-γ have 
also been shown to promote cell adhesion.147, 169, 290 In this study, cytokines such as 
IL-6 and TNF-α were studied in particular due to their association with poor prognosis 
for breast cancer patients.  The concentration of cytokines used for the in vitro 
experiments was based on similar studies that have investigated the effect of these 
cytokines on invasiveness of breast cancer cell lines.252 CD44V4, a major E-selectin 
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ligand for breast cancer cells, was found to be upregulated on MDA–MB-231 cells 
treated with TNF-α. TNF-α has been reported to increase CD44 expression on ovarian 
cancer cells upon the activation of the c-Jun NH2-terminal kinase190 and, although not 
in the context of cancer, affects the glycosylation and sulfation of various 
glycoproteins.48 On the other hand, IL-6 has been shown to induce a significant 
increase in the expression of α1,3/4-fucosyltransferases (FUT11 (fucosyltransferase 11 
gene) and FUT3) as well as the amounts of sLex and 6-sulfo-sLex epitopes in human 
bronchial mucosa.91 Although CD44V4 is a major E-selectin ligand for breast cancer 
cells, there are other ligands such as MUC1 which play an active role in rolling and 
firm adhesion of breast cancer cells on inflamed endothelium, as reported in our recent 
study.84 The flow cytometry results of the present study comparing control and IL-6 
treated MDA-MB-231 cells suggest that IL-6 also promotes the synthesis of sLex on 
breast cancer cells, potentially providing more opportunity for sLex: E-selectin 
mediated heterotypic interaction between cancer cells and the activated endothelium.   
 Selectin-based technology has been used to capture viable circulating tumor 
cells (CTCs) that can be further characterized by releasing the bound CTCs in the 
absence of calcium.110, 111 Recently, E-selectin-mediated adhesive interactions were 
utilized inside an E-selectin coated polydimethylsiloxane (PDMS) microbubble 
system to capture colon CTCs under flow conditions.1 Presently, most CTC studies 
have focused on the survival and metastasis of individual tumor cells in the 
circulation. However, emerging evidence supports the importance of circulating tumor 
microemboli (CTM) during cancer progression.108 CTM represent a “collective 
migration” of tumor cells and have been found to exhibit higher metastatic potential 
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than that of individual CTCs.207 It has been proposed that these multicellular clumps 
of tumor cells can metastasize by becoming mechanically trapped in the smallest 
capillaries due to their large size.70 Tumor spheroid/aggregate grown MDA-MB-231 
breast cancer cells were found to upregulate their number of E-selectin ligands and 
binding moieties and demonstrated the most robust rolling behavior on E-selectin 
coated surfaces, compared to MDA-MB-231 cells from plasma and cytokine 
treatments, suggesting that CTMs may efficiently escape the bloodstream via a 
metastatic adhesion cascade.   
 Highly metastatic tumor cells have been reported to exhibit increased 
homotypic aggregation, gaining resistance to apoptosis.87 There is also evidence to 
suggest that breast cancer cells cultured as 3-D spheroids express a higher level of IL-
6 mRNA.104 A recent study by our group reported that homotypic and heterotypic 
interactions in breast cancer cells cultured as 3-D spheroids alter their adhesion 
phenotype. These interactions were shown to increase the interaction of breast cancer 
cells with human recombinant E-selectin.39 Furthermore, when MDA-MB-231 cells 
were cultured as 3-D spheroids in media, high concentrations of IL-6 and TNF-α were 
found in the spent media and cell adhesion to E-selectin surfaces were found to be 
dependent on IL-6 concentration.  
 A novel mechanism (Figure 3.6) was proposed that may explain the 
aggressiveness of ‘triple-negative’ breast carcinoma. First, the pro-inflammatory 
cytokines act on single cells to induce an aggregated morphology and an increased 
proliferation rate. Cell aggregation then upregulates the secretion rate of IL-6 and 
TNF-α thereby increasing cytokine concentrations. This may cause a positive 
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feedback mechanism where the increased cytokine concentrations cause more 
aggregation and proliferation that further stimulate cytokine secretion. The ultimate 
effect of aggregation is the increased expression of E-selectin ligands and binding 
moieties that facilitate stable rolling on the inflamed endothelium to enable subsequent 
extravasation. 
 In summary, results from this study indicate that plasma and cytokines can 
promote homotypic aggregation and that cell proliferation as tumor spheroids can 
change the adhesion phenotype of cancer cells to immobilized E-selectin under 
physiological flow, which may contribute to the higher metastatic potential of CTM. 
Taken together, these results suggest that therapeutic approaches targeting cytokine 
receptors and adhesion molecules on cancer cells may help reduce the likelihood of 
metastasis and deserve further attention.  
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Figure 3.1: Plasma triggers an adhesive phenotypic switch of breast cancer (BCa) 
cells on E-selectin coated surface under flow. (a) Left: Untreated MDA-MB-231 cells 
(2-D culture with regular medium) show no interactions with the E-selectin coated 
surfaces under flow. Right: Cells establish stable rolling on E-selectin coated surface 
after 48 h plasma treatment. (b) Flow cytometry results of CD44V4 (left) and sLex 
(right) expression on untreated and plasma treated MDA-MB-231 cell surfaces. Mean 
fluorescence intensity ratio of sample over isotype has been included. (c) Left: 
Average rolling velocity of untreated (control) and plasma treated MDA-MB-231 cells 
(n =35 cells). Shear stress of 1 dyn/cm2 was used. Right: Average numbers of cells 
interacting with the E-selectin coated surface per 5 x 105 µm2 of untreated (n = 30 
frames) and plasma treated (n = 36 frames) MDA-MB-231 cells. Bars represent mean 
± SEM. P < 0.0001, two-tailed unpaired student t-test.  
 
  103 
Figure 3.1: Plasma triggers an adhesive phenotypic switch of breast cancer cells 
on E-selectin coated surface under flow 
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Figure 3.2: Pro-inflammatory cytokines IL-6 and TNF-α also induce adhesive 
recruitment of BCa cells and is blocked by the anti-inflammatory drug Metformin.  
(a) Average rolling velocity (left) and average number of MDA-MB-231 cells 
interacting with E-selectin coated surfaces (right) after treatments including 5 ng/mL 
of IL-6 (n=71), 5 ng/mL TNF-α (n = 48), IL-6 + TNF-α (5 ng/mL each), 5 ng/mL of 
IL-6 with 0.1 mmol Metformin, 5 ng/mL of IL-6 with 1 µg/mL anti-IL-6R MAb, 
5ng/mL of IL-6 with neuraminidase treatment prior to rolling experiment. For 
conditions where MDA-MB-231 cells were treated with IL-6 with MAb, Metformin, 
or neuraminidase (after IL-6 treatment), there were insufficient numbers of cells found 
on the E-selectin coated surface for velocity analysis. Bars represent mean ± SEM. P < 
0.0001, two-tailed unpaired student t-test. Average number of MDA-MB-231 cells 
from control experiment was found to be significantly less than all other conditions 
(P<0.0001). (b) Flow cytometry measurements of CD44V4 (left) and sLex (right) 
expression on untreated, IL-6 (5 ng/mL), and TNF-α (5 ng/mL) treated MDA-MB-231 
cell surfaces. Mean fluorescence intensity ratio of sample over isotype has been 
included.  
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Figure 3.2: Pro-inflammatory cytokines also induce adhesive recruitment of 
breast cancer cells and is blocked by Metformin 
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Figure 3.3: Plasma, IL-6, and TNF-α promote breast cancer cell growth as aggregates.  
Morphology and viability of MDA-MB-231 cells cultured in (a) regular medium, (b) 
IL-6 (5 ng/mL) spiked medium, (c) IL-6 (5 ng/mL) and 0.1 mmol Metformin added 
medium, (d) TNF-α (5 ng/mL) spiked medium, (e) IL-6 and TNF-α (5 ng/mL each) 
spiked medium, and (f) healthy donor plasma. A blue fluorescent cell-permeable 
nucleic acid dye (for live cell staining) and a red fluorescent cell-impermeable nucleic 
dye (for dead cell staining) were used to visualize the live and dead populations. (g) 
Cell proliferation results via MTT assay of control media, IL-6, TNF-α, and 
Metformin treated MDA-MB-231 cells.  
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Figure 3.3: Plasma, IL-6, and TNF-alpha promote breast cancer cell growth as 
aggregates 
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Figure 3.4: 3-D tumor spheroid culture further increases the interactions between BCa 
cells and E-selectin coated surfaces by upregulating CD44V4 and sLex expression. 
(a) Micrographs of MDA-MB-231 cells cultured in 2-D monolayer (left) and 3-D 
spheroid on PDMS (right). (b) Flow cytometry results of CD44V4 (left) and sLex 
(right) expression on untreated (2-D monolayer grown) and tumor spheroid cultured 
MDA-MB-231 cells. Tumor spheroid cultured cells were treated with enzyme free 
dissociation buffer prior to experiments to obtain mostly single cell populations. Mean 
fluorescence intensity ratio of sample over isotype has been included. (c) Average 
rolling velocity (left) and average number of MDA-MB-231 cells found interacting 
with E-selectin coated surfaces (right) cultured in medium (untreated), 3-D spheroid, 
and spheroid conditioned medium. Bars represent mean ± SEM. Two-tailed unpaired 
student t-test was used. (d) CD44 mRNA expression of MDA-MB-231 cells that are 
cultured in control, IL-6, TNF-α, tumor spheroid, and plasma conditions, respectively, 
measured via qPCR.  
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Figure 3.4: 3-D tumor spheroid culture further increases the adhesive 
interactions by upregulating CD44V4 and glycan expression 
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Figure 3.5: IL-6 and TNF-α concentrations in blood can regulate the recruitment of 
BCa cells to the inflamed endothelium. (a) Calculated concentrations of IL-6 (left) and 
TNF-α (right) of healthy female donor plasma and tumor spheroid conditioned media 
on ELISA standard curves. IL-6 concentration in the tumor spheroid conditioned 
media was diluted with equal volume of culture media to remain in the detectable 
range (0-200 pg/mL) of the ELISA kit. (b) Average rolling velocities (left) and 
average numbers of MDA cells found interacting with E-selectin coated surfaces 
(right) from untreated conditions and culture media spiked with a range of IL-6 
concentration including 1, 5, 10, and 25 ng/mL. For the cell number analysis, all 
conditions are significantly different (p< 0.0001) except for the 5 and 10 ng/mL 
treatments. Bars represent mean ± SEM. Two-tailed unpaired student t-test was used.  
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Figure 3.5: IL-6 and TNF-alpha can regulate the recruitment of breast cancer 
cells to the endothelium 
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Figure 3.6: A positive feedback loop: activation and maintenance of the adhesive 
phenotypic switch. Step A: Tumor cells encounter proinflammatory cytokines such as 
IL-6 and TNF-α secreted by tumor promoting immune cells in the microenvironment. 
Step B: Cytokine conditioned tumor cells form aggregates. Step C: 
Aggregates/spheroids of tumor cells release more IL-6 and TNF-α, turning on a 
phenotypic switch for more tumor cells nearby by upregulating E-selectin ligand and 
binding moiety expressions, and promote heterotypic interactions between tumor cells 
and the inflamed endothelium. Step D: Tumor cells ready to invade the endothelium.  
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Figure 3.6: A schematic of the positive feedback loop: activation and 
maintenance of the adhesive phenotypic switch 
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CHAPTER 4 VASCULAR RECRUITMENT OF HUMAN 
RETINOBLASTOMA CELLS BY MULTI-CELLULAR ADHESIVE 
INTERACTIONS WITH CIRCULATING LEUKOCYTES  
 
* This section is adapted from the following publication: Y. Geng, G. M. Seigel, S. 
Narasipura, and M. R. King. Cellular and Molecular Bioengineering. 3:361-8, 2010  
 
 
 
 
 
 
 
 
 
 
  
  115 
4.1 INTRODUCTION 
Retinoblastoma (RB) is a malignant tumor of the neural retina that affects 
approximately 250-350 children under the age of six every year in the United States.18   
In some Central and South America countries, retinoblastoma is one of the most 
common solid tumor malignancies in children.26 Retinoblastoma usually manifests 
before the age of three and the tumors can grow locally within the eye as well as 
extend outside the globe by migrating down the optic nerve into the central nervous 
system and the cerebrospinal fluid. In addition, the tumors can spread through the 
vasculature to form metastases in distant organs. Patients with hereditary RB have a 
much higher risk for developing secondary malignancies later in life, mainly soft 
tissue sarcoma, osteosarcoma, and melanoma.4,10 Reports have indicated that the rate 
of secondary tumor formation in these patients is increased by radiation treatment and 
possibly in combination with chemotherapy.3 Chemoresistant, radiation-resistant stem-
like cells exist in many forms of cancer20,22 and may relate to these secondary 
malignancies. One hallmark of many stem-like cell populations is the presence of 
ABCG2 (BCRP), a stem cell marker32 and a cell surface transmembrane pump that 
can confer resistance to a wide variety of chemotherapy agents, including 
anthracyclines, mitoxantrone, and camptothecins.17 The calcium-dependent transporter 
activity of ABCG2 has been used to identify and isolate stem-like cells from a variety 
of normal and malignant tissues based on the ability of ABCG2 positive cells to 
exclude Hoechst dye 3334.1,7,27 Seigel and colleagues have identified subpopulations 
of cancer stem-like cells in retinoblastoma that express stem cell markers such as 
ABCG2, as well as human embryonic stem cell markers, such as Nanog and 
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Oct3/424,25 that provide an intriguing model for the study of tumor cell adhesion and 
metastasis.  
The basic mechanisms of how neutrophils adhere to the vascular endothelium 
and migrate to inflammatory sites have been studied extensively over the past two 
decades. To start the neutrophil recruitment cascade, the initial capture of neutrophils 
from the bloodstream and rolling along the vessel wall is mediated by P-selectin and 
E-selectin presented by stimulated endothelial cells.11,12 Activated beta-2 integrins 
(CD11a/CD18 or LFA-1, and CD11b/CD18 or Mac-1) on neutrophils then facilitate 
the firm arrest of neutrophils by binding to ICAM-1 on endothelial cells.6  
Circulating tumor cells such as colon carcinoma3 and acute myeloid leukemia19 
express selectin ligands and integrins, which allow them to interact directly with the 
endothelium and metastasize through the blood stream. Other circulating metastatic 
cancer cells, however, have been found to adhesively associate with neutrophils in the 
circulation, to escape the circulation and engraft in the extravascular space.14,16 The 
similar properties shared between metastatic cancer cells and leukocytes such as the 
ability to interact with endothelium and cause basement membrane degradation 
suggests that leukocytes may play a role in promoting tumor growth and survival, as 
well as transendothelial migration.23,30 The interaction between cancer cells and 
leukocytes has been found in breast cancer, advanced gastric cancer, colon cancer, and 
malignant melanoma.15,21,31 
It has been established that the accumulation of neutrophils at inflammatory 
sites is a collective phenomenon.8 Homotypic interactions between neutrophils were 
found to be responsible for enhancing the accumulation of neutrophils rolling on P-
  117 
selectin surfaces in vitro.29 Walcheck et al. showed that transient tether formation 
between a rolling neutrophil and a cell suspended freely in the fluid can cause the 
rolling and capture of free-flowing cells near the surface. 
   It is not clear how retinoblastoma cells may adhere to the endothelium and 
subsequently extravasate through it under flow conditions in the microcirculation. In 
this study, it was shown that retinoblastoma cancer stem cells can interact with a 
model endothelial surface via secondary recruitment by activated leukocytes, as a 
potential mechanism for metastatic spread.   
 
4.2 MATERIALS AND METHODS 
Reagents 
FITC-conjugated mAb for anti-human CD 338 (ABCG2) clone 5D3, PE-conjugaged 
mAb for anti-human CD 54 (ICAM-1) clone HCD54 and FITC-conjugated Mouse 
IgG2b, κ isotype control were purchased from BioLegend, (Sandiago, CA). PE-
conjugaged Mouse IgG1, κ isotype control was purchased from eBioscience (San 
Diego, CA). Recombinant E-selectin-IgG chimera was obtained from R&D Systems 
(Minneapolis, MN). Trypan blue stain (0.4%) was obtained from Lonza (Wilkersville, 
MD). Blotting grade blocker non-fat dry milk was obtained from Bio-Rad 
Laboratories (Hercules, CA). Protein-G was purchased from EMD Biosciences (San 
Diego, CA). Ca2+ and Mg2+ free HBSS (Invitrogen, Camarillo, CA, USA), Ca2+ and 
Mg2+ free DPBS (Invitrogen, Camarillo, CA, USA), calcium carbonate (Sigma 
Chemical Co., St. Louis, MO, USA), endotoxin free water (MO BIO Laboratories, 
Carlsbad, CA, USA), endotoxin free human serum albumin (Sigma Chemical Co., St. 
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Louis, MO, USA), and low endotoxin (1 ng/mg), essentially globulin-free BSA 
(Sigma Chemical Co., St. Louis, MO, USA) were used to make buffer solutions for 
neutrophil isolation and flow experiments. 
 
Retinoblastoma Cell Cultures 
Retinoblastoma cell lines RB143 (a gift from Dr. Bruce Ksander) and WERI-Rb27 (a 
gift from Dr. John Ludlow) were maintained in Dulbecco’s Modified Eagle’s Medium 
(Sigma), with 20% calf serum for RB143 cells and 10% calf serum for WERI-Rb27 
cells (Hyclone, Logan UT) at 37ºC in a 5% CO2 incubator. 
 
Immunocytochemistry 
The following primary antibodies were used for immunocytochemistry:   
10 µg/ml rabbit anti-Nestin (Sigma), 4.16 µg/ml rabbit anti-ICAM-1 (Cell Signaling 
Technologies, Danvers, MA), 1 µg/ml goat anti-doublecortin (Santa Cruz 
Biotechnology, Santa Cruz, CA), 5 µg/ml mouse anti-CD147 (Neurothelin, 
EMMPRIN, Basigin; BD Pharmingen, Franklin Lakes, NJ), and 1:200 dilution of 
mouse anti-ABCG2 (Abcam, Cambridge, MA).  
For diaminobenzidine (DAB) staining, RB143 cells were prepared as cytospins 
by centrifugation and resuspension in cytospin fixative (72% isopropyl alcohol, 19% 
acetone, 7.6% glycerol). After at least 10 min of fixation, the cell suspensions were 
spun onto slides at 1000g for 5 min in a Shandon Cytospin 2. Cytospins underwent 
immunocytochemistry using the following protocol: Cytospin slides were incubated 
for 5 min with PBS, 5 min with 3% H2O2 and rinsed twice with PBS. Cells were 
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blocked for 15 min with 2% bovine serum albumin, followed by a PBS wash. Cells 
were incubated in primary antibody or isotype control antibody for 1 h, washed twice 
with PBS, and incubated with 1 µg/ml of appropriate biotinylated secondary antibody 
(anti-mouse, rabbit or goat from Vector Laboratories, Burlingame, CA) for 45 min.  
After two PBS washes, the cells were incubated for 20 min with horseradish 
peroxidase-labelled avidin (ABC Elite kit, Vector Laboratories, Burlingame, CA).  
The cells were washed twice with PBS and then treated with DAB (Zymed 
Laboratories, Carlsbad, CA) for 5 min to develop the brown reaction product. Cells 
were then viewed by brightfield microscopy with Nomarski optics (Nikon Eclipse, 
ES600). 
For double immunofluorescent staining, cells were fixed and maintained in 
suspension. After PBS wash, cells were incubated at 4ºC with primary antibodies 
(mouse anti-ABCG2 and rabbit anti-ICAM-1 or isotype control antibody) for 1 h, 
rinsed twice, then incubated for 1 h with a mixture of fluorescent secondary antibodies 
(2.5 µg/ml each of FITC anti-rabbit Ig and TRITC anti-mouse Ig, Sigma). Cells were 
rinsed, placed on a slide and coverslipped for viewing with fluorescence microscopy 
(Nikon Eclipse, ES600). 
 
Flow Cytometry 
Both RB143 and WERI-Rb27 cells were de-clumped prior to antibody incubation 
using an enzyme-free cell dissociation media that preserves the cell surface receptors 
rather than cleave them. After two washes with 1X DPBS, the cells were resuspended 
in 1X DPBS to a final concentration of 200,000-300,000 cells in each sample. 
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Antibodies or appropriate isotype controls were added to cell suspensions and 
incubated over ice for 45 min. Following the incubations, the cells were washed three 
times with 1mL of 1X DPBS to remove any unbound antibody. Flow cytometry 
samples were analyzed using an Accuri C6 flow cytometer (Accuri Cytometers Inc., 
Ann Arbor, Michigan, USA) and plots were created using the FlowJo v. 7.6.3 (Tree 
Star Inc., Ashland, Oregon) software package. 
 
Preparation of Immobilized Protein Surfaces 
Polyurethane microtubes with an inner diameter of 300 µm (Braintree Scientific Inc., 
Braintree, MA, USA) were cut to a length of 50 cm. Recombinant human E-selectin-
IgG chimeric protein was dissolved in 1X PBS to a final concentration of 5 µg/mL. 
The microtube surface was first rinsed with 75% ethanol and then 1X PBS. The 
surface was subsequently incubated with 10 µg/mL of protein-G solution for 1.5 h, 
followed by a 2 h incubation with selectin chimera then blocked with 5% milk protein 
in PBS for 1 h. Control tubes were blocked with 5% milk protein in PBS for 1 h.  
 
Neutrophil Isolation and Activation 
Human peripheral blood was collected from consenting healthy adult donors (as per 
IRB-approved protocol). Neutrophils were isolated by centrifugation at 500g for 50 
min at 23°C using 1-Step Polymorphs (Accurate Chemical and Scientific Corporation, 
Westbury, NY, USA.), creating separate visible layers of plasma, mononuclear cells, 
neutrophils, and erythrocytes and platelets. The neutrophil layer was extracted and 
washed twice in Ca2+ and Mg2+ free HBSS to remove the polymorph residue, and any 
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remaining red blood cells were lysed hypotonically with 1:6 and 10X PBS. 
Neutrophils were then resuspended at various concentrations of HBSS containing 
0.5% HSA, 2mM Ca2+, and 10 mM HEPES, buffered to 7.4. Prior to flow 
experiments, neutrophils were stimulated with 1nM IL-8 (R&D Systems Inc., 
Minneapolis, MN, USA) for 10 min at RT on a rocker (Rocker II Model 260350, 
Boekel Scientific). 
  
Recruitment of Retinoblastoma Cells by Association with Neutrophils under Flow 
Microtubes with functionalized E-selectin surfaces were secured on the stage of an 
Olympus IX81 inverted microscope (Olympus America Inc., Melville, NY, USA). 
After mixing IL-8 stimulated neutrophils and CTG-labeled RB cells for 5 min on a 
rocker, the cell solution was introduced into the microtube using a syringe pump (KDS 
230, IITC Life Science, Woodland Hills, CA) at a wall shear stress of 1.0 dyne/cm2. 
The dynamic adhesion between RB cells and human peripheral leukocytes was 
characterized over a physiological range of wall shear stress values (0.2-5 dyn/cm2).  
 
Data Acquisition 
Videos of flowing and adhering RB-neutrophil aggregates were recorded using a 
microscope-linked Hitachi CCD camera KP-M1AN (Hitachi, Japan) and a Sony DVD 
Recorder DVO-1000MD (Sony Electronics Inc., San Diego, California, USA).  For 
each flow experiment, a 12 cm functionalized E-selectin surface was scanned and the 
aggregates were quantified and normalized. The average ratio of leukocytes to cancer 
cells per aggregate was measured as a function of shear stress, receptor density, and 
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cell concentration. 
 
Statistical Analysis 
Adhesive interactions of RB143 and WERI-Rb27 cells with neutrophils at various 
ratios were quantified and plotted using Prism 5.0b for Microsoft (GraphPad Software, 
San Diego, CA, www.graphpad.com). Rolling cells were defined as those translating in 
the direction of flow with an average velocity less than 50% of the calculated 
hydrodynamic free stream velocity. Two-tailed unpaired t-test and ANOVA were 
employed with a significance level of α=0.05 where applicable. 
 
4.3 RESULTS 
When RB143 and WERI-Rb27 cells were perfused through E-selectin coated microtube 
surfaces without neutrophils, neither demonstrated rolling adhesion as defined above. 
No expression of E-selectin ligands was found via flow cytometry in either the RB143 
or WERI-Rb27 cell line (data not shown). There was, however, an ABCG2+ stem-like 
cell subpopulation within both cell lines that co-expressed high levels of ICAM-1 
(Figure 4.1). ICAM-1 is a beta-2 integrin ligand and a surface marker that correlates 
with tumor metastatic potential.28 As shown in Figure 4.1, ~90% of ABCG2+ RB143 
cells expressed ICAM-1, compared with less than 20% expression of ICAM-1 in 
ABCG2- cells. This co-staining for ABCG2 and ICAM-1 is also demonstrated in the 
micrograph of Figure 4.1B.  
 Results from the aggregation assay indicate that RB-leukocyte aggregate 
formation is ICAM-1 dependent (Figure 4.2). In these experiments, RB143 and WERI-
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Rb27 cell concentrations were held constant at 1 million/mL while varying neutrophil 
concentrations from 2 million/mL to 5 million/mL. The total number of aggregates 
observed (including adhering and rolling/flowing) from all four different conditions 
(RB143 1:2, RB143 1:5, WERI 1:2, WERI 1:5) were not significantly different (p = 
0.0814). Approximately 80% of the captured events in all four conditions were RB cells 
rolling or flowing with their anchoring neutrophils on the microtube surface.  
Significantly fewer events were observed in blocking and control experiments, as seen 
in in Figure 4.2. Overall, RB-neutrophil aggregate formation showed no correlation with 
initial cell ratios or cell lines (p = 0.814, ANOVA). It was also observed that some 
flowing neutrophils are captured by a retinoblastoma:neutrophil aggregate attached to 
the surface; such cells were recorded as “tethered” neutrophils since they were available 
for future collisions with flowing retinoblastoma cells. 
To further characterize the size of aggregates formed, the number of neutrophils 
that bound to RB cells in each aggregate (both adhering and rolling/flowing) was 
quantified for two experiments with RB143 cells, for two different initial 
RB143:neutrophil cell ratios of 1:2 and 1:5. The normalized results showed no 
significant difference in the number of aggregates captured. In the experiment in which 
the RB143:neutrophil initial ratio was 1:2, the aggregation profile exhibits an 
approximately binomial distribution. Overall, the majority of aggregates captured were 
one-to-one (i.e., one RB with one neutrophil) binding events, shown in Figure 4.3. Over 
40 adhering one-to-one binding events were analyzed in which both RB and neutrophil 
were attached to the E-selectin surface (shown in Figure 4.4). The orientation angle and 
center-to-center distance of the captured RB cell, relative to the anchoring neutrophil, 
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was quantified for each observed heterotypic adhesion event. It was found that 90% of 
these one-to-one aggregates, RB cells and neutrophils formed angles between 0° and 
180°, i.e., downstream to their anchoring neutrophils.  
 
4.4 DISCUSSION 
The goal of this study was to address the mechanism by which RB cells adhere to the 
endothelium that could allow subsequent extravasation and metastasis to distant sites. 
Although RB cells do not express selectin ligands or beta-2 integrins themselves, 
ABCG2+ RB stem-like cells do express ICAM-1 suggesting a role for leukocyte:RB 
adhesive interactions as a mechanism that can promotes RB arrest on the endothelium 
under flow. 
 ICAM-1 is expressed on a variety of primary tumors, metastases, and normal 
cells.5 In the present study, flow cytometry results suggest preferential expression of 
ICAM-1 on the surface of ABCG2+ RB143 cells. A similar trend in WERI-Rb27 cells 
was observed (results not shown). This suggests the hypothesis that RB cells, especially 
ABCG2+ RB cancer stem-like cells, may be recruited to an E-selectin surface by first 
attaching to activated neutrophils via LFA-1: ICAM-1 binding (Figure 4.5).  
 The results from the microtube aggregation assay show that aggregate formation 
is insensitive to the initial ratio of neutrophils and RB cells. One might expect to 
observe more aggregates as the neutrophil concentration is increased from 2 to 5 
million/mL for both RB cell lines. However, no significant increase in the number of 
aggregates is observed in experiments using RB143 nor WERI-Rb27 cells since all 
four conditions (RB143 1:2, 1:5; WERI-Rb27 1:2, 1:5) show similar trends in terms of 
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the distribution of adhering and rolling/flowing aggregates. The significant decrease in 
the number of RB-neutrophil aggregates captured in the presence of ICAM-1 blocking 
antibodies suggests that the phenomenon of RB-neutrophil binding is highly ICAM-1 
specific. In addition to the sensitivity and specificity, it was found that the majority of 
RB-neutrophil aggregates were one-to-one binding, i.e., once a neutrophil binds to a 
RB cell, it is less likely to recruit another RB cell, likewise the RB cells, once bound 
in one-to-one aggregates, are less likely to bind to a second neutrophil. This may be 
due to the relocation of receptors to the cell:cell contact area, as observed in neutrophil 
relocation on the neutrophil surface.9,13 Furthermore, it was observed that 90% of the 
bound RB cells are downstream to their anchoring neutrophils, which shares 
similarities to the secondary recruitment mechanism observed for neutrophil-
neutrophil interactions.29 
 Interestingly, in the aggregation assay (Figure 4.3), at least 20% of RB cell and 
neutrophil aggregates were observed to flow or roll rather than adhere to the E-selectin 
surface. This suggests a step-wise binding mechanism in which the RB cells and 
neutrophils first interact and form aggregates in flow, roll together on the surface 
through the neutrophil sialyl Lewis (sLex):E-selectin binding, and then firmly adhere 
to the surface (Figure 4.5). Alternatively, the neutrophils could first adhere to the E-
selectin surface and then recruit RB cells. However, the experiments in which 
activated neutrophils were first perfused through the E-selectin surface with 
subsequent RB cell introduction showed no aggregate formation. This indicates that 
neutrophil recruitment of RB cells precedes neutrophil firm adhesion to E-selectin. 
Since adhesion molecules, such as ICAM-1 expressed on ABCG2+ RB stem-like 
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cells, are critical for invasion and metastasis, anti-adhesion strategies as a potential 
adjunct to conventional cancer therapies were proposed. This study provides insight 
for future experimental designs investigating RB metastasis and developing 
therapeutic approaches to prevent secondary tumor formation in patients that survive a 
primary RB tumor. 
 
4.5 CONCLUSIONS  
In this study, it was discovered that ABCG2+ stem-like RB143 and WERI-Rb27 cells 
preferentially express ICAM-1, which acts as a bridge linking RB cells to leukocytes in 
the bloodstream via LFA-1:ICAM-1 interactions. It was found that neutrophil and RB 
cell aggregate formation is insensitive to initial cell ratio, highly ICAM-1 specific, and 
preferentially forms one-to-one aggregates (one neutrophil to one RB cell). 
Furthermore, it was hypothesized that a step-wise binding mechanism in which the 
neutrophils and RB cells first interact and form aggregates, roll on the E-selectin 
surface, and firmly adhere to the surface. Results from our work could lead to the design 
of anti-adhesion therapies that target metastatic cancer cells (especially cancer stem 
cells) and combat the invasive spread of cancer.  
 
 
 
 
  
  127 
Figure 4.1: ABCG2+ RB cells preferentially express ICAM-1. (a) Detection of an 
ABCG2+/ICAM1+ subpopulation within RB143 cells labeled with FITC-conjugated 
anti-ABCG2 monoclonal antibody and PE-conjugated anti-CD54 (ICAM-1) 
monoclonal antibody. The upper right panel consists of isotype control antibodies 
(background), followed by panels for individual ABCG2 or ICAM-1 fluorescence.  
The lower right panel demonstrates double labeling and the degree of overlap between 
ABCG2 and ICAM-1. (b) Double immunofluorescent labeling of ABCG2 (red) and 
ICAM-1 (green).  The same microscopic field is shown in all panels and merged with 
brightfield to display all cells in the field. 
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Figure 4.1: ABCG2+ RB cells preferentially express ICAM-1 
 
(b)  
 
  
(a) 
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Figure 4.2: Aggregate Formation is ICAM-1 Specific and Insensitive to Initial Cell 
Ratios. RB143 and WERI-Rb27 retinoblastoma cell lines were used in the microtube 
aggregation assay. For both cell lines, RB cell concentration was held constant at 1 
million/mL while neutrophil concentrations were varied from 2 million to 5 
million/mL. Antibody blocking experiments were done using monoclonal anti-human 
ICAM-1 antibody. In the “E-selectin negative” experiments, the microtube surface 
was only incubated with protein G. In PMN-negative experiments, only RB cells were 
perfused in the functionalized E-selectin surface. ANOVA and student t tests were 
used for statistical analyses. * p < 0.01; ** p<0.005 
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Figure 4.2: Aggregate formation is ICAM-1 specific and insensitive to initial cell 
ratios 
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Figure 4.3: RB-leukocyte binding events are primarily one-to-one binding.  
RB143 concentration was held constant at 1 million/mL while neutrophil 
concentrations were varied from 2 million to 5 million/mL. 1r1p = one RB with one 
neutrophil observed in aggregates, etc. Student t test was used for statistical analysis. P 
= 0.885 
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Figure 4.3: RB-leukocyte binding events are primarily one-to-one binding 
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Figure 4.4: Bound RB is downstream to its anchoring leukocyte under physiological 
flow. 40 adhering one-to-one binding events were analyzed in which both the RB and 
neutrophil were attached to the E-selectin surface. The angle of association between RB 
cells and neutrophils was calculated by measuring the deviation of RB cells from a 
vertical line drawn straight upward from the center of the neutrophil. Average distance 
between the centers of RB cells and neutrophils was found to be 22 µm.  
 
 
 
 
 
 
 
 
 
 
 
  134 
Figure 4.4: Bound RB is downstream to its anchoring leukocyte under 
physiological flow 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  135 
Figure 4.5: Hypothesis: RB cells are recruited by leukocytes in the bloodstream via 
LFA-1:ICAM-1 interactions. This illustration shows a three-step binding mechanism 
that facilitates the RB-neutrophil aggregate formation. (1) Neutrophils and RB cells 
are flowing in the microtube; (2) Neutrophils and RB cells interact and form 
aggregates; (3) The aggregates are firmly arrested to the surface through the neutrophil 
sLex:E-selectin binding.  
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Figure 4.5: A schematic of RB cells recruited by leukocytes in the bloodstream 
via LFA-1:ICAM-1 interactions 
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CHAPTER 5 CHARACTERIZATION OF THE INTERACTIONS OF 
ENDOTHELIAL ADHESION MOLECULES WITH 
UNDERGLYCOSYLATED MUC1  
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5.1 THREE TO TANGO: MUC1 AS A LIGAND FOR BOTH E-SELECTIN 
AND ICAM-1 IN THE BREAST CANCER METASTATIC CASCADE 
* This section is adapted from the following publication: Y. Geng, K. Yeh, T. 
Takatani, and M. R. King. Front. Oncol. 2:76, 2012 
 
5.1.1 INTRODUCTION 
The mucin family of glycoproteins is traditionally associated with the protection of the 
epithelial layer and provides lubrication of luminal epithelial surfaces. More recently, 
certain mucins have been identified as markers for metastatic cancers. Of particular 
importance, the mucin MUC1 is overexpressed in numerous cancers including breast, 
ovarian, lung, pancreatic, prostate, gastric, and colorectal cancers.31, 221, 86, 4, 292 where 
high expression generally correlates with increased mortality rates.259, 65, 93,139, 168 It is 
then reasonable to hypothesize that cancer’s adaptation and alteration of MUC1 may 
play a vital role in metastatic progression. 
Cancer metastasis through the bloodstream is initiated by the invasion of tumor 
cells from the primary site into the blood vessel.186 These circulating tumor cells 
(CTCs) can then adhere to the endothelial lining, which leads to extravasation and the 
formation of secondary tumor sites. For CTC adhesion, cells may first establish 
transient interactions with the activated endothelium which facilitates cell tethering 
and rolling events.246, 265, 279 These types of interactions are produced via selectins, a 
family of adhesion molecules expressed by the endothelium, and carbohydrate 
moieties, such as sialyl Lewis x (sLex) or sialyl Lewis a (sLea), present on the selectin 
ligands expressed by CTCs.20, 270 Once the cell has sufficiently reduced its rolling 
velocity, firm adhesion can be acquired through the interaction of the intracellular cell 
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adhesion molecule 1 (ICAM-1) on the endothelium and integrins on CTCs. This series 
of events is commonly referred to as the metastatic adhesion cascade.202 
MUC1 is not only over-expressed in many cancer types but is also aberrantly 
underglycosylated. The core structure of the extracellular domain of MUC1 mainly 
consists of 25-150 repeat units of 20 identical amino acid sequences rich in serines and 
threonines resulting in a length 5-10 times that of most membrane molecules. 
Normally, these amino acids would be heavily and richly O-glycosylated however 
aberrant MUC1 has been shown to express shortened oligosaccharides such as sLex 
and sLea, where MUC1 has been shown to bind efficiently to E-selectin.162 
Interestingly, high levels of MUC1 carrying sLex/a correlates to poor prognosis in 
patients with lung adenocarcinoma.113 Aberrant MUC1 also has the propensity to 
expose its core epitope due to underglycosylation where it has become the target of 
various probes to determine MUC1 expression.184 Furthermore, ICAM-1 has been 
shown to recognize and bind to the core epitope of MUC1.100 Therefore, CTCs may 
utilize aberrant MUC1 to facilitate tethering and rolling due to the increased length of 
MUC1 relative to other selectin ligands, and firmly adhere the cell via ICAM-1 
interactions.219  
In this study, we investigate the role of MUC1 in breast cancer cell adhesion 
under flow with two cell lines: ZR-75-1 which is known to have a high metastatic 
potential, and MCF7 which is weakly metastatic. The differential adhesion of these 
two cell lines to the endothelium are studied in vitro via micro-renathane tubes coated 
with varying ratios of E-selectin and ICAM-1 which represent a model of metastasis-
prone microvasculature.72 We hypothesize that the underglycosylated form of MUC1 
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may serve as a ligand for both E-selectin and ICAM-1, which will allow for efficient 
interaction between CTCs in transit and the inflamed endothelium. 
 
5.1.2 MATERIALS AND METHODS 
Reagents 
Recombinant E-selectin-IgG1 chimera and recombinant ICAM-1-IgG1 chimera were 
purchased from R&D systems (Minneapolis, MN). Blotting grade blocker non-fat dry 
milk was obtained from Bio-Rad Laboratories (Hercules, CA) and Protein-G was 
purchased from EMD Biosciences (San Diego, CA). FITC mouse anti-human CD227 
(clone HPMV), FITC Mouse IgG1 k isotype control, purified mouse anti-human 
CD15s (clone CSLEX), APC rat anti-mouse IgM, and FITC goat anti-mouse IgG/IgM 
were all purchased from BD Biosciences (San Jose, CA). FITC mouse anti-human 
CD44v4 was obtained from AbD Serote (Germany).  FITC and APC anti-human IgG 
antibodies were purchased from Invitrogen (Carmarillo, CA). Ca2+ and Mg2+ free 
DPBS (Invitrogen, Camarillo, CA, USA), calcium carbonate (Sigma Chemical Co., St. 
Louis, MO, USA), and low endotoxin (1 ng/mg), essentially globulin-free Bovine 
Serum Albumin (Sigma Chemical Co., St. Louis, MO, USA) were used to prepare 
flow buffer for cell adhesion assays.  
 
Breast Cancer Cell Culture  
Breast cancer cell lines ZR-75-1 and MCF7 were purchased from ATCC and 
maintained in 10% Fetal Bovine Serum (FBS; Cellgro), 1% penicillin-streptomycin 
(Invitrogen), and RPMI 1640 medium (ZR-75-1) or eagle's minimal essential medium 
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with 0.01 mg/mL bovine insulin (MCF7) at 37°C with 5% CO2 in a humidified 
incubator. 
 
Flow Cytometry 
Cells were removed from tissue culture flasks prior to antibody incubation using an 
enzyme-free cell dissociation buffer solution.  After washing with 1x DPBS, the cells 
were resuspended in 1% BSA in DPBS to a final concentration of approximately 
250,000 cells in each sample. Antibodies against MUC1 or appropriate isotype 
controls were added to the cell suspensions and incubated over ice for 45 min. 
Specifically, mouse anti-human MUC1 mAb clone HPMV (reacts with the peptide 
core of MUC1) and mouse anti-human MUC1 mAb clone SM3 (recognizes the 
underglycosylated form of MUC1) were used in this study. Following incubation, 
cells were washed twice with 500 µL of 1% BSA to remove any unbound antibody. 
Flow cytometry samples were analyzed using a BD Accuri C6 flow cytometer (Ann 
Arbor, MI). .  
 
Soluble ICAM-1 Binding Assay  
Recombinant human ICAM-1-IgG1 chimeric protein (R&D) was fluorescently tagged 
with Alexa 647 anti-human IgG antibody and incubated with ZR-75-1 and MCF7 cells 
in 1XDPBS with 2% BSA for 30 min at room temperature. Unbound proteins were 
washed off with 1XDPBS twice prior to flow cytometry and confocal microscopy 
imaging.  
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Preparation of Combined Protein Surfaces 
Micro-renathane tubing (microtube) with an inner diameter of 300 µm (Braintree 
Scientific Inc., Braintree, MA, USA) were cut to lengths of 50 cm. Recombinant 
human E-selectin-IgG1 and ICAM-1-IgG1 chimeric proteins were each dissolved in 1x 
PBS and mixed in various ratios (E-sel/ICAM-1: 10/0, 7.5/2.5, 5/5, 2.5/7.5, 0/10) to a 
final protein concentration of 10 µg/mL. The microtube surface was first rinsed with 
1x DPBS and then incubated with 10 µg/mL of protein-G solution for 1 h, followed by 
a 2 h incubation with the premixed E-selectin and ICAM-1 protein solution, then 
blocked with 5% milk protein in PBS for 1 h. To evaluate the correlation between 
incubation concentrations and surface coverage, FITC conjugated E-selectin and APC 
conjugated ICAM-1 were mixed in the ratios described above. Fluorescence images 
were taken and analyzed using Image J (http://rsbweb.nih.gov/ij/).  
 
Cell Adhesion Assay  
After surface functionalization as described above, microtubes were secured to the 
stage of an Olympus IX81 motorized inverted microscope (Olympus America, 
Melville, NY).  A CCD camera (model no: KP-M1AN, Hitachi, Tokyo, Japan) and a 
DVD recorder (model no: DVD-1000MD, Sony Electronics) were used to record 
experiments for offline analysis.  ZR-75-1 and MCF7 breast cancer cells suspended 
in flow buffer were perfused through protein coated microtubes using a syringe pump 
(KDS 230, IITC Life Science, Woodland Hills, CA) at a wall shear stress of 1.0 
dyne/cm2.  
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Confocal Immunofluorescence Microscopy  
ZR-75-1 and MCF7 cells were removed from tissue culture flasks, washed with 1X 
DPBS, resuspended with 2% BSA in 1X DPBS, loaded to a pre-assembled cytospin 
cuvette, and spun at 750 rpm for 3 min in a Shandon Cytospin 3 centrifuge (Harlow 
Scientific, Arlington, MA). Cytospin slides were than dried and fixed with 4% 
paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA) prior to antibody 
labeling. Indirect surface staining for MUC1 was performed using mouse anti-human 
MUC1 mAb (clone SM3) and Alexa 647 rat anti-mouse mAb as a secondary antibody. 
For some cytospin slides, nuclear staining with DAPI was performed for 10 min at 
room temperature prior to imaging. Samples from the soluble ICAM-1 binding assay 
were deposited on cytospin slides for imaging. A Zeiss 710 laser scanning confocal 
microscopy at the Cornell University microscopy and imaging core facility was used 
to collect images at 40X magnification.  
 
Data Acquisition and Analysis  
‘‘Rolling’’ cells were defined as those observed to translate in the direction of flow 
with an average velocity less than 50% of the calculated hydrodynamic free stream 
velocity. The rolling velocity was calculated by measuring the distance a rolling cell 
traveled over a 30 second interval. Videos of rolling cells were taken at three 
randomly selected locations along the microtube. “Tethering” cells were defined as 
cells that were observed to roll intermittently with fluctuating velocity. The quantity of 
cells rolling, adherent and tethering was determined by recording images at 30 
randomly selected locations along the microtube. All errors are reported as standard 
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error of the mean, and statistical analyses were performed using Prism (GraphPad 
Software, San Diego, CA). 
 
Molecular Dynamics  
The crystal structure of SM3 bound to the MUC1 core fragment (1SM360) was 
obtained from the Protein Data Bank for use as starting coordinates. The MUC1 
fragment was equally extended beyond the SM3:MUC1 interaction to include all 
amino acids of one complete tandem repeat unit (PATSGPAPRTDPASTVGHAP) and 
the furthest threonine/serine from SM3 was O-glycosylated with the sLex carbohydrate 
group. Using the YASARA (http://yasara.org) package of molecular dynamics (MD) 
programs, the complex was solvated in a water cube with an initial length of 100 Å to 
allow for free protein rotation and neutralized to 0.9% NaCl with physiologically 
neutral pH (7.4). The YAMBER3 self-parameterizing force field145 was implemented 
with periodic boundary conditions, the particle mesh Ewald method for electrostatic 
interactions,68 and a recommended 7.86 Å force cutoff for long-range interactions. 
Temperature and pressure were held constant at 300 K and 1 atm, respectively, while 
the water box was allowed to adjust slightly to constrain the water density to 0.997 
g/L. Conformational stresses were then removed via short steepest descent 
minimizations and simulated annealing was run until sufficient convergences were 
reached. A free dynamics simulation was then run for 10 ns to obtain the final 
equilibrated structure. 
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5.1.3 RESULTS 
Differential MUC1 Expression on ZR-75-1 and MCF7 Cells and Their Ability to Bind 
to ICAM-1 under Static Conditions  
MUC1 core peptide expression was measured for both ZR-75-1 and MCF7 cells via 
flow cytometry using MUC1 mAb clone HPMV and found to be significantly higher 
on ZR-75-1 cells (Figure 5.1a). MUC1 mAb clone SM3 was also used to detect the 
underglycosylated form of MUC1, which has been identified as a tumor associated 
form of MUC1 181. Although no significant shift was observed, mean fluorescence 
intensity of sample/isotype for ZR-75-1 cells was observed to be five times higher 
than MCF7 cells (Figure 5.1b). Furthermore, confocal microscopy images with MUC1 
antibody (SM3) labeling showed brighter signals on ZR-75-1 cells (Figure 5.1c). 
Strong homogenous cytoplasmic staining of MUC1 (SM3) was observed on some ZR-
75-1 cells (Figure 5.1c right) but not on MCF7 cells. To assay MUC1:ICAM-1 
binding under static conditions, human recombinant ICAM-1 was conjugated with a 
fluorescently tagged secondary antibody and incubated with both cell types. Flow 
cytometry and confocal microscopy results both show significantly stronger binding of 
ICAM-1 to ZR-75-1 cells compared to MCF7 cells (Figure 5.1d).  
 
E-selectin Ligand and Binding Moiety Expression on ZR-75-1 and MCF7 cells  
The mean fluorescence intensity (MFI) ratios of sample over isotype control for the E-
selectin binding moiety sLex expression on ZR-75-1 and MCF7 were found to be 8.43 
and 8.56, respectively, via flow cytometry (Figure 5.2a). CD44 variant 4 (CD44v4), 
among the multiple variants of common E-selectin ligand CD44, has been identified as 
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a major E-selectin ligand for breast cancer cells.287 CD44v4 expression was measured 
on ZR-75-1 and MCF7 cells via flow cytometry and no significant difference was 
observed (Figure 5.2b).  
 
E-selectin and ICAM-1 Combined Surface  
The initial layer of protein G orients the adhesion molecules to maximally interact 
with cell surfaces as the cells are perfused through the tubes. As the E-selectin:ICAM-
1 concentration ratios were increased, the fluorescence intensity of bound E-selectin in 
the microtube was found to linearly increase while ICAM-1 fluorescence linearly 
decreased (Figure 5.2c), verifying the desired protein concentrations on the microtube 
surfaces.   
 
MUC1 is Involved in the Cancer Adhesion Cascade in Association with E-Selectin and 
Its Ligands  
Figures 5.3a and 5.3b divide the cells that interact with the surface into three 
categories: tethering, rolling, and adherent. ZR-75-1 cells were found to roll quite 
consistently when E-selectin was present at any concentration on the surface where 
there was a slight decrease in the percent of rolling cells as the E-selectin 
concentration decreases (Figure 5.3a). Conversely, the percent of ZR-75-1 tethering 
cells increased as the E-selectin:ICAM-1 ratio decreased. Interestingly, adherent ZR-
75-1 cells were observed only when both E-selectin and ICAM-1 exist on the surface 
and 7.5:2.5 was found to be the optimal ratio of E-selectin:ICAM-1 that yields the 
greatest number of adherent cells. However, as the E-selectin:ICAM-1 ratio decreased 
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so did the percent of adherent cells. On the other hand, MCF7 rolling and tethering 
showed little sensitivity to varying the E-selectin:ICAM-1 ratios where MCF7 
tethering cells only slightly increased as the ratio decreased, as shown in Figure 5.1b. 
Most notably, no adherent MCF7 cells were observed on the surface for any 
concentration ratio. For both ZR-75-1 and MCF7 cells, when only ICAM-1 coats the 
surface no cells interacted adhesively. Anti-MUC1 mAb (clone SM3) was found to 
block the adhesive interactions on ZR-75-1 cells with the surface, leaving only the 
tethering and rolling populations (Figure 5.3c). 
The cell flux for each cell type (Figures 5.1.4a-c) shows little sensitivity to the 
combined surface concentration ratios. However, overall the ZR-75-1 cell flux is much 
greater than both MCF7 and SM3 blocked ZR-75-1 cell fluxes, roughly by a factor of 
2. Comparing ZR-75-1 to MCF7 and SM3 blocked ZR-75-1 cells, the cell fluxes 
inversely correlate with the cell rolling velocities as shown in Figures 5.5a and 5.5b 
where the ZR-75-1 cell rolling velocities were found slower than MCF7 cell rolling 
velocities. For example, for surfaces coated with only E-selectin, MCF7 cells rolled at 
approximately 6-7 µm/s whereas ZR-75-1 cells roll at approximately 2 µm/s. SM3 
blockade was found to cause an increase in rolling velocity to approximately 4 µm/s, 
significantly faster than untreated cells. A structure of SM3 bound to the 
underglycosylated core epitope of MUC1 is depicted in Figure 5.5c, where SM3 not 
only blocks ICAM-1 interactions, but is sufficiently bulky compared to sLex to inhibit 
some amount of E-selectin interactions as well. Unlike cell flux, both ZR-75-1 
(untreated and blocked) and MCF7 cell rolling velocities were sensitive to the E-
selectin concentration where cell rolling velocities increased as the E-selectin 
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concentration decreased (Figure 5.5a and 5.5b). Furthermore, the MCF7 cell rolling 
velocity at the lowest E-selectin concentration was double that of the cell rolling 
velocity at the highest E-selectin concentration which shows a greater sensitivity to E-
selectin compared to ZR-75-1 cells. 
 
5.1.4 DISCUSSION 
The detection and enumeration of circulating tumor cells (CTCs) holds great potential 
in breast, colorectal, and prostate cancer prognosis, yet the basic biophysics of how 
these CTCs interact with the endothelium is not fully understood. Similar to leukocyte 
recruitment to the endothelium, CTC tethering and rolling on the blood vessel wall 
under hydrodynamic shear stress are also mediated by the selectin family of adhesion 
molecules.82 After stable rolling on the endothelium, leukocytes can firmly adhere to 
the inflamed endothelium via leukocyte beta-2 integrin (Mac-1, LFA-1): ICAM-1 
binding.55, 58,129 Similarly for epithelial-type CTCs, tumor associated MUC1 may play 
the role of beta-2 integrins on leukocytes by binding ICAM-1 to enable firm adhesion 
and initiate subsequent events in the metastatic cascade.216  
Tumor associated MUC1 on breast cancer cells was first identified as a novel 
adhesion ligand for endothelial ICAM-1 by Regimbald et al. via static adhesion assays 
between MCF7 cells and stimulated HUVEC cells as well as immobilized 
recombinant ICAM-1.219 MCF7 cells do not express common ICAM-1 ligands, such 
as LFA-1, Mac-1, or CD43. However under static conditions, MUC1 was found to 
interact with ICAM-1, which could mediate firm adhesion of CTCs to the inflamed 
endothelium. In contrast, we characterized the adhesive role of tumor associated 
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MUC1 under hydrodynamic shear stress by perfusing both ZR-75-1 (which 
overexpresses MUC1) and MCF7 cells through functionalized microtubes, more 
representative of the blood vessel microenvirnoment. Furthermore, the inflamed 
endothelium was simulated by immobilizing both E-selectin and ICAM-1 with 
varying ratios on the microtube surface, creating a more physiologically relevant and 
controllable environment to study the adhesion events of circulating ZR-75-1 and 
MCF7 cells under flow. 
ZR-75-1 cells show a much greater expression of underglycosylated MUC1 
compared to MCF7 cells, which significantly affects their adhesion behavior when 
perfused through the combined surface microtubes. Interestingly, although ZR-75-1 
and MCF7 cells have similar expression levels of sLex, one of the E-selectin binding 
moieties, ZR-75-1 cells roll on the combined protein surface at a significantly slower 
rolling velocity, indicating that ZR-75-1 cells establish stronger interactions with E-
selectin. Recall that underglycosylated forms of MUC1 also contain shortened 
oligosaccharides where sLex is one of the most common carbohydrates of aberrant 
MUC1.31 Therefore MUC1, when appropriately decorated with sLex in its 
underglycosylated form, is expected to extend further from the cell surface compared 
to other selectin ligands due to its size and is perhaps more able to interact with E-
selectin to efficiently mediate tethering and rolling events. The greater rolling 
velocities of ZR-75-1 cells blocked with SM3 also suggests MUC1 as an important E-
selectin ligand because SM3 could inhibit some amount of E-selectin:MUC1 
interactions due to the size of SM3 compared to sLex (Figure 5.5c). As a result of the 
slower rolling velocity and greater MUC1 expression, only ZR-75-1 cells firmly 
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adhered to the combined surface, where firm adhesion is facilitated by MUC1:ICAM-
1 interactions. In our study, the observation of firmly adhered cells to the combined 
surface under shear stress is consistent with the metastatic potential of the ZR-75-1 
cell line (highly metastatic) and the MCF7 cell line (weakly metastatic). 
In conclusion, we propose a mechanism by which MUC1 can act as a ligand 
for E-selectin, initiating tethering and rolling events of CTCs on the endothelium, and 
subsequently serve as an ICAM-1 ligand, mediating firm adhesion of CTCs (Figure 
5.6). The synergistic effect of MUC1:E-selectin and MUC1:ICAM-1 may play an 
important role in breast cancer metastasis through the bloodstream where 
underglycosylated MUC1 can significantly slow the rolling velocity of CTCs thereby 
allowing for more frequent occurrence of firm adhesion events and subsequent 
extravastion. In summary, our results provide new insights into the roles of MUC1 in 
the metastatic adhesion cascade and suggests future examination into clinical aspects 
where the underglycosylated form of MUC1 can be targeted since aberrantly 
underglycosylated MUC1 expression is highly correlated to poor prognosis in breast 
and colon cancer patients.  
  
 
 
 
 
 
 
 
 
 
  
  151 
Figure 5.1: MUC1 expression and ICAM-1/E-selectin binding capabilities of ZR-75-1 
and MCF7 cells. (a) Flow cytometry histogram plots of ZR-75-1 and MCF7 labeled 
with anti-MUC1 mAb clone HPMV, respectively. (b) Quantification of the mean 
fluorescence intensity (MFI) ratio of sample/isotype for both cell types with anti-
MUC1 mAb clone SM3 and HPMV, respectively. Student’s t-test was used for 
statistical analysis and results from both labeling experiments were found to be 
significantly different for ZR-75-1 and MCF7 cells (p≤0.01). (c) Left and middle: 
confocal microscopy images of MCF7 and ZR-75-1 labeled with anti-MUC1 mAb 
(clone SM3), respectively. Right: strong signal of SM3 anti-MUC1 mAb in the 
cytoplasmic region of selective ZR-75-1 cells. (d) Left: flow cytometry histogram of 
fluorescently tagged ICAM-1 labeling on ZR-75-1 and MCF7 cells. Middle and right: 
confocal microscopy images of MCF7 and ZR-75-1 cells labeled with fluorescently 
tagged ICAM-1. 
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Figure 5.1: MUC1 expression and ICAM-1/E-selectin binding capabilities of ZR-
75-1 and MCF7 cells 
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Figure 5.2: Characterization of ligand expression and surface functionalization. (a) 
and (b) Flow cytometry histogram overlays of ZR-75-1 and MCF7 cells labeled with 
anti-sLex (clone CSLEX ) mAb and anti-CD44V4 mAb, respectively. (c) E-selectin 
and ICAM-1 fluorescence intensities as concentration ratios vary during surface 
preparation. The r2 values for E-selectin and ICAM-1 fluorescence intensity trend lines 
were found to be 0.986 and 0.995, respectively.  
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Figure 5.2: Characterization of ligand expression and surface functionalization 
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Figure 5.3: Adhesion phenotypes on combined protein surface under physiological 
flow of (a) ZR-75-1, (b) MCF7, and (c) SM3 blocked ZR-75-1 cells. Two-way 
ANOVA was used for statistical analysis and results from all conditions were found to 
be significantly different (p≤0.001).  
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Figure 5.3: Adhesion phenotypes of ZR-75-1 and MCF7 cells on combined 
protein surfaces 
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Figure 5.4: Quantification of average number of cells captured on the surfaces with 
varying ratios of E-selectin and ICAM-1 for (a) ZR-75-1, (b) MCF7, and (c) SM3 
blocked ZR-75-1 cells. One-way ANOVA was used for statistical analysis. For all 
three experiments, results from all conditions were found to be significantly different 
with p values of 0.0008, 0.0093, and 0.0016 for ZR-75-1, MCF7, and SM3 blocked 
ZR-75-1, respectively. ** p≤0.01 *** p≤0.001 
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Figure 5.4: Quantification of average number of cells captured on the combined 
surfaces with varying ratios of E-selectin and ICAM-1 
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Figure 5.5: Adhesion profile of SM3 blocked ZR-75-1 and MCF7 cells. (a) and (b) 
Rolling velocities of ZR-75-1 (untreated and blocked) and MCF7 cells on combined 
and E-selectin surfaces with varying incubation concentrations under flow, 
respectively. (c) Equilibrated structure of SM3 (gray) bound to the core epitope of one 
repeat unit of MUC1 (red) singly O-glycosylated with sLex (blue) on a threonine 
residue. Below is the amino acid sequence of a MUC1 repeat unit where the bracket 
indicates the interaction site of SM3 and the blue arrow indicates the chosen O-
glycosylated amino acid. Student’s t-test and ANOVA were used for statistical 
analysis. * p≤0.05 *** p≤0.001 NS: non-significant  
 
 
 
 
 
 
  160 
Figure 5.5: Adhesion profile of SM3 blocked ZR-75-1 and MCF7 cells 
 
 
 
 
 
 
 
 
 
 
 
 
  
E-
se
l 1
0 I
CA
M 
0
E-
se
l 1
0 I
CA
M 
0 (
SM
3) 
E-
se
l 7
.5
E-
se
l 7
.5 
IC
AM
 2.
5
E-s
el 
7.5
 IC
AM
 2.
5 (
SM
3) 
E-
se
l 5
E-
se
l 5
 IC
AM
 5
E-
se
l 5
 IC
AM
5 (
SM
3) 
E-
se
l 2
.5
E-
se
l 2
.5 
IC
AM
 7.
5
E-s
el 
2.5
 IC
AM
 7.
5 (
SM
3) 
0
5
10
15
20
ZR-75-1 (E-sel only)
ZR-75-1
ZR-75-1 (SM3 blocked) 
*** *** *** ***
C
el
l R
ol
lin
g 
V
el
oc
ity
 (µ
m
/s
)
E-
se
l 1
0 I
CA
M 
0
E-s
el 
7.5
 
E-s
el 
7.5
 IC
AM
 2.
5 
E-
se
l 5
E-
se
l 5
 IC
AM
 5
E-s
el 
2.5
 
E-
se
l 2
.5 
IC
AM
 7.
5
0
5
10
15
20 MCF7 (E-sel only)
MCF7
NS NS
*
C
el
l R
ol
lin
g 
V
el
oc
ity
 (µ
m
/s
)
(a) (b)
(c) 
  161 
Figure 5.6: Proposed mechanism by which MUC1 can act as a ligand for E-selectin, 
initiating tethering and rolling events of CTCs on the endothelium, and subsequently 
serve as an ICAM-1 ligand, mediating firm adhesion of CTCs.  
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Figure 5.6: A schematic of MUC1 as a ligand for both E-selectin and ICAM-1 
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5.2 TARGETING UNDERGLYCOSYLATED MUC1 FOR THE SELECTIVE 
CAPTURE OF HIGHLY METASTATIC BREAST CANCER CELLS UNDER 
FLOW  
*This section is adapted from the following publication: Y. Geng, T. Takatani, K. 
Yeh, J. W. Hsu, and M. R. King. Cellular and Molecular Bioengineering. 6:148-159, 
2013  
 
5.2.1 INTRODUCTION 
Leukocyte recruitment to the inflamed endothelium and cancer metastasis through the 
bloodstream via circulating tumor cells (CTCs) have been proposed to share a similar 
stepwise mechanism that allows for cell adhesion and extravasation.82, 186, 202, 239, 243 
Referred to as adhesion cascades (leukocyte and CTC), cells first tether and roll on the 
blood vessel wall via transient interactions between P- and E-selectin present on the 
inflamed endothelium34, 243 and carbohydrate moieties, such sialyl Lewis X (sLex) or 
sialyl Lewis a (sLea) found on leukocytes and CTCs.240, 241 Sufficiently slow cell 
rolling permits firm cell adhesion events mediated by endothelial intercellular 
adhesion molecule-1 (ICAM-1) at locations of transendothelial migration.18, 72 Work 
by our group has capitalized on these selectin:carbohydrate based interactions to 
capture CTCs as well as hematopoietic stem and progenitor cells with the ability to 
maintain cell viability.110, 111, 194, 195 Further differentiation between CTCs and 
contaminating leukocytes will allow isolation processes to be further optimized with 
respect to both yield and purity. 
Three cell adhesion molecules constitute the members of the selectin family. 
E-selectin, primarily expressed by inflamed endothelial cells, has been extensively 
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studied for its role in leukocyte recruitment in response to vascular injury157 as well as 
CTC adhesion.82, 120 P-selectin is a granule protein expressed by both platelets and 
endothelial cells, and therefore has been linked to the adhesion of platelets,99 
leukocytes,173 and cancer cells126 to the endothelium. L-selectin differs in that it is 
expressed by lymphocytes and leukocytes, not endothelial cells, and therefore is not 
normally considered in the context of cancer cell adhesion. All selectins contain the 
epidermal growth factor and lectin domains where the carbohydrate moieties can bind 
via calcium dependent interactions.175 These carbohydrate moieties are attached to O-
glycosylated proteins on the cell surface, referred to as selectin ligands, and in the 
context of cell adhesion to the vascular wall, both the metastatic and leukocyte 
adhesion cascades rely on similar selectin ligands to facilitate initial tethering and 
rolling events.23, 268 
      Leukocytes express three main selectin ligands: P-selectin glycoprotein ligand 
1 (PSGL-1), E-selectin ligand (ESL-1), and CD44.103 CTCs, on the other hand, not 
only potentially express these three selectin ligands56, 261 but also a myriad of other 
selectin ligands such as CD24, CD43, CEA, and PCLP.2, 260, 261, 288 Recently two novel 
E-selectin ligands, mainly present on breast cancer cells, have been postulated: Mac-
2BP237 and MUC1.69, 288, 289 Interestingly, the underglycosylated form of MUC1 
(uMUC1) has been shown to be upregulated in various breast cancer cells43, 184 and 
clinically, high uMUC1 expression is correlated to poor prognosis and increased 
metastases.267 Moreover, the core of MUC1 has also been shown to be an ICAM-1 
ligand.100 Motivated by these findings, we recently elucidated the synergistic role of 
uMUC1 as both E-selectin and ICAM-1 ligands during the CTC adhesion cascade.84  
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Although selectin ligands can potentially bind to all three selectins via 
calcium:carbohydrate dependent binding, selectin ligands often preferentially bind to 
particular selectins. Hidalgo et al. attempted to clarify the specific functions of each 
selectin ligand during the leukocyte adhesion cascade.103 PSGL-1, which preferentially 
binds to P- and L-selectin,241 was found responsible for the initial capture and 
tethering of leukocytes. ESL-1, which preferentially binds to E-selectin,249 generated 
rolling cells from tethering events. Lastly, CD44 interactions with E-selectin have 
been found to control cell rolling velocity.103 L-selectin (present on leukocytes) is 
polarized after leukocyte firm adhesion where further possible interactions with 
PSGL-1 on other leukocytes in the bloodstream can occur. It is also possible for L-
selectin to interact with E-selectin on the endothelium to further enhance cell 
capture.291 Our group has exploited this selectin preference while studying the 
efficiency of halloysite nanotubes on CTC capture,110, 111 where P-selectin was utilized 
when cells expressed PSGL-1 and E-selectin was used otherwise. We have also found 
that pathologically decreasing extracellular pH can enhance PSGL-1 binding to P- and 
L-selectin, while having no effect on E-selectin:PSGL-1 binding.35 Taken together, the 
use of different selectins can offer another axis of control to more efficiently and 
selectively capture CTCs. 
      In our previous study of MUC1, we examined the adhesion profiles of ZR-75-
1 and MCF7 cells on combined surfaces of E-selectin and ICAM-1.84 We found that 
whereas both cell lines exhibited high levels of MUC1, only ZR-75-1 cells exhibited 
uMUC1 which lead to slower rolling velocities (facilitated by E-selectin) and the 
existence of firm adhesion events (facilitated by ICAM-1) which strongly suggested 
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that the uMUC1 glycoprotein significantly participates in the adhesion of metastatic 
cancer cells to the inflamed endothelium. To extend the E-selectin/ICAM-1 combined 
surface study in the context of cell adhesion facilitated by uMUC1, we first utilize the 
ZR-75-1 and T47D cell lines, which both have been shown to express high levels of 
uMUC1, to further characterize the differential adhesion of uMUC1 to E-selectin 
coated surfaces. We then explore the preferential binding of uMUC1 to E-, P-, and L-
selectin via experimental rolling assays under shear stress and molecular dynamics 
(MD) simulations. Since uMUC1 is only expressed by CTCs in the bloodstream, we 
further hypothesize that utilizing a combined E-selectin and SM3 (antibody that 
specifically binds to uMUC1) surface may provide a novel approach to target CTCs 
for capture or treatment, where the E-selectin:uMUC1 interactions facilitate cell 
rolling and the SM3:uMUC1 interactions selectively capture rolling CTCs.  
 
5.2.2 MATERIALS AND METHODS 
Reagents 
Recombinant human E-selectin-IgG chimera was purchased from R&D systems 
(Minneapolis, MN). Blotting grade blocker non-fat dry milk was purchased from Bio-
Rad Laboratories (Hercules, CA) and Protein-G was purchased from EMD 
Biosciences (San Diego, CA). FITC mouse anti-human CD227 (clone HPMV), FITC 
Mouse IgG1 k isotype control, purified mouse anti-human CD15s (clone CSLEX), 
APC rat anti-mouse IgM, FITC mouse anti-human CD44, and FITC goat anti-mouse 
IgG/IgM were all purchased from BD Biosciences (San Jose, CA). Mouse anti-human 
MUC1 mAb clone SM3 (recognizing the underglycosylated form of MUC1) was 
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purchased from Abcam (Cambridge, MA). Mouse anti-human CA19-9 (sLea) was 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA).  APC anti-human IgG 
antibodies were purchased from Invitrogen (Carmarillo, CA). Ca2+ and Mg2+ free 
DPBS (Invitrogen, Camarillo, CA, USA), calcium carbonate (Sigma Chemical Co., St. 
Louis, MO, USA), and low endotoxin (1 ng/mg), essentially globulin-free Bovine 
Serum Albumin (Sigma Chemical Co., St. Louis, MO, USA) were used to prepare 
flow buffer for cell adhesion assays. CELLviewTM glass bottom dishes from Greiner 
Bio-one were used to plate cells for confocal microscopy experiments.  
 
Breast Cancer Cell Culture  
Breast cancer cell lines ZR-75-1 and T47D were purchased from ATCC and 
maintained in 10% Fetal Bovine Serum (FBS; Cellgro), 1% penicillin-streptomycin 
(Invitrogen), and RPMI 1640 medium at 37°C with 5% CO2 in a humidified incubator. 
 
Flow Cytometry 
Cells were removed from tissue culture flasks prior to antibody incubation using an 
enzyme-free cell dissociation buffer solution. After washing with 1x DPBS, the cells 
were resuspended in 1% BSA in DPBS to a final concentration of approximately 
250,000 cells per sample. Antibodies against MUC1 or appropriate isotype controls 
were added to the cell suspensions and incubated over ice for 45 min. Specifically, 
mouse anti-human MUC1 mAb clone HPMV (reacts with the peptide core of MUC1) 
and mouse anti-human MUC1 mAb clone SM3 (recognizing the underglycosylated 
form of MUC1) were used in this study. Antibodies against CD44, sLea, and sLex 
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were also used in this study to quantify the ligand and glycan expression on both cell 
types. Following incubation, cells were washed twice with 500 µL of 1% BSA to 
remove any unbound antibody. Flow cytometry samples were analyzed using a BD 
Accuri C6 flow cytometer (Ann Arbor, MI).  
 
Confocal Immunofluorescence Microscopy  
ZR-75-1 and T47D cells were plated in CELLviewTM glass bottom dishes overnight 
prior to imaging. Surface staining for MUC1, uMUC1 and sialyl lewis x was 
performed using mouse anti-human MUC1 mAb (clone SM3) and Alexa 647 rat anti-
mouse mAb as a secondary antibody as described in Ref. 84. Cells were also 
incubated with conjugated human recombinant E-selectin chimera for 30 min at room 
temperature (RT). A Zeiss 710 laser scanning confocal microscopy at the Cornell 
University microscopy and imaging core facility was used to collect images at 40X 
magnification.  
 
Preparation of Immobilized Protein Surfaces 
Polyurethane microtubes with an inner diameter of 300 µm (Braintree Scientific Inc., 
Braintree, MA, USA) were cut to a length of 50 cm. Recombinant human E-selectin-
IgG chimeric protein was dissolved in 1X PBS to a final concentration of 5 µg/mL. 
The microtube surface was first rinsed with 75% ethanol and then 1X PBS. The 
surface was subsequently incubated with 10 µg/mL protein-G solution for 1.5 h, 
followed by a 2 h incubation with selectin chimera then blocked with 5% milk protein 
in PBS for 1 h. Control tubes were blocked with 5 % milk protein in PBS for 1 h.  
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Flow-Based Adhesion Assay 
Microtubes functionalized with E-selectin/Fc chimera (described above) were taped 
onto a piece of thin glass in the viewing area of the Olympus IX81 inverted 
microscope (Olympus America Inc., Melville, NY, USA). A CCD camera (model no: 
KP-M1AN, Hitachi, Tokyo, Japan) and a DVD recorder (model no: DVD-1000MD, 
Sony Electronics) were used to record experiments for offline analysis.  ZR-75-1 and 
T47D breast cancer cells suspended in flow buffer containing calcium were perfused 
through the microtubes using a syringe pump (KDS 230, IITC Life Science, 
Woodland Hills, CA) at a wall shear stress of 1.0 dyne/cm2.  
 
Neuraminidase Treatment  
For certain experiments, ZR-75-1 and T47D cells were treated with 0.1 U/mL Vibrio 
Cholerae Neuraminidase (Roche Applied Science, Indianapolis, IN) for 45 min at 
37°C to cleave the terminal sialic acid residues. After enzyme treatment cells were 
washed and perfused through the functionalized microtubes.  
 
siRNA Transfection   
Cells were transfected with MUC1 siRNA 20 nM (QIAGEN) for 12 hr. Total RNA 
was isolated from transfected cells using TRIzol (Life Technologies). A real-time PCR 
was carried out using oligo dT first strand primers, MUC1 specific primers 
((5′TGCATCAGGCTCAGCTTCTA 3′ and 5′ GAAATGGCACATCACTCACG3′, 
IDT Integrated DNA Technologies), and SYBR Green PCR Kit (QIAGEN). MUC1 
  170 
expression was normalized against GAPDH. 
 
Polymorphonuclear Neutrophil (PMN) and Buffy Coat Isolation 
Human peripheral blood was collected from healthy adult donors after informed 
consent by venipuncture into BD Vacutainer tubes, approved by the Cornell 
University Institutional Review Board for Human Participants. PMN isolation was 
performed following a protocol described previously.83 Briefly, PMNs were isolated 
by centrifugation at 500g for 50 min using 1-Step Polymorphs (Accurate Chemical 
and Scientific Corporation, Westbury, NY, USA). The PMN layer was extracted and 
washed twice in Ca2+ and Mg2+ free HBSS to remove the polymorph residue, and any 
remaining red blood cells were lysed hypotonically with 1:6 and 4X PBS. PMNs were 
then resuspended at various concentrations of HBSS containing 0.5% HSA, 2 mM 
Ca2+, and 10 mM HEPES, buffered to 7.4. Similarly, buffy coat layer isolation was 
performed using Ficoll density gradient and washed with HBSS.  
 
Cancer Cell Capture from Spiked Buffy Coat  
ZR-75-1 cells were fluorescently labeled with Cell Tracker Green (Invitrogen), a live 
cell dye, for 30 min at 37°C. 100,000 or 50,000 of the labeled ZR-75-1 cells were then 
spiked into 1 mL of normal buffy coat and perfused through protein coated microtubes 
in two separate experiments. Capture efficiency was calculated using the estimated 
total number of cells in the microtube from 20 images recorded at random locations 
along the length of the microtube based on a previously published calibration.111 
 
  171 
Data Acquisition and Analaysis 
‘‘Rolling’’ cells were defined as those observed to translate in the direction of flow 
with an average velocity less than 50% of the calculated hydrodynamic free stream 
velocity. The rolling velocity was calculated by measuring the distance a rolling cell 
traveled over a 30 second interval. Videos of rolling cells were taken at three 
randomly selected locations along the microtube. For capture experiments, adherent 
cells were counted after perfusion with cell-free buffer for 5 min. The quantities of 
cells rolling and adhering were determined by recording images at 20 randomly 
selected locations along the microtube. All errors are reported as standard error of the 
mean, and statistical analyses were performed using Prism (GraphPad Software, San 
Diego, CA). 
 
Molecular Dynamics Simulations 
Free dynamics simulations were performed using the YASARA (http://yasara.org) 
package of molecular dynamics (MD) programs with the YAMBER3 self-
parameterizing force field145 and no external force field parameters. All simulations 
held the temperature and pressure constant at 300 K and 1 atm, respectively, while 
utilizing periodic boundary conditions, the particle mesh Ewald method for 
electrostatic interactions,67 equilibrium pH (7.4), and the recommended 7.86 Å force 
cutoff for long-range interactions. Complexes were solvated in a water box and 
neutralized by adding Ca2+ and Cl- ions to a concentration of ~50 mM calcium where 
the water boxes were defined as cubes with lengths measuring approximately 85 Å to 
allow for free protein rotation. The water boxes were also allowed to adjust slightly to 
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constrain the water density to 0.997 g/L. Conformational stresses were removed via 
short steepest descent minimizations followed by simulated annealing until sufficient 
convergences were reached. Free dynamics simulations were then run for 20 ns time 
periods. 
The lectin and epidermal growth factor crystal structures of P-selectin bound to 
PSGL-1 (1G1S 241), E-selectin bound to sLex (1G1T241), and L-selectin (3CFW) were 
obtained from the Protein Data Bank for use as starting atomic coordinates. Predicted 
uMUC1 bound to P-selectin was obtained by altering the PSGL-1 amino acid 
sequence of the P-selectin:PSGL-1 complex (1G1S subunit A) to the uMUC 1 
sequence where two amino acids were included beyond the O-glycosylated site for 
consistency with the PSGL-1 crystal structure. Extra amino acids were extended to 
include the entire 20 unit uMUC1 sequence (PDTRPAPGSTAPPAHGVTSA). In 
separate trials, residues S9, T10, and T18 were O-glycosylated with the carbohydrate 
moiety where sLex was coordinately bound to the calcium of P-selectin. To obtain 
starting E-selectin:uMUC1 and L-selectin:uMUC1 complexes, the E-selectin (1G1T) 
and L-selectin (3CFW) crystal structures were aligned on the various P-
selectin:uMUC1 complexes via the MUSTANG algorithm.140 
 
5.2.3 RESULTS AND DISCUSSION 
Selectin Ligand Expression 
The surface expression of common selectin ligands and their carbohydrate binding 
moieties was first characterized. Both T47D and ZR-75-1 cells were found to express 
some amount of CD44 (Figure 5.7A&E) while neither expressed PSGL-1 (data not 
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shown, also suggested by Shirure et al.237). These two cells lines differed in their 
expression of the important selectin-binding moieties sLea and sLex. T47D cells 
exhibited very little sLea (Figure 5.7B) and no sLex (Figure 5.7C) while ZR-75-1 cells 
showed significant expression of both sLea and sLex (Figures 5.7F&G). The 
differential expression of these selectin binding moieties resulted in a greater 
preference of ZR-75-1 over T47D cells in soluble E-selectin binding assays, as 
revealed by confocal microscopy (Figures 5.7D&H). T47D cells, however, showed 
weak staining of bound E-selectin which may be due to the minimal surface 
expression of sLea. 
       In previous research to examine the adhesive capabilities of uMUC1, we 
utilized the ZR-75-1 and MCF7 cells lines due to their high expression of the MUC1 
glycoprotein.84 It was found that while both cell lines expressed MUC1, ZR-75-1 cells 
expressed significantly more MUC1 as indicated by SM3 antibody staining. The SM3 
antibody has been shown to bind to the MUC1 core epitope corresponding to the 
underglycosylated form of MUC1 (uMUC1).60 We hypothesized that the metastatic 
potential of ZR-75-1 cells (highly metastatic) and MCF7 cells (weakly metastatic) 
correlate with the expression of uMUC1. In this study, we tested the MUC1 
expression of T47D cells (weakly metastatic) compared to ZR-75-1 cells. 
Interestingly, both cell lines highly express MUC1 as revealed by the CD227 antibody 
(Figures 5.8A&E) and exhibited high expression of uMUC1 as revealed by SM3 
labeling and flow cytometry (Figures 5.8C&G). Furthermore, both cell lines showed 
strong homogeneous surface staining of MUC1 (Figures 5.8B&F) and uMUC1 
(Figures 5.8D&H) via confocal microscopy where ZR-75-1 cells showed greater 
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staining for both antibodies, indicating relatively higher MUC1 and uMUC1 
expression over T47D cells. While MCF7 and ZR-75-1 cells differentially expressed 
uMUC1, T47D and ZR-75-1 cells varied only in their expression of the carbohydrate 
binding moieties sLex and sLea.  
 
Cell Rolling Assay 
Lack of sLex expression generally suggests a lack of selectin adhesive interactions 
under flow conditions. However, T47D cells interacted with the E-selectin surface 
(consistent with confocal staining by soluble E-selectin and likely due to sLea) which 
facilitated rolling events, albeit extremely fast cell rolling velocities, > 15 µm/s, and 
lower numbers of interacting cells, < 15 cells/frame, for an E-selectin concentration of 
5 µg/mL (Figures 5.9A&B). Increasing the E-selectin concentration to 10 ug/mL 
significantly decreased the cell rolling velocities to ~5 µm/s and slightly increased the 
number of interacting cells to ~18 cells/frame indicating that cell interactions were 
indeed E-selectin dependent. Furthermore, perfusing cells with uMUC1 blocked with 
SM3 through microtubes with 5 µg/mL E-selectin concentration resulted in no 
significant change in cell rolling velocities or number of interacting cells, suggesting 
that the E-selectin binding moiety responsible for these weak interactions was most 
likely not presented by MUC1. Thus, the hypothesized correspondence between 
uMUC1 expression and metastatic potential must be amended to include the 
expression of sLex, since T47D cells (weakly metastatic) express uMUC1 but not 
sLex.   
ZR-75-1 cells, on the other hand, showed greater interactions with the E-
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selectin coated microtubes yielding slower cell rolling velocities of ~3 µm/s and 
greater numbers of interacting cells, nearly 39 cells/frame, for the 5µg/mL 
concentration of E-selectin (Figures 5.9A&B), consistent with the evident expression 
of sLex on the cell surface. Doubling the E-selectin concentration statistically 
decreased the cell rolling velocities to ~2 µm/s while only slightly increasing the 
number of interacting cells to around 40 cells/frame. SM3 blocking of ZR-75-1 cells 
nearly doubled the cell rolling velocity and dramatically decreased the number of 
interacting cells to about 6 cells/frame. This demonstrates the interruption of the E-
selectin:uMUC1 interaction as first described in previous work.84 Inhibiting sLex 
moieties from the cell surface via neuraminidase treatment significantly increased cell 
rolling velocities to > 7 µm/s and decreased the number of interacting cells to ~13 
cells/frame, further demonstrating the importance of the sLex binding moiety. Finally, 
knocking down MUC1 via siRNA transfection yielded an effect similar to SM3 
blocking where cell rolling velocities significantly increased to 4.3 µm/s and the 
number of interacting cells decreased to ~13 cells/frame. After siRNA treatment, as 
indicated in Figures 5.2.3C and 5.2.3D, both mRNA and protein levels of MUC1 were 
reduced by at least 50% compared to the control ZR-75-1 cells.  
Interestingly, perfusing ZR-75-1 cells through P-selectin coated microtubes 
produced around 25 interacting cells/frame (Figure 5.9A), however, no cells were 
found rolling or firmly adhered to the surface (Figure 5.9B). This interaction was 
abolished after siRNA knockdown of uMUC1. Therefore, the uMUC1:P-selectin 
interaction facilitated tethering events where cells experienced momentary arrest to the 
surface followed by rapid release of the cells into the flow buffer. Furthermore, 
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perfusing ZR-75-1 cells through combined E- and P-selectin coated microtubes 
resulted in around 50 interacting cells/frame, significantly more than E-selectin only 
surfaces (Figure 5.9A), where cell rolling velocities increased nearly double compared 
to E-selectin-only surfaces (Figure 5.9B). This further indicates the specific role of P-
selectin for cell tethering rather than cell rolling. Perfusing cells through L-selectin 
coated microtubes did not produce any interacting cells indicating that the uMUC1:L-
selectin interaction is too weak to influence cell motion. 
 
Molecular Dynamic Simulations 
To further explore the differential interactions between the uMUC1 glycoprotein and 
each selectin, MD simulations were used to dock several O-glycosylated variants of 
uMUC1 to E-, P-, and L-selectin. Figure 4 shows E-selectin:uMUC1 complexes where 
the S9 (Figures 5.10A&B), T10 (Figures 5.10C&D), and T18 (Figures 5.10E&F) 
amino acid sites of the uMUC1 core epitope were O-glycosylated with a sLex moeity.  
Sites T3 and S19 sites were not tested because these sites should not be in a 
glycosylated form as suggested by SM3 binding.60 Each variant of uMUC1 binding 
indicated a different degree of residue contact. In the majority of cases, residues R108 
and K112 experienced hydrogen bonding interactions, where both residues interacted 
with the core epitope of uMUC1 exclusively and not sLex. On the other hand, residue 
R97 only interacted with the sLex forming hydrogen bonds in Figures 5.10A, D, and 
E. In a single case (Figure 5.10E, site T18) all three residues formed contacts and 
since the PSGL-1 glycoprotein is considered a P-selectin specific ligand due to 
enhanced interactions facilitated by the R85 and H114 residues of P-selectin,241 these 
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MD results suggest that the uMUC1 glycoprotein can be regarded as an E-selectin 
specific ligand. 
Figure 5.11 depicts the uMUC1 interactions with P-selectin (top) and L-
selectin (bottom), where one of each S9 (Figure 5.2.5A&B), T10 (Figures 5.11C&D), 
and T18 (Figures5.11E&F) glycosylated site is shown for clarity. In the case of P-
selectin, residues R85, H108, and K112 formed hydrogen bonding contacts to the 
uMUC1 core epitope. For L-selectin, only residues R97 and K111 formed contacts 
where both residues contacted sLex and not the uMUC1 core epitope. Again, 
glycosylating the T18 site of uMUC1 yielded the most interactions for both P-selectin 
and L-selectin (Figures 5.11E&F, respectively). In comparison with E-selectin, P-
selectin lacked residue R97 to form contacts with sLex whereas L-selectin lacked 
residues R108 and K112 to form contacts with the uMUC1 core epitope. Thus, to 
qualitatively interpret the experimental rolling assays, E-selectin facilitates cell rolling 
due to its ability to contact both the uMUC1 core epitope and sLex. P-selectin 
effectively tethers cells due to its ability to contact the uMUC1 core epitope but was 
unable to produce cell rolling possibly because of insufficient binding with sLex. 
Lastly, L-selectin initiated no interacting cells due to its inability to interact 
specifically with uMUC1. These data suggest that uMUC1 can be considered both E- 
and P-selectin specific ligands where each selectin facilitates different roles in the 
metastatic adhesion cascade, whereas L-selectin most likely plays no part in functional 
uMUC1 binding. 
  
Capturing Breast Cancer Cells Using uMUC1 mAb 
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Applying these insights into the selective adhesion of the uMUC1 glycoprotein, a 
combined E-selectin and SM3 surface was prepared to capture cancer cells.  It was 
found that SM3 bound minimally to PMNs (Figure 5.12A) via flow cytometry, with 
the mean fluorescence intensity index significantly lower compared to ZR-75-1 cells 
(Figure 5.12B). Perfusing ZR-75-1 cells through a microtube coated with only E-
selectin resulted in nearly 50 rolling cells/frame (Figure 5.12C) with no adherent cells 
on the surface. Coating the microtube surface with both E-selectin and SM3 did not 
change the number of rolling cells, but allowed for firm adhesion events facilitated by 
uMUC1:SM3 interactions where subsequent perfusion of buffer resulted in over an 
average of 17 captured cells per frame. The ratio of firm adhesion events to total 
number of cells found on the protein coated surface was comparable to the ratio for the 
E-selectin/ICAM-1 combined surface as studied previously.84 Perfusing isolated 
PMNs over the same E-selectin/SM3 combined surface resulted in over 50 rolling 
events per frame with no adherent cells. Furthermore, since ICAM-1 also facilitates 
firm adhesion events with leukocytes, the E-selectin/SM3 combined surface may 
provide a more selective method to separate CTCs from whole blood.  
Processing normal buffy coat spiked with Cell Tracker labeled ZR-75-1 cells 
through microtubes coated with E-selectin only or E-selectin with SM3 antibody 
resulted in capture efficiencies of 0.4% and 26.7%, respectively (Figure 5.12D). Here, 
‘captured’ cells refers to the number of firmly adherent cells. Cells that were 
effectively captured by this combined surface strategy must express both the sLex 
glycan and the uMUC1 glycoprotein. The sLex glycan facilitates the initial tethering 
and rolling events due to its interactions with surface E-selectin when presented by 
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uMUC1 or other E-selectin ligands such as CD44. Cells that initiate stable cell rolling 
can then form firm adhesion events due to the interaction of uMUC1 and the surface 
SM3. Therefore, uMUC1 and sLex expression is essential for cell capture, whether or 
not the sLex is found on uMUC1. However, our current and previous results indicated 
that sLex terminated uMUC1 is an E-selectin specific ligand that effectively 
contributes to cell rolling. Moreover, of the three cell lines studied here and 
previously, only the highly metastatic ZR-75-1 cells expressed both sLex and uMUC1 
where uMUC1 was found to be decorated with sLex. The capture percentage of non-
cancer cells was not presented in this study due to high variance of blood cell count 
between donor buffy coats. Furthermore, due to the high degree of ZR-75-1 cell 
aggregation, the spiking cell concentration performed in this study was much higher 
than clinical values as well as concentrations used in our previous studies using 
clinically-motivated devices.110, 111 Although at the proof-of-concept stage, the 
combined E-selectin/SM3 surface described in this study shows potential for 
selectively capturing CTCs expressing uMUC1.  
 
5.2.4 CONCLUSIONS 
In previous work, we examined two cell lines (MCF7 and ZR-75-1) that exhibited 
variants of the MUC1 glycoprotein where both cell lines expressed MUC1, however 
only ZR-75-1 expressed the underglycosylated form uMUC1. We had previously 
found that uMUC1 has the ability to interact with E-selectin and ICAM-1 and, for 
these two cell lines, the metastatic potential corresponded with uMUC1 expression 
since ZR-75-1 cells are highly metastatic and MCF7 cells are weakly metastatic.14 
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Here, we further explored the function of uMUC1 during the metastatic adhesion 
cascade by extending the study to the T47D cell line (weakly metastatic). It was found 
by examining various E-selectin ligands that T47D and ZR-75-1 cells differed only in 
their expression of the E-selectin binding moiety sLex where T47D cells lacked this 
expression. Without sufficient sLex, T47D cells showed little interaction with E-
selectin coated microtubes, resulting in extremely fast rolling velocities and low 
numbers of interacting cells. Thus, for these three cell lines, the metastatic potential 
seems to correlate with the expression of uMUC1 as well as sLex.  
       ZR-75-1 cell interactions with E-selectin, however, were highly dependent on 
uMUC1 expression where cell velocities significantly decreased when uMUC1 was 
blocked with either the SM3 antibody or uMUC1 siRNA knockdown. Moreover, 
uMUC1 interactions with P-selectin exclusively facilitated cell tethering events on P-
selectin-only and E- and P-selectin combined surfaces whereas L-selectin surfaces 
produced no cell interactions. Utilizing MD simulations, E-selectin was shown to 
interact with uMUC1 via three distinct residue contacts to both the uMUC1 core 
epitope and sLex. On the other hand, P-selectin possessed three distinct contacts that 
interacted with only the uMUC1 core epitope and L-selectin only interacted with sLex. 
These MD data suggest that specific interactions with both the core epitope and sLex is 
required to produce cell rolling events whereas interactions with just the core epitope 
produce tethering events and interactions with only the carbohydrate unit do not 
produce any cell interactions. 
Based on these observations, we propose a combined surface of E-selectin and 
SM3 to preferentially capture cells exhibiting uMUC1. It was found that the E-
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selectin/SM3 microtubes captured approximately 26% of the number of interacting 
cancer cells.  Since PMNs are not targeted by the SM3 mAb, it is expected that this 
E-selectin/SM3 surface strategy may offer a novel and viable method to selectively 
isolate cancer cells from whole blood. 
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Figure 5.7: Ligand expression and E-selectin binding capability of T47D and ZR-75-1 
cells. Flow cytometry histogram plots of T47D (in red) and ZR-75-1 (in blue) cells 
labeled with anti-CD44 mAb (A and E), anti-sLea mAb (B and F), and anti-sLex (clone 
CSLEX, C and G), respectively. Isotype controls are represented by solid gray peaks 
in each plot. D and H: Confocal microscopy images of T47D and ZR-75-1 cells 
labeled with pre-conjugated recombinant human E-selectin/Fc (shown in green) and 
DAPI nucleic acid stain (shown in blue), respectively. Scale bar: 50 µm  
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Figure 5.7: Ligand expression and E-selectin binding characterization of T47D 
and ZR-75-1 cells 
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Figure 5.8: MUC1 expression of T47D and ZR-75-1 cells. Flow cytometry histogram 
plots of T47D (in red) and ZR-75-1 (in blue) cells labeled with anti-MUC1 (CD227) 
mAb (clone HPMV, A and E) and anti-uMUC1 mAb (clone SM3, C and G). B and F: 
Confocal microscopy images of T47D and ZR-75-1 cells labeled with anti-CD227 
mAb (green) and DAPI nucleic acid stain (blue), respectively. D and H: Confocal 
microscopy images of T47D and ZR-75-1 cells labeled with anti-uMUC1 mAb, 
respectively. I and J: Co-staining of CD227 mAb (green) and sLex (red) on ZR-75-1 
cells. Scale bar: 50 µm 
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Figure 5.8: MUC1 expression of T47D and ZR-75-1 cells 
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Figure 5.9: Adhesion profile of T47D and ZR-75-1 cells on E-, P-, and L-selectin 
coated surfaces. Adhesion phenotype of T47D (in red) and ZR-75-1 (in blue) cells 
represented by their rolling velocity on E-selectin coated surface (A) and average 
number of cells observed on the surface (B). E-sel, P-sel, and L-sel indicate the 
surface proteins E-selectin, P-selectin, and L-selectin, respectively. Numbers 
following the surface protein abbreviations denote the surface protein concentration in 
µg/mL, for example ‘E-sel5’ signifies the surface protein E-selectin at a concentration 
of 5 µg/mL was utilized. Combined surfaces utilizing both E- and P-selectin were 
utilized with constant E-selectin concentrations (5 µg/mL) and varying P-selectin 
concentrations (10 and 25 µg/mL) and are denoted as ‘E-sel5 P-sel10’ and ‘E-sel5 P-
sel25’, respectively. Text in parentheses following the surface protein indicators 
denote specific treatments of either ZR-75-1 or T47D cells where (SM3 Blocked) and 
(Neuraminidase) indicates that cells were incubated with either anti-SM3 neutralizing 
antibody or neuraminidase, respectively. (siRNA) indicates that cells were transfected 
with MUC1 siRNA. Lack of parentheses indicates that no treatments were performed. 
Student’s t test was performed for all results compared to E-sel5 within each cell line. 
Combined surfaces E-sel5 P-sel10 and E-sel5 P-sel25 for the ZR-75-1 cell line were 
also paired. All significances are p<0.001, unless otherwise indicated by ** (p<0.01), 
* (p<0.05), or NS (not significant). C: Quantification of MUC1 mRNA level 
knockdown efficiency via qPCR. D: Quantification of cell surface MUC1 protein level 
knockdown efficiency via flow cytometry (mean fluorescence intensity index was 
plotted).  
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Figure 5.9: Adhesion profiles of T47D and ZR-75-1 cells on E-, P-, and L-selectin 
coated surfaces 
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Figure 5.10: Equilibrated uMUC1 (magenta) and sLex (orange) structures bound to E-
selectin (green). With respect to the uMUC1 sequence, 
PDTRPAPGSTAPPAHGVTSA, the top and bottom rows correspond with the 
‘reverse’ and ‘forward’ sequence, respectively. uMUC1 residues S9 (A and B), T10 (C 
and D), and T18 (E and F) are glycosylated as indicated by the uMUC1 sequence and 
the orange arrow. The atoms of select E-selectin amino acids (R97, R108, and K112) 
are depicted to show varying degrees of contacting residues.  
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Figure 5.10: Equilibrated uMUC1 and sialyl lewis x structures bound to E-
selectin 
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Figure 5.11: Equilibrated uMUC1 (magenta) and sLex (orange) structures bound to P-
selectin (gray, top row) and L-selectin (blue, bottom row). With respect to the uMUC1 
sequence, PDTRPAPGSTAPPAHGVTSA, all interactions correspond with the 
‘reverse’ sequence. uMUC1 residues S9 (A and B), T10 (C and D), and T18 (E and F) 
are glycosylated as indicated by the uMUC1 sequence and the orange arrow. The 
atoms of select P-selectin amino acids (R85, H108, and K112) and L-selectin amino 
acids (R97 and K111) are depicted to show varying degrees of contacting residues.  
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Figure 5.11: Equilibrated uMUC1 and sialyl lewis x structures bound to P-
selectin and L-selectin 
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Figure 5.12: Capture efficiency of uMUC1 expressing cells in normal buffy coat. A: 
Flow cytometry histogram plot of isolated polymorphonuclear neutrophils (PMNs) 
labeled with anti-uMUC1 mAb (clone SM3, in blue) and isotype control (in grey). B: 
Mean fluorescence intensity quantification of uMUC1 expression of ZR-75-1 cells (in 
black) and PMNs (in grey). C: Average total number of ZR-75-1 cells (left and middle 
bar sets) and PMNs (right bar set) observed on surfaces coated with E-selectin at a 
concentration of 5 µg/mL (E-sel5) and the combination of E-selectin and SM3 at 
concentrations of 5 and 50 µg/mL, respectively (E-sel5 SM3 50). Columns in gray 
indicate the average number of cells (either ZR-75-1 or PMNs) while perfusing with 
cell solution and columns in white indicate the average number cells quantified after 
washing the surfaces with flow buffer for 5 min. Student’s t test was performed for 
both comparisons. *** p<0.001 ** p<0.01 * p<0.05 NS: not significant. D: Numbers 
of captured ZR-75-1 cells from cancer cell spiked buffy coat on surfaces coated with 
E-selectin (5.0 µg/mL) and the combination of E-selectin (5.0 µg/mL) and SM3 (50 
µg/mL). Two separate experiments were performed with 100,000 cells (24,176 
captured) and 50,000 cells (14,587 captured), resulting in 24.2% and 29.1% yield, 
respectively.  
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Figure 5.12: Capture efficiency of uMUC1 expressing cells in normal buffy coat 
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CHAPTER 6 CONCLUDING REMARKS 
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6.1 INTRODUCTION 
Hydrodynamic shear force plays an important role in the leukocyte adhesion cascade 
that involves the tethering and rolling of cells along the endothelial layer, their firm 
adhesion or arrest, and their extravasation or escape from the circulatory system by 
inducing passive deformation, or cell flattening, and microvilli stretching, as well as 
regulating the expression, distribution, and conformation of adhesion molecules on 
leukocytes and the endothelial layer. 
Similarly, the dissemination of CTCs from the primary tumor sites is believed 
to involve tethering, rolling, and firm adhesion steps before their eventual 
extravasation which leads to secondary tumor sites (metastasis). Of particular 
importance to both the leukocyte adhesion cascade and the extravasation of CTCs, 
glycoproteins are involved in all three steps (capture, rolling, and firm adhesion) and 
consist of a variety of important selectin ligands. Moreover, these selectin ligands are 
differentially expressed by varying cancer cell types where the specific ligand 
expression (well-established, novel, or non-existent) and their ability to interact with 
E-selectin can determine the mechanistic pathway for CTC adhesion to the inflamed 
endothelium. 
 
6.2 DICUSSION  
The colon cancer cell line COLO 205, interestingly grows simultaneously in both 
adherent and suspended states in culture, consistently reaching an equilibrium 7:3 
(adherent:suspended) ratio. The adherent state demonstrates cell-cell interactions in 
small aggregates whereas the suspended state consists mostly of single cells. Loss of 
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epithelial markers such as junctional- and cell-cell adhesion proteins is an important 
characteristic in the EMT, a critical step necessary for metastasis. Manipulation of the 
EMT markers β-catenin and E-cadherin expression, either by siRNA knockdown of β-
catenin or incubation with E-cadherin antibody-coated microbeads, shifts the 
equilibrium ratio to 9:1. Interestingly, human plasma supplemented media shifts the 
equilibrium ratio in the opposite direction to 1:9, favoring the suspended state. In the 
context of metastasis, the suspended COLO 205 population represents a more invasive 
phenotype. Suspended cells expressed 60% more sLex and 80% more sLea than 
adherent cells which resulted in significantly slower rolling velocities on E-selectin 
coated microtubes. Moreover when cells were cultured in human plasma, the 
expression of phosphorylated β-catenin increased, shifting the majority of cells into 
the suspended population where sLex and E-selectin ligand CD44 expression both 
increased as well. The dynamic COLO 205 population switch presents unique 
differences in the phenotype of their subpopulations and could serve as a good model 
for studying cell heterogeneity and the EMT process in vitro. 
Furthermore, E-selectin mediated cell sorting of COLO 205 and MDA-MB-
231 cell lines on functionalized microbubble and PDMS surfaces was achieved due to 
the differential E-selectin adhesion of COLO 205 and MDA-MB-231 cells. The 
toxicity of the anti-cancer drug, doxorubicin, on COLO 205 cells in spheroids was 
tested and compared to cells in 2D culture. COLO 205 spheroids cultured in flow 
showed a threefold increase in resistance to doxorubicin compared to COLO 205 
monolayer cells cultured under static conditions, consistent with the resistance 
observed previously in other MCTS models. The advantages presented by our 
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microfluidic system, such as the ability to control the size uniformity of the spheroids 
and to perform real-time imaging on cells in the growth platform, show potential for 
high throughput drug screening development. 
Despite their high metastatic potential, human breast carcinoma cells MDA-
MB-231 lack interactions with E-selectin functionalized surfaces under physiological 
shear stresses. Interestingly, the pro-inflammatory cytokines IL-6 and TNF-a, which 
play an important role in potentiating the inflammatory cascade, are significantly 
elevated in metastatic breast cancer (BCa) patients. We hypothesized that human 
plasma, 3-D tumor spheroid culture, and cytokine-supplemented culture media could 
induce a phenotypic switch that allows BCa cells to interact with E-selectin coated 
surfaces under physiological flow. Flow cytometry, immunofluorescence imaging, and 
flow-based cell adhesion assay were utilized to investigate the phenotypic changes of 
MDA-MB-231 cells with various treatments. Our results indicated that plasma, IL-6, 
and TNF-a promote breast cancer cell growth as aggregates and induced adhesive 
recruitment of BCa cells on E-selectin coated surfaces under flow. 3-D tumor spheroid 
culture exhibited the most significant increases in the interactions between BCa and E-
selectin coated surfaces by upregulating CD44V4 and sLex expression. Furthermore, 
we showed that IL-6 and TNF-α concentrations in blood may regulate the recruitment 
of BCa cells to the inflamed endothelium. Finally, we proposed a mechanism that 
could explain the invasiveness of ‘triple-negative’ breast cancer cell line MDA-MB-
231 via a positive feedback loop of IL-6 secretion and maintenance. Taken together, 
our results suggest that therapeutic approaches targeting cytokine receptors and 
adhesion molecules on cancer cells may potentially reduce metastatic load and 
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improve current cancer treatments. 
Retinoblastoma (RB) is a rare retinal cancer of childhood. RB survivors tend to 
develop additional tumors later in life, although the physical mechanisms of RB 
metastatic spread are largely unknown. Yet, human RB cell lines RB143 and WERI-
Rb27 do not express selectin ligands or beta-2 integrins and cannot directly interact 
with inflamed endothelium. In this study, we showed that RB cells express ICAM-1, a 
beta-2 integrin ligand that correlates with metastasis and was preferentially co-
expressed on RB cells that also express ABCG2, a stem cell marker associated with 
chemoresistance and metastasis. Based on the presence of ICAM-1+ RB cells, we 
tested the hypothesis that RB cells could be recruited to an E-selectin surface via 
attachment to activated PMNs. We characterized the dynamic adhesion between RB 
cells and PMNs within E-selectin coated microtubes under a physiological range of 
wall shear stress values (0.2–5 dyn/cm2). We showed that activated PMNs were 
necessary for the recruitment of RB cells through ICAM-1:LFA-1 binding. Results 
from this work may lead to new strategies that target the metastatic spread of tumor 
cells via CTC:leukocyte aggregation. 
Lastly, the aberrantly underglycosylated mucin MUC1 has been shown to both 
abundantly express selectin binding moieties (sialyl Lewis x and a) and to consistently 
expose its core epitope. Flow cytometry was initially used to determine MUC1 
expression on ZR-75-1 and MCF7 cells, while immunofluorescence microscopy was 
used to confirm the aberrant form of MUC1 and MUC1:ICAM-1 interactions. Each 
cell line was then perfused through combined E-selectin and ICAM-1 coated 
microtubes, as a model of the microvascular endothelium. ZR-75-1 and MCF7 were 
  199 
found to express abundant and low levels of underglycosylated MUC1, respectively. 
The rolling/adhesion profiles showed that ZR-75-1 cells, when compared to MCF7 
cells, interacted with E-selectin more efficiently resulting in sufficiently slow rolling 
velocities to form MUC1:ICAM-1 interactions thereby facilitating firm adhesion. 
Interestingly, the observed differential adhesion was consistent with the relative 
metastatic potential of the ZR-75-1 (highly metastatic) and MCF7 (weakly metastatic) 
cell lines. 
To further characterize the novel E-selectin ligand, uMUC1, the T47D cell line 
was subsequently verified to highly express uMUC1 utilizing flow cytometry and 
confocal microscopy. However it was found that only ZR-75-1 cells expressed the E-
selectin binding moiety sLex. Furthermore, perfusing T47D cells through E-selectin 
coated microtubes resulted in fast rolling velocities and low numbers of interacting 
cells and that blocking uMUC1 with the SM3 antibody had no effect. ZR-75-1 cells, 
on the other hand, were highly dependent on the E-selectin:uMUC1 interaction as 
exemplified by significant increases in cell rolling velocities and decreases in the 
number of interacting cells when blocking with SM3 or when uMUC1 expression was 
knocked down via siRNA transfection. Whereas uMUC1 interactions with E-selectin 
supported cell rolling, P-selectin: uMUC1 interactions exclusively facilitated cell 
tethering, while L-selectin surfaces supported no cell adhesive interactions. These 
experimental observations were consistent with molecular dynamics simulations of 
uMUC1 bound to E-, P-, and L-selectin where the degree of residue contact correlated 
with the differential adhesion of uMUC1 to each selectin. Finally, an E-selectin and 
SM3 combined surface coating captured approximately 30% of the total number of 
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interacting cancer cells comparable to the number of adhered cells when utilizing E-
selectin and ICAM-1 combined surfaces. The E-selectin/SM3 surface strategy may 
offer a viable method to selectively capture cancer cells from whole blood samples. 
 
6.3 FUTURE WORK 
To extend the studies discussed in this thesis, relevant animal models can be designed 
to validate the in vitro cell line based results. For the retinoblastoma study, ICAM-1 
siRNA transfected and control RB143 cells can be injected into NOD-SCID mice and 
monitored for tumor development. It was hypothesized that ICAM-1:LFA-1 facilitated 
the aggregate formation between RB cells and circulating leukocytes, allowing RB 
cells to follow the metastatic cascade through the blood stream. ICAM-1 siRNA 
transfected RB143 cells are expected to show significantly less metastatic lesions 
compared to control RB cells due to the lack of the RB:leukocyte aggregation. 
Similarly, 3D tumor spheroid grown and monolayer grown MDA-MB-231, adherent 
and suspended COLO 205 cells, and MUC1 siRNA transfected and control ZR-75-1 
cells can be evaluated for their metastatic potentials using animal models.  
 
Utilizing the selectin-based cell capturing devices may have applications 
besides CTC isolation. Circulating fetal cells in maternal blood during pregnancy were 
first observed by Schomorl in 1893. Reliable prenatal diagnosis of fetal aneuploidy 
and single gene disorders currently involves invasive procedures such as chorionic 
villus sampling (CVS) and amniocentesis. These invasive tests are each associated 
with a low, but finite risk of one fetal loss in every 100 to 175 sampling procedures. 
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The detection of fetal cells and fetal DNA circulating in maternal blood has 
encouraged the development of noninvasive prenatal screening and diagnosis. Current 
technologies focusing on fetal cells isolation include cell size and density, optical, 
magnetic, adhesion, and electrical based separation techniques. Many of these 
techniques destroy fetal cells as part of the isolation process which does not allow in 
vitro expansion of the isolated fetal cells for future characterization. Moreover, theses 
technologies fail to provide sufficient enrichment of the circulating fetal cells needed 
to proceed further with genetic testing. A novel generation of Non-Invasive Prenatal 
Testing based on the sequencing of free fetal DNA, is emerging to overcome fetal cell 
isolation pitfalls. However, these techniques are costly and limited to screening 
purposes.  
 Utilizing flow cytometry and confocal microscopy, fetal cell lines labeled with 
trophoblast markers EpCAM (TROP-1) and HLA-G indicated that while JAR 
expressed abundant EpCAM (Figure 6.1A and B) and moderate HLA-G, HTR-
8/Svneo showed minimal expression of both markers. Interestingly, both cell lines 
were found to express sLex, an essential glycan decorating common E-selectin ligands. 
JAR cells were found to roll stably on E-selectin coated surfaces at 4.36 ± 0.38 µm/s 
under 1 dyn/cm2 shear stress. Significant capture of JAR cells was observed when 
spiked into normal buffy coat (Figure 6.1C). EpCAM-positive cells were found in 
maternal buffy coat (Figure 6.1D) and FISH analysis was performed for chromosome 
Y detection. These results show the effectiveness of a microfluidic device coated with 
halloysite nanotubes and functionalized with E-selectin and anti-EpCAM antibody to 
capture viable trophoblast cell lines JAR and HTR-8/SVneo and EpCAM-positive 
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fetal cells from maternal blood. This biomimetic approach allows a smooth capture of 
circulating fetal cells which indicates great potential as a novel non-invasive prenatal 
screening/diagnosis platform to replace CVS and amniocentesis and offers a much 
greater breadth of application for selectin-based cell capturing devices. 
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Figure 6.1: Characterization of trophoblast cell line JAR and isolation of EpCAM-
positive fetal cells. (A) JAR cells highly express EpCAM (Yellow:isotype; Green: 
sample). (B) JAR cells labeled with anti-EpCAM mAb. (C) Fluorescently labeled JAR 
cells in normal buffy coat captured on the functionalized surface. (D) EpCAM-
positive fetal cell isolated from maternal blood.  
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Figure 6.1: Characterization of trophoblast cell line JAR and isolation of 
EpCAM-positive fetal cells 
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